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Abstract 
Diabetes occurs when the pancreas does not secrete sufficient insulin or 
when cells become resistant to insulin regardless of the quantity of 
produced. Diabetes in Saudi Arabia is reported to have reached epidemic 
proportions. This ever-increasing incidence has been blamed on low levels 
of physical activity and high levels of obesity. 
The effects of Nigella seeds and Ajwa dates on blood glucose levels in 
patients with type 2 diabetes and the possible beneficial effects on the 
complications associated with type 2 diabetes were investigated. 
This study used a randomised clinical intervention trial. 75 Saudi adults, 
with type 2 diabetes, aged between 18 and 60, were divided into 3 groups. 
Groups were assigned the following diets; Group D-NS - the modified diet 
supplemented with 2g of Nigella sativa seeds daily; Group D-AJ - the 
modified diet supplemented with 1 Ajwa date daily; Group D-D the modified 
diet without supplements. The study period was 12 weeks. Anthropometric 
measurements and blood samples for the determination of HbA1c, fasting 
blood sugar were taken at the beginning and end of the study. A similar 
group of 75 healthy volunteers was recruited in the UK for comparative 
studies. 
There was a significant decrease in the levels of FBG (P <.001), 2PPBG 
(P <.001), and an improvement in some markers of glycaemia plus better 
control of BGL and HbA1c in Group D-NS compared to the levels in Groups 
D-AJ and D-D. Thus following a modified diet supplemented with Nigella 
seeds may have a role in controlling the outcomes for type 2 diabetes 
patients. Large scale clinical trials to determine the optimum dose and 
duration of Nigella seed diet treatments are now needed.  
The modified diet supplemented with Ajwa dates apparently had no 
advantages. Further investigations in relation to the quantity and frequency 
of use of Ajwa dates as a dietary supplement are essential before any 
conclusions can be drawn as to their effectiveness.  
 
 
II 
 
Declaration 
I declare that this thesis is all my own work and has not been copied from any 
other sources, or accepted for any other degree in any University. To the best 
of my knowledge this thesis contains no material written or distributed 
previously by any other parties, apart from where I have otherwise stated.  
Reham Algheshairy 
  
 
 
III 
 
Acknowledgment 
First of all, countless thanks to Almighty Allah Subhana-hu-Wataala who 
blessed me with enough courage to accept this challenge, enough power to 
bear the pressure of this project, and enough wisdom to manage the work. 
I also highly acknowledge the role of the Ministry of Higher Education of Saudi 
for providing financial assistance in the form of ''PhD Scholarship” for my 
study. 
I would like to thank my supervision team (Dr. Haruna Musa, Dr. Rebecca 
Gregg) for their continuous support and encouragement in helping me to finish 
my research. Their guidance helped me throughout this research project and 
through the process of writing this thesis. A special thanks to Professor 
Christopher Smith, my PhD Supervisor, to whom I am grateful to from the 
bottom of my heart for his support and his continuous motivation. 
I express my deep sense of gratitude to Dr. Khaled Tayeb, Consultant of 
Endocrine and Dialectology, Head of the Diabetes Centre at Al-Noor Specialist 
Hospital in Makkah.  I am extremely grateful and indebted to him for his expert 
and valuable guidance. My sincere thanks also goes to Miss. Ghadah Tayeb, 
the diabetic dietician at Al-Noor Specialist Hospital in Makkah, who provided 
me an opportunity to join her team, and who gave me access to the patient’s 
files. I am really grateful to all the volunteers who participated in the study and 
made this research possible by providing their blood. 
I pay a very warm gratitude to my husband (Jalal Maqbool) and to my 
daughters (Rateel and Taliah) who always believed in me and for their support 
and encouragement during my PhD journey. 
Last but not the least, I would like to thank my family: my Father (Mohammad 
Algheshairy), my mother (Fathia Shazli), my sisters (Rehab, Nofe and Renad) 
and brothers (Ahmed and Abdulallah), my nephew Khaled, my aunties and my 
cousins for their prayers and best wishes to me.  I would like to thank all the 
wonderful friends I have met during the last 5 years. I have really enjoyed my 
time with them. Special thanks to Alaa Qadi and Wedad Azhar, PhD students 
at MMU for their help during my research. 
Reham Algheshairy  
 
 
IV 
 
 
Conference presentations  
Reham Algheshairy, Rebecca Gregg, Christopher Smith, Weili Li (2015). The 
control of type 2 diabetes with specific references to dietary factors. The 8th 
Saudi Student Conference Organised by Ministry of Higher Education KSA in 
London (29 to 31 January 2015). 
Reham Algheshairy, Rebecca Gregg , Christopher Smith, Weili Li (2015) The 
control of type 2 diabetes with specific references to dietary factors. The 
international Conference on Diabetes metabolism with Oral and technical 
presentation at world academy of Science engineering and technology, 
London, (16 to 17 February 2015) 
Reham Algheshairy, Khaled Tayeb, Christopher Smith, Rebecca Gregg, 
Haruna Musa (2016). Effect of Nigella sativa seeds and Ajwa date on Blood 
glucose level in Saudi patients with Type 2 Diabetes Mellitus.The 18th 
International Conference on Food Science, Nutrition and Dietetics, London, 
(24- 25 November 2016). 
  
 
 
V 
 
List of Abbreviation  
AP Arterial pressure 
BHF British Heart Foundation 
BGL  Blood Glucose Level 
BMI Body mass index 
BNF British Nutrition Foundation 
BP Blood pressure 
CHOs Carbohydrates 
CI Confidence intervals 
CVD Cardiovascular disease  
DASH Dietary Approaches to Stop 
Hypertension 
DBP Diastolic blood pressure 
DM Diabetes Mellitus (DM) 
DRVs Dietary Reference Values 
FBG Fasting blood Glucose  
FDA Food and Drug Administration  
GI Glycaemic Index 
HbA1c Glycated haemoglobin 
HDL High density lipoprotein 
IDF Insoluble Dietary Fibre 
IDF The International Diabetes 
Federation 
IDDM Insulin Dependent Diabetes Mellitus 
KSA The Kingdom of Saudi Arabia 
LDL Low density lipoprotein 
M Mean  
mg/dl 
 
Milligram/decilitre 
mmol/L Millimole 
 
 
VI 
 
NICE The National Institute for Clinical 
Excellence 
NIDDM Non-insulin Dependent Diabetes 
Mellitus 
NO  Nitric oxide 
NsO Nigella sativa oil  
Ns Nigella sativa seeds  
PA Physical activity 
PDE Phoenix Dactylifera Extract 
RCT Randomized control trial 
SA Saudi Arabia  
SBP Systolic blood pressure 
SDF Soluble Dietary Fibre 
SMBG Self-monitoring blood glucose level 
SMOH The Saudi Ministry of Health 
SD Standard deviation 
SPSS Statistical Package for the Social 
Science 
TG Triglycerides 
TC Total cholesterol 
T2DM Type 2 Diabetes Mellitus 
TAC Total antioxidant capacity 
WHO The World Health Organization 
2hPP Two hour postprandial  
 
  
 
 
VII 
 
List of Figures  
FIGURE 2.1. INCIDENCE OF DIABETES IN THE KSA 2000 – 2016 ................................................. 13 
FIGURE 2.2. GDP(GROSS DOMESTIC PRODUCT) FOR THE KINGDOM OF SAUDI ARABIA ............... 13 
FIGURE 2.3. THE POPULATION PREVALENCE OF DIABETES .......................................................... 14 
FIGURE 2.4. THE INFLUENCE OF FOOD THAT IMPACT THE GI ON THE BLOOD GLUCOSE LEVEL ........ 21 
FIGURE 2.5. NIGELLA SATIVA SEEDS AND PLANT FLOWER ............................................................ 27 
FIGURE 2.6. BIOACTIVE COMPOUND THYMOQUINONE (TQ) FROM NIGELLA SATIVA EXTRACT. ........ 29 
FIGURE  2.7. NUTRITIONAL FACTS FOR NIGELLA SATIVA SEEDS ................................................... 29 
FIGURE 2.8. DATES STAGES ...................................................................................................... 46 
FIGURE 2.9. DATE GROWING STAGE  ......................................................................................... 46 
FIGURE 2.10. THE CHEMICAL COMPOSITION OF AJWA DATES ...................................................... 50 
FIGURE  3.1. STUDY DESIGN AND PROGRESSION FLOW CHART FOR DIABETIC GROUP ................... 57 
FIGURE 3.2. STUDY DESIGN AND PROGRESSION FLOW CHART FOR HEALTHY (NON-DIABETIC) GROUP
 ....................................................................................................................................... 62 
FIGURE 3.3. THE DIABETES FOOD PYRAMID .............................................................................. 68 
FIGURE 3.4. A FLOW CHART DEMONSTRATING THE PROCESS FOLLOWED WHEN MEASURING OUT THE 
NIGELLA SATIVA SEED DOSES ............................................................................................ 71 
FIGURE 3.5. A FLOW CHART SHOWING THE PROCESS FOR AJWA DATES ....................................... 73 
FIGURE 3.6. THE BLOOD GLUCOSE CONCENTRATION IN TYPE 2 DIABETES AND NORMAL PEOPLE 
OVER TIME........................................................................................................................ 74 
FIGURE 3.7. DCA VANTAGE ANALYZERTM. ................................................................................. 77 
FIGURE 4.1. BODY MASS INDEX BMI OF THE DIABETIC PARTICIPANTS ......................................... 91 
FIGURE 4.2. BMI (OBESITY LEVEL) OF THE DIABETIC PARTICIPANTS ............................................. 91 
Figure 4.3. The correlation coefficient for BMI after treatment of dietary factors (Nigella 
sativa, Ajwa dates and modified diet group) of the diabetic participants and 
SBP…………………………………………………………………………………………………..92
Figure 4.4.The correlation coefficient for BMI after (12 weeks) treatment of dietary factors 
(Nigella sativa, Ajwa dates and modified diet) of the participants and 
DBP…………………………………………………………………………………………………..93   
FIGURE 4.5. MEASURING SELF-MONITORING BLOOD GLUCOSE (SMBG) ..................................... 94 
FIGURE 4.6. DISTRIBUTION OF HBA1C IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES ......................................................................................................................... 95 
FIGURE 4.7. DISTRIBUTION OF HBA1C IN SHORT-DURATION AND LONG-DURATION SUB-GROUP FOR 
DIABETIC PATIENTS WHO HAD AJWA DATE .......................................................................... 96 
FIGURE 4.8. DISTRIBUTION OF HBA1C IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (NIGELLA SATIVA SEEDS) ................................................................................... 97 
FIGURE 4.9. DISTRIBUTION OF HBA1C IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (MODIFIED DIET) ................................................................................................ 97 
FIGURE 4.10. DISTRIBUTION OF FBG IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (AJWA DATES GROUP) ....................................................................................... 98 
 
 
VIII 
 
FIGURE 4.11. DISTRIBUTION OF FBG IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (AJWA DATES GROUP) ....................................................................................... 99 
FIGURE 4.12. DISTRIBUTION OF FBG IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (NIGELLA SATIVA SEEDS) ................................................................................. 100 
FIGURE 4.13. DISTRIBUTION OF 2HPP IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (NIGELLA SATIVA SEEDS) ................................................................................. 101 
FIGURE 4.14. DISTRIBUTION OF FBG IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (MODIFIED DIET GROUP) .................................................................................. 102 
FIGURE 4.15. DISTRIBUTION OF 2HPP IN ELDERLY DIABETIC PATIENTS WHO HAD LONG DURATION OF 
DIABETES (MODIFIED DIET GROUP) .................................................................................. 103 
FIGURE 4.16. REPEATED MEASURES OF FBG IN DIABETIC PATIENTS ........................................ 104 
FIGURE 4.17. REPEATED MEASURES OF 2HPP IN DIABETIC PATIENTS ......................................... 106 
FIGURE 4.18. REPEATED MEASURES OF HBA1C IN DIABETIC PATIENTS ...................................... 108 
FIGURE 4.19. REPEATED MEASURES OF SBP IN DIABETIC PATIENTS ......................................... 110 
FIGURE 4.20. REPEATED MEASURES OF DPB IN DIABETIC PATIENTS ......................................... 112 
FIGURE 4.21. BODY MASS INDEX BMI OF THE PARTICIPANTS .................................................... 117 
FIGURE 4.22. BMI (OBESITY LEVEL) OF THE HEALTHY PARTICIPANTS ........................................ 118 
FIGURE 4.23. REPEATED MEASURES OF FBG IN HEALTHY SUBJECTS ........................................ 119 
FIGURE 4.24. REPEATED MEASURES OF 2HPP IN HEALTHY SUBJECTS ........................................ 121 
FIGURE 4.25 COMPARISON OF FBG IN HEALTHY PARTICIPANTS AND DIABETIC PATIENTS ............ 127 
FIGURE 4.26. COMPARISON OF 2HPP IN HEALTHY PARTICIPANTS AND DIABETIC PATIENTS........... 129 
  
  
 
 
IX 
 
List table of Tables  
TABLE 2.1. THE PREVALENCE OF TYPE 2 DIABETES IN SAUDI POPULATION ................................... 12 
TABLE 2.2.STUDIES OF DIABETES IN SAUDI ARABIA .................................................................... 16 
TABLE 2.3. THE GLYCAEMIC INDEX OF FOOD .............................................................................. 22 
TABLE 2.4.THE NUTRITIONAL VALUE OF NIGELLA SEEDS ............................................................. 30 
TABLE 2.5. SUMMARY OF THE STUDIES FOR NIGELLA SATIVA SEEDS ............................................ 39 
TABLE 2.6. THE COMPOSITION FOR AJWA DATES (PHOENIX DACTYLIFERA L) (PER 100 G) ............ 48 
TABLE 2.7. THE AJWA DATE CONTAIN HIGHER POLYPHENOL CONTENT  ........................................ 49 
TABLE 2.8. AMINO ACID CONTENT OF AJWA DATE FLESH (MG/100 G DRY WEIGHT).. ..................... 50 
TABLE 3.1 THE STUDY DESIGN FOR THE CLINICAL TRIAL (SA) ...................................................... 61 
TABLE 3.2. THE DASH DIET PLAN FOR 2000 CALORIES A DAY FOR HEALTH CONDITIONS (HIGH 
BLOOD PRESSURE PATIENTS) ............................................................................................ 66 
TABLE 3.3. MEAN INTAKE FOR THE MODIFIED DIET COMPARED WITH THE GUIDELINE DAILY AMOUNTS 
(GDAS) ........................................................................................................................... 68 
TABLE 3.4. THE SERVING SIZE DAILY FROM THE DIABETES FOOD PYRAMID  .................................. 69 
TABLE 3.5. THE NUTRITIONAL FACTS FOR AJWA DATES (SERVING SIZE 100 GRAMS) ..................... 72 
TABLE 3.6. HBA1C CLASSIFICATION .......................................................................................... 76 
TABLE 3.7. THE CLASSIFICATION OF BLOOD PRESSURE ............................................................... 78 
TABLE 3.8. GROUPS OF PARTICIPANTS ...................................................................................... 82 
TABLE 4.1. CHARACTERISTICS OF DIABETIC PATIENTS ............................................................... 87 
TABLE 4.2. CORRELATIONS BETWEEN CLINICAL MEASURES AND PARTICIPANT CHARACTERISTICS 90 
TABLE 4.3. COMPARISON OF FBG ACROSS TIME AND GROUPS IN DIABETIC PATIENTS ............... 105 
TABLE 4.4. COMPARISON OF 2HPP ACROSS TIME AND GROUPS IN DIABETIC PATIENTS .............. 107 
TABLE 4.5. COMPARISON OF HBA1C ACROSS TIME AND GROUPS IN DIABETIC PATIENTS ........... 109 
TABLE 4.6.  COMPARISON OF SBP ACROSS DURATION AND GROUPS IN DIABETIC PATIENTS ...... 111 
TABLE 4.7.  COMPARISON OF DBP ACROSS DURATION AND GROUPS IN DIABETIC PATIENTS ...... 112 
TABLE 4.8. DEMOGRAPHIC AND CONTEXTUAL CHARACTERISTICS OF HEALTHY PARTICIPANTS ... 115 
TABLE 4.9.  COMPARISON OF FBG ACROSS DURATION AND GROUPS IN HEALTHY SUBJECTS ..... 120 
TABLE 4.10. COMPARISON OF 2HPP ACROSS DURATION AND GROUPS IN HEALTHY PARTICIPANTS
 ..................................................................................................................................... 122 
TABLE 4.11. CHARACTERISTICS OF SIX GROUPS OF PARTICIPANTS .......................................... 124 
TABLE 4.12. COMPARISON OF FBG IN HEALTHY PARTICIPANTS AND DIABETIC PATIENTS ............. 128 
TABLE 4.13. COMPARISON OF FBG IN HEALTHY PARTICIPANTS AND DIABETIC PATIENTS ........... 129 
 
  
 
 
X 
 
Table of Contents 
Abstract ................................................................................................................................ I 
Declaration ......................................................................................................................... II 
Acknowledgment............................................................................................................ III 
Conference presentations ............................................................................................ IV 
List of Abbreviation ......................................................................................................... V 
List of Figures ................................................................................................................. VII 
List table of Tables .......................................................................................................... IX 
Chapter 1 Introduction ................................................................................................... 1 
1.1. Introduction ............................................................................................................... 2 
1.2. Hypothesis: ................................................................................................................. 4 
1.3. The general Aim of the study ............................................................................... 4 
1.4. Contribution to Knowledge .................................................................................. 5 
1.5. Overview of thesis chapter ................................................................................... 6 
Chapter 2 Literature Review ........................................................................................ 8 
2.1. Introduction ............................................................................................................... 9 
2.2. Background of Diabetes Mellitus ....................................................................... 9 
2.3. Prevalence of Diabetes ......................................................................................... 11 
2.4. Type 2 Diabetes in Saudi Arabia ....................................................................... 12 
2.5. Treatment of type 2 Diabetes ............................................................................ 17 
2.6. Risk Factors for type 2 Diabetes ....................................................................... 18 
2.7. Lifestyle modification and Type 2 Diabetes ................................................. 20 
2.7.1. Dietary factors and type 2 Diabetes ............................................................. 20 
2.7.2. Physical activity and Type 2 Diabetes ......................................................... 25 
2.8. Control and Management of Type 2 Diabetes Mellitus ............................. 26 
2.9. Nigella sativa seeds ............................................................................................... 27 
2.9.1. Nigella sativa seeds botanical information ............................................... 27 
2.9.2. Chemical composition and Nutritional value of Nigella sativa Seeds
 .............................................................................................................................................. 28 
2.9.3. The General benefits of Nigella sativa ......................................................... 30 
2.9.4. Effects of Nigella sativa on Diabetes and Blood Glucose ....................... 32 
2.9.5. Nigella sativa seeds on Blood Pressure and Antioxidants ................... 35 
 
 
XI 
 
2.9.6. Effect of Nigella sativa on Cholesterol Levels ........................................... 37 
2.10. Ajwa dates .............................................................................................................. 45 
2.10.1. History of Ajwa dates ...................................................................................... 45 
2.10.2. Chemical composition and Nutritional facts of Ajwa dates .............. 47 
2.10.3. Ajwa dates and antioxidants ........................................................................ 51 
2.10.4 Ajwa dates and Diabetes ................................................................................ 51 
2.10.5 Ajwa dates and blood pressure .................................................................... 52 
Chapter 3 Methodology ................................................................................................ 54 
3.1. Introduction ............................................................................................................. 55 
3.2. Ethical considerations .......................................................................................... 55 
3.3. Determination of sample size and study duration ..................................... 55 
3.3.1. Sample size for main study ....................................................................................... 55 
3.3.2. Study duration .............................................................................................................. 56 
3.4.Trial 1 (Diabetic Type 2 Group) ......................................................................... 57 
3.4.1. Study design and study population ....................................................................... 57 
3.4.2. Recruitment and selection of participants ......................................................... 58 
3.4.3. Inclusion and Exclusion criteria ............................................................................. 60 
3.5. Trial 2 (Healthy Groups) ..................................................................................... 61 
3.5.1. Study Design and study population ....................................................................... 61 
3.5.2.  Recruitment and selection of participants ........................................................ 62 
3.5.3. Inclusion and Exclusion criteria for the healthy group.................................. 64 
3.6. Data collection and processing ......................................................................... 65 
3.6.1. Questionnaire design for trial 1 and 2 ................................................................. 65 
3.6.2. Dietary design for Trial 1 and 2 .............................................................................. 66 
3.6.2.1. Nutritional Analysis for Modified Diet .............................................................. 70 
3.6.3. Nigella sativa seeds preparation ............................................................................ 71 
3.6.4. Ajwa dates preparation ............................................................................................. 71 
3.6.5. Anthropometric measurements for Trial 1 and 2 ............................................ 73 
3.6.6. Blood glucose levels measurements (Trial 1and 2) ........................................ 74 
3.6.6.1 Blood glucose measurements (monitoring systems) ................................... 75 
3.6.7. Glycated Haemoglobin A1c Measurement HbA1c (Trial 1) .......................... 75 
3.6.7.1. The Test Principle for HbA1c ............................................................................... 77 
3.6.8.Blood pressure measurements (Trial 1) .............................................................. 77 
3.6.8.1. Blood pressure mechanism (oscillatory blood pressure monitoring 
principle) .................................................................................................................................... 78 
3.7. Validity and reliability ......................................................................................... 79 
3.8. Compliance with appointments, measuring and diet ............................... 80 
3.9. Statistical analysis ................................................................................................. 82 
Chapter 4 Results ........................................................................................................... 85 
 
 
XII 
 
4.1. Introduction ............................................................................................................. 86 
4.2. Trial 1 (Diabetic Patients) .................................................................................. 86 
4.2.1. Characteristics of Diabetic Patients ...................................................................... 86 
4.2.2. Blood Glucose Profile of Diabetic Patients ............................................. 104 
4.2.2.1. Fasting Blood Glucose (FBG) in Diabetic Patients ..................................... 104 
4.2.2.2. Two Hours Post Prandial Glucose (2hpp) in Diabetic Patients ... 106 
4.2.3. Glycated Haemoglobin (HbA1c) in Diabetic Patients ......................... 108 
4.2.4. Blood Pressure in Diabetic Patients ......................................................... 110 
4.2.4.1. Systolic Blood Pressure (SBP) in Diabetic Patients .................................. 110 
4.2.4.2. Diastolic Blood Pressure (DBP) in Diabetic Patients ............................... 111 
4.3. Trial 2: Healthy Participants ........................................................................... 114 
4.3.1. Characteristics of Healthy Participants ............................................................ 114 
4.3.2. Blood Glucose Profile of Healthy Participants ...................................... 119 
4.3.2.1. Fasting Blood Glucose (FBG) in Healthy Participants .............................. 119 
4.3.2.2. Two Hours Post Prandial Glucose (2hpp) in Healthy Subjects ............. 120 
4.4. Comparison of Diabetic Patients and Healthy Participants ................. 123 
4.4.1. Participants Characteristics (Trial 1 and Trial 2) ......................................... 123 
4.4.2 Blood Glucose Profile (Trial 1and2) ................................................................... 126 
4.4.2.1 Fasting Blood Glucose (FBG) .............................................................................. 127 
4.4.2.2 Two Hours Post Prandial Glucose (2hpp) ..................................................... 128 
4.5 Summary ................................................................................................................. 131 
Chapter 5 Discussion.................................................................................................. 132 
5.1. Introduction .......................................................................................................... 133 
5.2. Trial 1 (Diabetic Subjects) ............................................................................... 134 
5.2.1. Demographic and Lifestyle Data ......................................................................... 134 
5.2.1.1. Age and Duration of Diabetes in the Diabetic groups .............................. 134 
5.2.1.2. Smoking status ....................................................................................................... 136 
5.2.1.3. Education Levels for Diabetic patients .......................................................... 136 
5.2.1.4. Physical activity ..................................................................................................... 137 
5.2.1.5. Body Mass Index (BMI) ........................................................................................ 138 
5.2.1.6. Measuring Blood glucose level SMBG ............................................................. 139 
5.2.2. Discussion of individual parameters in the Diabetic group ...................... 140 
5.2.2.1. Fasting Blood Glucose Levels (FBG) ................................................................. 140 
5.2.2.2. Blood Glucose Levels (2hPP) ............................................................................. 141 
5.2.2.3. Glycated Haemoglobin HbA1c .......................................................................... 143 
5.2.2.4.Blood Pressure (Diastolic and Systolic Blood Pressure) ......................... 146 
5.3. Trial 2 (Healthy Subjects) ................................................................................ 153 
5.3.1 Demographic and Lifestyle Data........................................................................... 153 
5.3.2 Discussion of individual parameters in healthy groups ..................... 155 
5.3.2.1 Blood Glucose Levels (FBG and 2hPP) ............................................................ 155 
 
 
XIII 
 
5.4.Trial 1 and Trial 2 ................................................................................................ 156 
5.5. General Discussion ............................................................................................. 158 
Chapter 6 Conclusion ................................................................................................. 163 
6.1. Limitation of the Study ...................................................................................... 164 
6.2. Suggestions for Future Studies ....................................................................... 166 
6.3. Conclusion ............................................................................................................. 168 
6.4. Public Health Recommendation .................................................................... 169 
References ..................................................................................................................... 170 
Appendix ........................................................................................................................ 194 
 
 
1 
 
  
Chapter 1 Introduction 
1.1. Introduction   
1.2. Hypothesis  
1.3. Aims and Objectives of Study  
1.4. Contribution to knowledge  
1.5. Overview of Thesis Chapter  
  
 
 
2 
 
1.1. Introduction         
Cases of type 2 diabetes are on the rise across the world, especially in Saudi 
Arabia, due to the lack of awareness of the disease, the increasing prevalence 
of obesity, unhealthy dietary intake and poor lifestyle habits, such as lack of 
physical exercise.  
Traditional herbs, from natural sources, are often used as an alternative to 
medication to treat different diseases for a variety of reasons. Some of these 
include the fact that they are safe from side effects, easy to get hold of and 
cost less than most medications. Raw Nigella sativa (Ns) seeds were used as 
one of the dietary supplements in this study in order to make it easy for the 
participants to use them. According to Islamic history and tradition, it is widely 
believed that Nigella sativa has a wide range of health benefits, which could 
be used to help diabetic patients (see chapter 2, section 2.9). This was one of 
the reasons that Ns was used as a dietary supplement as part of this study. 
Although there are many studies (refer to page 39 in Chapter 2) that suggest 
that Nigella sativa has a beneficial effect on BGL, this study differs from others 
because the researcher examined the effect of raw Nigella sativa seeds on 
BGL, rather than the effect of a Ns derived substance (such as powder, oil, 
extract or a tea bag). This was done for several reasons. Firstly, to allow all 
the potential benefits that come from chewing the whole seed, as a fresh herb 
to be observed. Secondly, to allow all the bioactive natural components 
present in Ns and the vitamins, fibres, natural antioxidants, fats and minerals 
to work together, to see whether they had a beneficial effect on diabetic 
patients, and thirdly, because Ns can be easily bought and found.  
 The reason for using Ajwa dates and Nigella sativa seeds as dietary 
supplements in this research is due to the fact that both are natural products, 
containing polyphenol and antioxidant components, which could possibly be 
used as a safer alternative to chemical medications (as explained in chapter 
2). Moreover, both Ajwa and Nigella sativa have been the subject of 
experiments on animals in relation to their potential anti-diabetic effects 
(Fararh et al., 2004 and Ragab et al., 2013). However, although Nigella sativa 
has since been used in human studies and clinical trials (from 1997 to 2015, 
see chapter 2, section 2.9), there remains a gap in research on Ajwa dates 
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and their effects on humans. It is for this reason that one of the research 
questions that this thesis aims to address is ‘Does Ajwa have a potential effect 
on blood glucose levels?’ 
This thesis focuses on the effect of dietary factors (raw Nigella sativa seeds 
and Ajwa dates) on the blood glucose profile of patients with type 2 diabetes 
and on healthy participants. The non-diabetic healthy participants were 
examined in order to measure their blood glucose profile and compare the 
effects of different dietary factors on their BGL. This study consists of two trials: 
trial 1 was an examination of the effects of a modified diet or modified diet 
supplemented with either Ajwa dates (1 per day) or Nigella sativa seeds 
(2g/day) for 12 weeks on diagnostic markers of type 2 diabetes in diabetic 
patients: trial 2 was an examination of the effects of a modified diet or modified 
diet supplemented with either Ajwa dates (1 per day) or Nigella sativa seeds 
(2g/day) for 12 weeks on diagnostic markers of type 2 diabetes in healthy 
participants.  
The findings in this thesis contribute to human nutrition studies on the possible 
beneficial effects of Nigella sativa seeds and Ajwa dates when used as 
supplements to a diet modified for consumption by patients with type 2 
diabetes patients. The results clearly show that a modified diet designed 
specifically for KSA citizens with diabetes and taking into account local 
preferences and ethnic requirements is beneficial. The study also supports 
reports that Nigella sativa seeds added as a supplement to the modified diet 
is even more beneficial for diabetes patients.  
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1.2. Hypothesis:  
This study proposes that modification of a basic diabetic diet by the addition 
of certain foods; Nigella sativa seeds or Ajwa dates, will significantly improve 
the control of sugar levels in type II diabetic patients and healthy individuals.  
1.3. The general Aim of the study 
The project has two aims;  
first; to investigate the regulatory effects of the consumption of Nigella sativa 
seeds and Ajwa dates on blood glucose levels in diabetic patients with type 2 
diabetes; second; to investigate whether these dietary supplements have 
beneficial effects in controlling the complications that are associated with type 
2 diabetes. 
Aims  
● To develop a modified diet regime which is specifically applicable to the 
residents of the KSA taking into account local preferences, food taboos 
and eating habits. 
● To test the modified diet in the KSA in diabetic patients with type 2 
diabetes by monitoring fasting blood glucose and postprandial blood 
glucose levels and comparing these to a control group receiving the 
basic diet. 
● To determine whether adding Ajwa dates or Nigella sativa seeds to the 
modified diet improves the effects of the modified diet. 
● To investigate the relationship between the dietary factors (Nigella 
sativa, Ajwa dates) and postprandial blood glucose amongst 
intervention group if a relationship is demonstrated.  
Objectives  
The main objectives of this study were 
● To study the effect of three diet regimes: a modified diet, a modified diet 
supplemented with 2g/daily Nigella sativa seeds, a modified diet 
supplemented with 1 Ajwa date/daily on the glucose profiles of Type 2 
diabetes mellitus patients. To study the effect of three diet regimes: a 
modified diet, a modified diet supplemented with 2g/daily Nigella sativa 
seeds, a modified diet supplemented with 1 Ajwa date/daily on the 
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glucose profiles of healthy participants (non diabetic).  
● To study the effects of a modified diet, a modified diet supplemented 
with Nigella sativa seeds, a modified diet supplemented with Ajwa dates 
and on blood pressure (SBP and DBP) of type 2 diabetes mellitus 
patients.  
● To recommend the appropriate dietary intake of Nigella sativa seeds, 
Ajwa dates and modified diet for the amelioration of the symptoms 
associated with type 2 diabetes mellitus.  
1.4. Contribution to Knowledge  
There is great interest in the contribution of dietary factors to the treatment of 
type 2 diabetes. Some studies have shown that a plant-based diet has 
proactive effects against the development of metabolic complications such as 
insulin resistance in type 2 diabetes. Indeed these beneficial effects have been 
related to the presence of polyphenolic compounds, which possess a wide 
range of biological properties including antioxidant and insulin-sensitizing 
activities. (Jung et al., 2006) 
This research will provide a significant contribution to the understanding of the 
effects of dietary factors in the control of postprandial blood glucose levels in 
type 2 diabetes, specifically, Nigella seeds and Ajwa dates. Furthermore, it will 
broaden our knowledge of how these dietary factors may regulate blood 
glucose and lipid levels. Adding Nigella seeds to the diet has been shown to 
control hyperglycaemia in patients with type 2 diabetes, however there are no 
similar reports in relation to Ajwa dates, hence this study will add this 
knowledge. Additionally, the study may demonstrate that the natural fibre, 
antioxidant effects and polyphenolic compounds in Ajwa dates contribute to 
the control of factors which influence the diabetic complications and improve 
glucose metabolism and insulin sensitivity in diabetic patients. Accordingly, 
dietary modification programmes, if beneficial, may be employed as an 
alternative approach to control the risk of type 2 diabetes in clinical practice.  
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1.5. Overview of thesis chapter 
The study consists of 6 chapters:  
Chapter 1 Introduction, an overview of the introduction to type 2 diabetes, 
aims, objectives and hypothesis of this study and its contribution to 
knowledge.  
Chapter 2 Literature Review, which shows the background of type 2 
Diabetes and the classification of the different types of diabetes and the 
possible symptoms. It also presents the definition of T2DM and the 
prevalence of diabetes, with the discussion focussing specifically on the 
context of Saudi Arabia.  This chapter also highlights the possible risk factors 
related to T2DM and the lifestyle modifications.  The second section of 
chapter 2 presents details of Nigella sativa Seeds (Ns), their nutritional value 
and the possible benefits of Ns consumption on Blood Glucose levels (BGL) 
and Blood Pressure (BP). The third section describes Ajwa Dates (AJ), their 
chemical composition, nutritional properties and reported health benefits. 
Chapter 3 Methodology, illustrates the process of obtaining ethical approval 
for the study from Manchester Metropolitan University (MMU) and from AL-
Noor hospital of Makkah in Saudi Arabia, the study design and population for 
Trial 1 (Diabetic Group) and Trial 2 (Healthy Group). It also presents the 
inclusion and exclusion criteria for Trials 1 and 2, explains the recruitment 
and selection criteria for the diabetic and healthy participants and provides 
information about determination of sample size and study duration. This 
chapter also covers data collection and processing, how the questionnaire 
was designed and how the diet for the trials was developed.  Measurements 
for Trial 1 were: blood pressure, blood glucose profile (FBG and 2hPP blood 
glucose) and HbA1c levels. The measurements for Trial 2 were: blood 
glucose profile (FBG and 2hPP blood glucose). This chapter then presents 
the validity and reliability of the study, participants’ compliance with 
appointments, treatments, measurements and diet and finally the statistical 
analysis methods.   
Chapter 4 Findings; provides a detailed comparison of the results from the 
Diabetic groups (trial 1) analysing the characteristics of Diabetic Patients, 
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their Blood Glucose Profile (FBG, 2hPP), Haemoglobin (HbA1c) levels and 
Blood Pressure (Systolic and Diastolic Blood Pressure). The second part of 
this chapter looks at the findings for trial 2, Blood Glucose Profile (FBG and 
2hPP). Chapter 4 concludes with a comparison of the results for diabetic 
patients and healthy participants (Blood Glucose Profile) FBG, 2hPP blood 
glucose levels. 
Chapter 5 Discussion; discusses the demographic and lifestyle data, which 
includes age, duration of diabetes, smoking status, education level, physical 
activity, Body Mass Index (BMI) and measuring blood glucose level using 
Self monitoring Blood Glucose (SMBG). The chapter then goes on to discuss 
the individual parameters in the diabetic group (Trial 1) FBG, 2hPP, HbA1c 
and blood pressure measurements SBP and DBP. Then the discussion 
moves onto the demographic and lifestyle data of the Trial 2 group and 
discusses the individual parameters in the Healthy groups (FBG, 2hPP) and 
sums up with a general discussion.   
Chapter 6 Conclusion; presents the limitation of the thesis, discusses the 
suggestions for future studies and presents the overall conclusion before 
listing several public health recommendations. 
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2.1. Introduction  
This chapter will first provide some background information on Diabetes 
Mellitus (DM) and then explains the difference between Type 1 and Type 2. It 
will then move on to discuss the prevalence of T2DM in the Kingdom of Saudi 
Arabia and identify some of the associated risk factors, which include obesity, 
diet, level of physical activity and level of education. The chapter will then 
discuss the lifestyle modifications that are needed to control and manage Type 
2 DM before presenting the current literature on the effects of Nigella sativa 
seeds and Ajwa dates on Type 2 DM.  
2.2. Background of Diabetes Mellitus  
Diabetes Mellitus (DM) can be defined as a metabolic disease that occurs due 
to a variety of factors including chronic hyperglycaemia and defects in both or 
either insulin secretion and insulin action (Haslett et al., 2002). A sufferer of 
DM can live normally, although the condition is permanent. The World Health 
Organization (WHO) have stated that HbA1c levels can be used as a 
diagnostic test for diabetes, whereby the cut-off point for diagnosing diabetes 
is 48 mmol per mol (6.5%)(WHO, 2011). They recommend that diabetic 
patients should measure their glycated haemoglobin (HbA1c) levels every 3 
months in order to help sufferers of diabetes control their plasma glucose level. 
The standard level of Fasting Blood Glucose (FBG) for diabetes should be 
FBG ≥7.0 mmol/l and for the two hours postprandial should be  ≥11.1 
(Matthews et al., 2008). 
The pancreas (beta cells) secretes a peptide hormone known as insulin and 
the primary function of this hormone is to remove glucose from the 
bloodstream and to transfer it to the cells of the body for metabolism. There 
are 2 forms of diabetes, type 1 and 2.  
In patients with type 2 diabetes, the glucose absorbed from the intestine enters 
the bloodstream and this should stimulate insulin secretion by the pancreas, 
which then stimulates uptake of the glucose by cells and conversion to body 
fat (Matthews et al., 2008). In the type 1 and type 2 diabetic patient, the 
pancreas cannot produce insulin in sufficient quantities (or produces none at 
all) so the absorbed glucose remains in the blood stream. This results in higher 
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blood glucose levels, which is the diagnostic measure that is used to identify 
diabetes patients. In type 1 diabetes patients, there is no insulin or such low 
levels that it is not effective usually as result of an inherited defect but 
occasionally as a result of disease (Matthews et al., 2008). These patients are 
treated with insulin. In type 2 diabetes, the insulin insufficiency occurs as a 
result of damage to the pancreas, which is not inherited. Type 2 usually occurs 
in later life because the loss of insulin production is gradual (Geissler and 
Powers, 2005; Matthews et al., 2008). 
Mann and Truswell (2007); Geissler and Powers (2005) explain the 
differences between Type 1 [Insulin Dependent Diabetes Mellitus (IDDM)] and 
Type 2 [Non-insulin Dependent Diabetes Mellitus (NIDDM)]. Type 1 (IDDM) 
occurs in about 10% of all cases and is most common in childhood and adults 
over 40 in the white population and adults over 25 in the South Asian 
population. On the other hand, Type 2 (NIDDM) is the most prevalent type of 
diabetes, which occurs in about 90% of all cases and is most common in 
adults. The symptoms for both types of diabetes include thirst, urination, slow 
healing, blurred vision, thrush or genital itching, tiredness and weight loss 
(Matthews et al., 2008). However, one of the main differences between the 
two types of diabetes is that in Type 1 (IDDM) the above symptoms come 
quickly while in Type 2 (NIDDM), the symptoms develop slowly. It is for this 
reason that Wass and Shalet (2002) claim that sufferers of T2DM face a 
heightened chance of complications as the condition may remain undiagnosed 
for a long time. Moreover, the treatments for Type 1 (IDDM) include an insulin 
injection with a dietary plan considering individual nutritional needs, while 
treatments for Type 2 (NIDDM) not only sometimes include an insulin injection, 
but also a diet plan, doing physical activity and reducing weight. Furthermore, 
Kumar and Clark (2005) have identified advanced age, obesity, family history 
and ethnicity (Common in South Asian, African-Caribbean and white 
populations) as the four key factors in the onset of type 2 diabetes.   
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2.3. Prevalence of Type 2 Diabetes 
According to the WHO (2016), approximately 1.5 million people died globally 
due to high blood glucose levels in 2012 and the incidence of diabetes in the 
same year was 3.7 million. Worldwide, countries now spend from one quarter 
to one sixth of their annual health care funds on treating the various forms of 
diabetes. The WHO (2016) recently reported that the prevalence of diabetes 
in adults worldwide rose to 422 million in 2014. Furthermore, in 2014, 13.7% 
of the incidents of diabetes were found in the Eastern Mediterranean Region  
(places such as Kuwait, Bahrain, Oman, Saudi Arabia, Egypt, Qatar, Jordan 
and Iraq).        
In developing nations, individuals in their prime, aged from thirty-five to sixty-
four, are most commonly struck down with diabetes. It has been affirmed by 
the World Health Organisation (2016) that developing nations will see a rise in 
the incidence of diabetes, especially low income countries. Nine out of every 
ten cases of the two forms of diabetes are the common Type 2 form of the 
condition, which brings with it an elevated risk of cardiovascular conditions and 
early morbidity (WHO, 2016). The WHO (2017) predicted an increase in cases 
of diabetes by 2025, which would make diabetes the 7th leading cause of 
death in the world (WHO, 2017).  
Since 2000, the International Diabetes Federation has produced a series of 
IDF Diabetes Atlases, with the latest seventh edition released in 2016, which 
shows the development of diabetes across the world (IDF 2000; IDF 2016). 
These reports show that the incidence of diabetes has been increasing 
worldwide throughout the period covered by the reports, but more interestingly 
the predicted incidences for the year 2050 has increased significantly. The 
atlases also show the reported incidence of diabetes for individual countries. 
According the International Diabetes Federation (IDF) the prevalence of 
diabetes in Saudi Arabia is very high and predicted to increase even further 
over the year.  
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2.4. Type 2 Diabetes in Saudi Arabia 
The Kingdom of Saudi Arabia (KSA) is one of the biggest and richest countries 
in the Middle East as it is one of the leading oil-producing countries. Over the 
past five decades, it has made considerable progress as a result of its intense 
industrialisation and lifestyle modifications (Bahijri et al., 2016), which Al-
Daghri et al, (2011) claim has resulted in a heightened incidence of Type 2 
DM. This rationale is supported by the findings of Al Nozha et al, (2004) (see 
table 2.1) and various other studies (see table 2.2), which suggest that the 
prevalence of T2DM is higher in urban areas when compared with rural areas 
of SA.     
Table 2.1. The prevalence of type 2 Diabetes in Saudi population (Al-Nozha et al, 2004)  
Saudi regions  Prevalence of type 2 Diabetes  
Urban population  25.5% 
Rural areas  19.5% 
Northern 27.9% 
Eastern   26.4% 
Southern Region  18.2% 
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Figure 2.1. Incidence of type 2 Diabetes in the KSA 2000 – 2016 (data taken from the 
IDF Atlases for each year indicated) 
Figure 2.1 shows the incidence of type 2 diabetes reported for the KSA 
between 2000 and 2016. This data demonstrates that the incidence of type 2 
diabetes in the Kingdom of Saudi Arabia was low, 8-11% in both 2000 and 
2003 but then a rapid rise occurred between 2003 and 2013 when the cases 
of diabetes reached 24%. From figure 2.1 it appears that the incidence of 
diabetes between 2013 and 2016 remained constant in Saudi Arabia.  
Interestingly this rise in the incidence of diabetes appears to be directly related 
to the increase in GDP (Gross Domestic Product) which also began to rise 
sharply after 2000 and peaked in 2012 (Fig 2.2)  
 
Figure 2.2. GDP (Gross Domestic Product) for the Kingdom of Saudi Arabia (World 
Bank) 
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These data support the general contention that the rise in Type 2 diabetes in 
the Kingdom of Saudi Arabia is associated with an increasingly sedentary 
lifestyle, which is related to the increase in personal income. The data 
presented in this thesis is consistent with the hypothesis that type 2 diabetes 
is related to lifestyle; hence education programmes which could potentially 
result in changes in lifestyle should generate improvements. 
A rise in diabetes among the adult population has been observed in research 
conducted since the late 1980s (Wilson, 2010). In 2011, an epidemiological 
research study on diabetes carried out by Al-Daghri et al, (2011) aimed to 
examine the position of the Saudi Arabian people and whether the initiatives 
undertaken by the healthcare community and the Ministry of Health had had 
any beneficial effects. They concluded that Type 2 DM was found in 
approximately 20% of the country’s adult population (Al-Daghri et al., 2011).  
In 2011 the International Diabetes Federation (IDF) placed the KSA within the 
top 10 countries in the world with the highest prevalence of diabetes (Whiting 
et al., 2011). In 2015, the figure had not changed much (see figure 2.3 below) 
as it stood at 23.9% according to a report by Naeem (2015).  
 
Figure 2.3.The population prevalence of Diabetes (Naeem, 2015) 
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Furthermore, Albakr et al., (2013) observed a rise in the awareness of 
diabetes, possibly indicative of Saudi Arabia’s improving health care system. 
However, Al-Quwaidhi et al (2014) reported that the prevalence of some risk 
factors for T2DM in the KSA such as obesity had been estimated to be among 
the highest in the world. In addition, the prevalence of obesity among females 
is higher than males in Saudi , that would increase the risk of having T2DM in 
female population (AL-Quwaidhi et al ., 2014). Bahijri et al, (2016) claims that 
one of the reasons for this could be the lack of development programmes 
designed to prevent or reduce the prevalence of T2DM in Saudi Arabia (SA). 
The above mentioned studies (Al-Quwaidhi et al., 2014 and Bahijri et al., 2016) 
claim that the prevalence of diabetes in SA has reached epidemic proportions. 
Almalki et al, (2011) further adds that this is due to Saudi’s not using the 
medical preventative services, despite the fact that they are covered by a free 
national health system. 
In 2016, the World Health Organisation reported that the prevalence of 
diabetes in SA stood at 14.4% with the percentage of males with diabetes 
being higher than females (14.7% and 13.8% respectively). They (ibid, 2016) 
claim this could be due to an increase in obesity level (33.7%) amongst the 
Saudi adult population (WHO, 2016). 
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Table 2.2.Studies of type 2 diabetes in Saudi Arabia  
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Prevalence of 
diabetes 
Male Fem
ale 
Total Male Femal
e 
Total 
Bahijri 
et al 
2016 
SA 
(Jedda
h) 
667 752 1419 ≥18  ADA 
FBG 
HbA1c  
12.9% 11.4% 24.3
% 
Al Zahidy 
et al 
2017 
SA  1150 1670 2820 20 – 
70  
_ 40.8% 59.2%  
Al-
Rubeaan
, et al. 
2015 
SA 2823
8 
2222
6 
5046
4 
≥25 _ 46% 44%  
Bani 
2015  
SA  
(Jazan
) 
146 102 248 ≥18 WHO 9% 19%  
Algurash
i et al 
2011 
SA 768 1024 1792 ≥20 Self 
reportin
g 
34.1% 27.6%  
Al-
Nozha 
2004 
SA 2099 1889 4004 30-
70 
 26.2% 21.5% 23.7
% 
Karim 
2000 
SA 1683 2064 3747 0 to 
70 
_ 8.52% 19.48
% 
28% 
El-Hazmi 
et al 
1998  
SA - - 2533
7 
0 to 
77 
 5.86% 4.83%  
Al-
Nuaim et 
al 1997 
SA - - 1317
7 
>15  12% 14%  
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2.5. Treatment of type 2 Diabetes 
Type 2 diabetic patients can be treated in the early stages of the disease, 
especially if it is diagnosed early. There are different treatments available, 
which work to manage blood glucose levels and to reduce the development of 
the disease itself. Among the actions that diabetics are encouraged to take is 
measuring their blood glucose levels as a daily routine, as this could help the 
patients to check the ideal level for fasting blood glucose (FBG 4 to 7 mmol/L) 
and 2 hour postprandial (2hPP < 8.5 mmol/L) blood glucose levels. 
Furthermore, in order to obtain a reliable measurement for BGL, diabetics are 
encouraged to measure the glycated blood levels (HbA1c) at least every 3 
months. They should check to ensure that HbA1c levels should be between 
6.5% (48 mmol/mol) to 7.5% (58 mmol/mol)(WHO,2011). 
Lifestyle and dietary modification are also among the most common 
treatments for type 2 diabetic patients. Diabetics are encouraged to maintain 
a healthy varied diet, physical exercise and a healthy weight (BMI 18.5-25 
kg/m2). The National Institute for Clinical Excellence (NICE, 2009) 
recommended that providing healthcare advice is an excellent means by 
which diabetic patients can be provided with the means to manage their 
disease by being made aware of such lifestyle and dietary modifications. 
Education allows them to understand how to treat themselves in a variety of 
ways. They can be taught to understand nutritional information, how to follow 
a dietary plan, how to administer their medication and how to monitor their 
BGL at home using self-monitoring blood glucose equipment (SMBG). 
In addition, for those diabetic patients with uncontrolled type 2 DM, who cannot 
control their BGL with a controlled diet alone, the main treatment for them is 
insulin medication (drugs to help the patients manage the BGL). Goldstein and 
Müller-Wieland (2016) reported that only 30% of the diabetic patients with type 
2 can be treated with insulin injections and diet. Despite this treatment for type 
2 DM, considering factors associated with medication, such as expense, bodily 
harm, means of treatment, reluctance to take medication and side effects, 
patients usually go back to using non-medicinal therapy (i.e. herbs). Thus, the 
traditional methods of therapy for type 2 DM are being revived as a means of 
healing the disease. 
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2.6. Risk Factors for type 2 Diabetes  
There are many risk factors associated with type 2 Diabetes Mellitus, some of 
which are a result of modifiable environmental factors, such as obesity and 
physical activity (Bassuk and Manson (2005); Van Gaal et al.,2006), while 
others are linked to non-modifiable factors such as age, family history and 
genetics (Thayer et al., 2010 ; Wass and Stewart, 2011). The following sections 
will present some of the links between these risk factors and diabetes. 
Although T2DM is more common among obese people (Horton (1990) and 
Franz et al., 2015), it cannot be concluded that obesity causes diabetes as 
there are cases whereby non-obese people as well as some very obese 
people are not diabetic (Malik et al., 2013; Horton (1990); Williams and Pickup 
(2004)  have revealed that the relationship between obesity and diabetes 
depends mainly depends upon three factors: duration of diabetes and degree 
and distribution of obesity. Moreover, Franz et al, (2015) claim that obesity 
increases the risk of developing type 2 diabetes given an inherited propensity 
to develop the condition. This suggests that a person’s genetic disposition is 
enhanced by environmental factors.  
Some of the lifestyle modifications that developing countries, such as KSA 
have made, have resulted in a high-caloric food intake and a decrease in 
physical exercise. This in turn has led to an increase in Body Mass Index 
(BMI), which Malik (2013) found to be a reason that obesity is such a common 
problem. This is a major concern, as these lifestyle modifications have lead to 
an increase in the number of diseases (such as DM), which have caused 
higher death rates in such societies than before these lifestyle modifications 
were introduced (Boutayeb, 2005;  Amuna and Zotor, 2008). In addition, 
Memish et al., 2014 reported that one of the main reasons for the increase in 
serious illness and death in KSA is obesity. 
Furthermore, a survey was conducted in the Kingdom of Saudi Arabia with the 
help of World Health Organization  (WHO) in 2005, to measure the increasing 
obesity rate and associated factors causing the increased rated of DM. 
However there have been no further surveys conducted to check efforts to 
prevent obesity carried out by Saudi Ministry of Health (SMOH). Furthermore, 
Memish et al, (2014) reported the findings from a survey conducted by the 
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SMOH and the Institute of Health Metrics and Evaluation in 2013, which 
demonstrated that obesity levels in SA had significantly risen from the late 
1980s to the mid1990s.   
The report showed that the Saudi population had many health issues such as 
high blood pressure, diabetes and high cholesterol levels, all of which are 
associated with obesity. The report claimed that the increased rate of obesity 
among the Saudi population was due to the lack of physical activity and low 
consumption of fruits and vegetables. Wang and Beydoun (2009), agree with 
this claim as they found that an increased daily consumption of fruits and 
vegetables was often associated with a decreased risk of obesity. 
Furthermore, Camoes (2011) also found that the rate of obesity increases in 
men and women due to less physical activity.  
Moreover, the Saudi Ministry of Health (SMOH) recognised that education is 
also an important factor that helps prevent obesity in those educated in SA. 
They identified the high risk groups as being old people, uneducated or 
inactive people. In addition, Gakidou (2014), claimed that the rate of obesity is 
higher in less educated people when compared to those who had received a 
higher level of education. It is for this reason that the SMOH monitored and 
regulated different health programmes, with the aim of decreasing overall 
obesity rates, by focussing on creating an awareness among the masses of 
the risk of diabetes, and trying to convince them to change their eating habits 
(MOH, 2012).  
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2.7. Lifestyle modification and Type 2 Diabetes   
2.7.1. Dietary factors and type 2 Diabetes  
A dietary plan prepared by a nutritionist could have a vital role in type 2 diabetic 
patients’ management. As Mann and Truswell (2007) explained dietary 
modifications could manage the disease by improving the blood glucose levels 
and reducing complications. Thus, eating a balanced diet to help control blood 
sugar is a very important part for the management of type 2 diabetic patient, 
since extra intake of sugar could be harmful for the patient, so controlling the 
diet could be helpful in controlling diabetes (Whiting et al., 2011).  
Glycaemic Index (GI) provides an indication of the speed at which certain 
foods increase blood glucose levels after eating a meal. Foods that score 70 
and above on the index are considered to have a high GI, and lead to a rapidly 
increasing blood glucose level. On the other hand, low glycaemic index foods 
range between 0 and 69, for which blood glucose levels rise slowly (Al-
Mssallem, 2014). Foods lower on the GI have determinable benefits on 
glucose control and can improve metabolic control among type 2 diabetic 
patients by reducing chronic inflammation, improving lipid metabolism and 
insulin sensitivity (Kalergis, 2005 and Du et al., 2008). 
Figure 2.4 below illustrates the effect of the glycaemic index on blood glucose 
levels. The diagram shows that food with high glycaemic indexes (illustrated 
by the red line) caused a sharp increase in blood glucose levels after eating a 
meal. Following this, there was a rapid decrease in the concentration of 
glucose in the blood half an hour after eating a meal. On the other hand, the 
green line (representing low Glycaemic index foods) shows the blood sugar 
levels rising slowly and then falls gradually afterwards (Elwins, 2009). 
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Figure 2.4.The influence of food that impact the GI on the blood glucose level 
 (Kinshuck Diabetes Organisation ,(2014) 
For this reason, Du et al, (2008) recommend low glycaemic index foods, such 
as fruits, vegetables, legumes, pasta, oats and rice, while restricting high 
glycaemic index foods, in order to control blood glucose levels among type 2 
diabetic patients. The conclusions of later research by Al-Mssallem (2014) 
also recommend that Saudi’s should be encouraged to follow a healthier diet 
by increasing the consumption of fruits and vegetables, which are rich in fibre. 
Generally, foods that are rich in fibre have a low glycaemic index, although 
certain foods that contain low amounts of fibre also have low glycaemic 
indexes. Furthermore, foods high in fibre that also have a low glycaemic index 
(as listed in table 2.3) tend to be absorbed slowly, thus having a fundamental 
effect on postprandial glucose levels. By reducing the absorption process,  
food remains in the intestine for more than two hours after eating a meal, which 
may help a diabetic patient feel fuller for longer (Al-Mssallem, 2014).   
Moreover, Al-Mssallem (2014) reported that most of the traditional Saudi 
foods, such as rice, vegetables, whole grain, wheat and palm dates, ranged 
between moderate GI (>55 and <70) and low GI (≤55). As shown in Table 2.3, 
the GI for dates with Arabic coffee is 63, while the GI for dates with sour milk 
or yoghurt is fairly low at 29. Miller et al., 2003 found that dates with yoghurt 
have a beneficial effect on blood glucose levels due to the presence of protein 
and its effect on postprandial blood glucose levels. However, the findings of 
later research by Al-Mssallem and Brown (2013) suggest that consuming 
dates with Arabic coffee increases the blood glucose level rapidly due to the 
caffeine in the coffee.     
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Table 2.3.The Glycaemic index of food (Hamilton Health Science 2003) 
Foods  Glycaemic index  Foods  Glycaemic index  
Apple  37 GI Yoghurt low fat  14 GI 
Carrots 51 GI Spaghetti  43 GI 
Cashews 22 GI Peanut putter 29 GI 
Cherries  25 GI White Rice  45 GI 
Orange  44 GI Kiwi fruit 50 GI 
Skimmed milk  32 GI Bananas  45 GI 
Dates with 
Arabic Coffee  
63 GI Sweet potato  49 GI 
Dates with sour 
milk or yogurt  
29 GI Lentils  26 GI 
Pasta  32 GI Dried apricots 31 GI 
Low fat yogurt  14 GI Lentil soup  44 GI 
Baked beans  48 GI  Macaroni  45 GI  
 
Mann and Truswell (2007) observed the relationship between food intake and 
the chances of developing DM and found that high starchy carbohydrate and 
sugary food consumption was the cause of a noticeable increase in the blood 
glucose levels of patients. Thus, they (ibid, 2007) claim that by having a 
balanced diet, the intake of natural carbohydrates such as legumes, 
wholegrain cereals and fruits could have a beneficial effect on glycaemic 
control, thus allowing diabetic patients to control their BGL. On the other hand, 
an unbalanced diet would mean an intake of high processed carbohydrates 
such as sugar, rice and flour, which could increase the BGL. Thus, by varying 
carbohydrate consumption, diabetic patients can control their blood glucose 
levels.  
The amount of food intake increases in diabetes patients but the reason 
behind this action is still not understood and this is the main cause of obesity 
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in diabetics. It was also found on the basis of various experiments that high 
sugar consumption especially the complex sugar, sucrose, is not directly 
involved in causing this disease Mann and Truswell (2007). According to a few 
observations, it is deduced that nutritional intake directly affects the chances 
of diabetes in patients.  
It is very important for a diabetic patient to increase the intake of fibre in their 
diet plans because dietary fibre is directly associated with blood glucose level 
and a patient’s lipid profile. Velazquez-Lopez (2016) observed that patients 
with Type 2 diabetes can easily reduce their blood glucose level by including 
fibre in their diets, while also lowering the level of triglycerides and lipid in the 
human body. Thus, the high amount of fibre in a diet is directly proportional to 
low HbA1c, high HDL-c levels and a lower body weight (Velazquez-Lopez, 
2016). In addition, Post et al, (2012) reported that dietary fibre was very helpful 
in lowering the blood sugar level in type 2 diabetes patients. Recent studies 
(Fujii 2013; Tanaka et al., 2013 and Yang et al., 2014) suggest that a high 
dietary intake of fibre had a strong link with the decline of HbA1c levels and 
reducing complications related to patients with type 2 diabetes, such as stroke 
(Post et al., 2012). 
Furthermore, Wycherley et al, (2010) recommend diabetic patients to follow a 
reduced-calorie diet in order to minimize the portion size of carbohydrate and 
increase the protein portion in order to control weight, blood glucose levels, 
HbA1c and blood pressure.  
It is very important for Type 2 diabetes patients to adhere to their dietary plans 
along with physical exercises to control the glucose level in their blood.  
However (Evert et al.,2013) found that diabetic patients who followed the strict 
diet plans as a part of their daily routine treatment, showed a greater control 
over their BGL than patients who only did exercise to keep themselves fit and 
healthy. In relation to diet plans, Nowlin et al, (2012) reported that high dietary 
intake of carbohydrate decreased body weight, but had an insignificant change 
on BGL and HbA1c levels.   
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Furthermore, Ajala et al, (2013) found that when patients with type 2 diabetes 
followed a dietary plan (low CHO, high protein and low GI) for 6 months, it had 
a beneficial effect on controlling the risk of developing the complications 
associated with type 2 diabetes such as CVD, increasing the BGL. 
Kratz et al, (2013) illustrated that there was a strong positive correlation 
between dietary intake of saturated fat and the development of complications 
such as dyslipidemia, obesity, high cholesterol level (HDL) and cardiovascular 
disease (CVD). On the other hand, Mann and Truswell (2007) found that a 
good source of fat such as polyunsaturated fats, had a beneficial effect on 
reducing the risk of CVD for diabetic patients. Saturated fatty acid are 
responsible for various heart diseases and overweight issues compared to 
polyunsaturated and monounsaturated fats (Velazquez-Lopez, 2016).  
Therefore, it is important for the healthy human body to consume poly and 
monounsaturated fats more than saturated fats to stay healthy (Kratz, 2013 
and Velazquez-Lopez, 2016). 
Fruit and vegetables are a rich source of flavonoids (Geissler and Powers, 
2005).  Khan (2014) reported that the dietary intake of food that is rich in 
antioxidants (phenolic content) such as black and green olives, dates, red 
grapes, pomegranate and ginger, have a beneficial effect on human health. 
Furthermore, fruit and vegetables are a good source of antioxidant vitamins 
(tocopherols, vitamin C, carotenoids), fibre, selenium, potassium, and folate 
(Mann and Truswell 2007). Foods rich in flavonoids and antioxidants had a 
beneficial effect on managing the vascular function in order to reduce 
cardiovascular diseases (CVD) (Geissler and Powers, 2005). Moreover, an 
increase in oxidative stress in the human body can lead to the development of 
several diseases such as cancer, CVD and inflammatory disease (Geissler 
and Powers, 2005).  The dietary intakes of foods that are rich in flavonoids 
could reduce reactive oxygen, reduce the oxidative stress and reduce the 
prevalence of chronic diseases.  
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2.7.2. Physical activity and Type 2 Diabetes  
Physical activity mainly affects the metabolism rate of glucose, which is why 
athletes have less glycaemia after a glucose load and insulin responses are 
diminished compared to untrained persons of similar weight (Knowler et al., 
2003). Conversely, profound physical inactivity such as bed rest is associated 
with the development of abnormal glucose tolerance and higher insulin levels 
(Ramachandran et al., 2006). These observations suggest that physical 
activity influences insulin resistance (Kosaka et al., 2005). There are few 
epidemiological studies that have established a relationship between T2DM 
and physical activity. For example, Lindström et al., 2006) found that the 
prevalence of diabetes type 2, was twice as high in those with lower degrees 
of physical activity. While suggestive of a protective effect, the amount and 
degree of physical activity needed to achieve protection from diabetes is 
unknown.  
Moreover, due to the lack of physical activity, Al Rukban (2003) claims that the 
Saudi youth is facing a problem with obesity. This association was true among 
men, but not women. Whereas men were almost equally distributed between 
all levels of physical activity, most women reported being inactive or having a 
low level of physical activity. According to Kriska (2003), physical activity (PA) 
is an important modifiable factor for type 2 diabetic patients in addition to a 
“diabetic diet” as it improves control of the complications associated with Type 
2 diabetes. Furthermore, (Geissler and Powers, 2005) suggests that physical 
activity may also have a beneficial effect on blood glucose levels in Type 2 
diabetic patients. Thus, making lifestyle modifications, such as increasing 
physical activity, could play an important role in controlling type 2 diabetes. 
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2.8. Control and Management of Type 2 Diabetes Mellitus 
There are several ways in which type 2 diabetic patients can control their 
disease. These include giving up on, or reducing smoking habits; being active; 
following a modified diet; being willing to self-monitor their blood glucose levels 
regularly and adhering to treatment (Geissler and Powers, 2005).  Moreover, 
larger institutions such governments, could also contribute towards the control 
and management of type 2 DM. Among the actions that they could be taken is 
providing an easy-to-follow health education programme for type 2 diabetic 
patients, which provides essential information that would help them control 
and manage their disease. Furthermore, health campaigns encouraging 
diabetic patients to reduce the amount of cigarettes they smoke gradually and 
eventually give up on smoking, could also contribute to a reduction in the risk 
of cardiovascular diseases (CVD), while clinical campaigns encouraging 
obese diabetic patients to change their lifestyle by losing weight, could also 
help to reduce the development of the disease (Mackay et al., 2013).   
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2.9. Nigella sativa seeds 
2.9.1. Nigella sativa seeds botanical information 
The Nigella sativa plant comes from the Ranunculaceae family of herbs. For over two 
millennia the seeds have been made into herbal medicines and in a number of nations 
and the seeds are also used as a food flavour and additive (Zubaida et al., 2001). 
Nigella Sativa seeds are also called black seeds as they are black in colour while 
triangular shaped, with one pointy smaller end (figure 2.5). The length of one of these 
seeds is one-eighth of an inch with a pure white and oily interior and gives off the 
smell of lemon and light carrot soupcon upon rubbing (Ahmad et al,,2013) 
 
Figure 2.5. Nigella sativa seeds and plant flower (Al-Ghamdi, 2001 and ASSI et al., 2016) 
Nigella sativa seed is termed as the ‘Habbatul barakah’ in Arabic, translated 
as ‘the seed of blessing’ for the therapeutic potential it holds as a medicinal 
herb among the Arabians. Although the USA and Europe have only recently 
begun to learn about Nigella sativa and its benefits, the Middle East, Far East, 
Asia and Africa are well accustomed to the amazing curing ability of this 
organic regime. Records of different historical periods also reveal that Nigella 
sativa has been used as medicine benefits throughout history. For example, 
its use have been traced back to the ear ly Egyptian traditions where 
Tutankhamen’s tomb was uncovered to hold Nigella sativa, which suggests 
that Nigella sativa was seen to be of value, since it was considered that objects 
found in the tomb of a ruler would help them in the life after death (Hussain 
and Hussain, 2016). 
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Furthermore, Hussain and Hussain (2016) have also found that for more than 
4000 years the Nigella Sativa has been known all over the world. Among other 
organic compounds Nigella sativa seeds have also been mentioned in the 
religious traditions of the Islamic faith as being a cure for every illness except 
death (Hussain and Hussain, 2016). Therefore, this suggests that Nigella 
sativa seeds were used for their medicinal properties over 1400 years ago in 
the Middle East. With continuous intake of this seed, recent research  that 
include  Zubaida et al., (2001); Fararh et al, (2004) Mohtashmi et al., (2011); 
Hussain and Hussain (2016) suggests that this seed has an immense ability 
to enhance the biological immunity.  
Many diseases such as bronchial asthma and bronchitis, rheumatism and 
similar inflammatory conditions have been treated with Nigella sativa seed with 
much anticipation in the Middle East and Far East countries for quite a while 
now ( Mutabagani (1997); Al-Ghamdi (2001); Keyhanmanesh et al., 2014 ). 
Among other functions this helps in boosting the release of nursing mother’s 
milk, healing gastrointestinal problems, enhancing biological immunity, 
strengthen digestive ability and excretion and also counter parasitic infestation 
(Rajkapoor et al., 2002 and Kanter et al., 2005). The oil extracted from this 
seed is also used topically to heal flu symptoms and has also been used to 
cure skin ailments for example eczema and boils (Keyhanmanesh et al., 
2014). 
2.9.2. Chemical composition and Nutritional value of Nigella 
sativa Seeds 
Nigella sativa seeds are full of nutrients, organic compounds and minerals. 
According to Khan (1999), they contain traces of minerals, ash, fixed oil, 
moisture, Arabic acid, cellulose, albumin and other dissolvable substances as 
well as traces of oleic acid (acid value 30.30). El-shiekh (1999) ; Ramadan 
(2007), Keyhanmanesh et al., (2014) ,Hussain and Hussain (2016), further 
found that these seeds are also made up of 18-21% protein, thus contain 
amino acids, as well as two kinds of fatty acids: saturated and unsaturated. 
Furthermore, Al- Jasser (1992) and Keyhanmanesh et al., (2014) also found 
that Nigella sativa seeds have many other elements such as potassium; 
phosphorous, sodium and iron is present in abundance.     
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Figure 2.6. Bioactive compound Thymoquinone (TQ) from Nigella sativa extract.  
(Hussain and Hussain 2016)  
According to Arora (2008), in the nutrition-rich seeds of Nigella sativa essential 
amino acids can be found as can carbohydrate, fat and vitamins as well as 
carotene, which the liver converts into vitamin A. Among other beneficial 
substances found within the Nigella sativa seed are potassium, iron and 
calcium. 
Different specimens of Nigella sativa seed from various countries have been 
investigated and it has been observed that it has a great nutritional importance 
i.e. protein (~22%), fat (38- 40%) and carbohydrates (~32%) (Takruri and 
Dameh, 1998). Moreover, Hussain and Hussain 2016 reported that the Nigella 
sativa seed has carbohydrates (38%), protein (21%) and total fat (35%). 
Nigella sativa has rich source essential fatty acid (EFA) such as oleic, linolenic 
(polyunsaturated omega-3 fatty acid) and linoleic acids (polyunsaturated 
omega-6 fatty acid).          
 
 Figure 2.7. Nutritional facts for Nigella sativa seeds (Iblackseed.com) 
The weight of the seed, according to its mineral and vitamin quantity, is made 
up of iron (105 mg) , copper (18 mg), zinc (60 mg), phosphorus (527 mg), 
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calcium (1860 mg) (Tekeli , 2014), thiamin (15.4 mg), niacin (57 mg), 
pyridoxine (5.0 mg) and folic acid (160 mg) (Takruri and Dameh (1998), 
Venkatachallam et al., 2010). Furthermore, Meziti et al., (2012) conducted an 
experiment, whereby he found the existence of sterols, triterpenes, tannins, 
flavonoids, cardiac glycosides, alkaloids, saponins, volatile oils, coumarins, 
volatile bases, glucosinolates and anthraquinones, and revealed the quality of 
Nigella sativa seeds along with many other Saudi Arabian herbs used in 
traditional therapy. In the same year, Gharby et al., (2015) uncovered 67 
compounds from the oil extracted from the Nigella sativa seed including 
monoterpenes (~46%); carbonyl compounds (~25%); phenols (~1.7%); 
alcohols (~0.9%) and esters (~16%). Gilani et al, (2004); Keyhanmanesh et 
al., 2014. 
Furthermore, Table 2.4 below shows the nutritional value of Nigella sativa 
seeds as found by recent studies mentioned in ASSI et al, (2016).  
Table 2.4.The Nutritional value of Nigella seeds (ASSI et al., 2016) 
General Nutritional 
information (Al-Ghamdi 
2001) 
Protein  16- 19.9 % 
Carbohydrates  33.9% 
Fiber  5.5% 
Water  6% 
Fixed oil  32- 40 % 
Volatile oil 0.4 – 0.45 % 
 
Vitamins (Zahoor et al 
2004) 
Thiamine  15 μg/g  
Riboflavin  1 μg/g 
Pyridoxine  5 μg/g 
Folic Acid  610 I.U/g  
Niacin  57 μg/g 
 
Minerals Contents  
(Zahoor et al 2004) 
Calcium 1.859 mg/g 
Phosphorus 5.265 mg/g 
Iron  105 μg/g 
Copper 18 μg/g 
Zink  60 μg/g 
Gram (g)Micrograms (μg),  milligrams (mg) 
2.9.3. The General benefits of Nigella sativa 
Nigella sativa seeds are widely used in the Middle East and Asian countries, 
are used as a good treatment for coughs and very effective when used with 
honey in the early morning on an empty stomach to stimulate the hunger 
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enzymes (ibid, 1987). Gilaniet al., (2004) also found that they can be used in 
medicines to treat different diseases such as fever, cold, headache, asthma, 
rheumatoid and other ailments of stomach and intestines.  
Nair (1991) tested the effect of Nigella sativa seeds oil extract on mice and 
found that it was an effective antioxidant, which reduces the toxic effects of 
anti-cancer medicines and helps to maintain the haemoglobin and white blood 
cell count.  
The biological resistance on hamsters is held up mainly through immunity and 
sustained cellular structure. The physical well-being and the performance of a 
body are made better. Nigella sativa enhances this course of action through 
triggering macrophage phagocytic effects through lymphocyte stimulation or 
directly. The hypoglycaemia and enhanced immunity of the biological system 
in rats due to the decreased liver gluconeogenesis is a conclusion of this ability 
(Fararhet al., 2004). Lymphocyte counts and allergic ailments have been 
treated through this. (Kaluset al, 2003) 
These previous in-depth studies on animals examined the effect of Ns in 
supporting the immune system and glucose levels. However, these animal 
studies were limited in how possible it is to extrapolate these findings to 
humans. 
Furthermore, Mohtashamiet al., (2011) claim that traditional medicine has 
made use of a number of different mixtures made with Nigella sativa seeds for 
the prevention and the treatment of not only diabetes but also a large variety 
of other illnesses such as blood pressure. In contrast, despite Mohtashami et 
al. (2011) showing a positive effect of NsO on fasting blood glucose in healthy 
adults, the study did not include diabetic patients. It could be that the reduction 
in fasting blood glucose with NsO works only with healthy participants. 
 
The Nigella sativa seeds oil has a beneficial effect on back pain, skin and 
suitable for rheumatoid Mutabagani (1997) and AL-Ghamdi (2001). 
 aderet al., (1993), Alimohammadiet al., (2013) and keyhanmaneshet al., 
(2014) mentioned that the reduction in the blood glucose levels with a Nigella 
sativa treatment caused by insulinotropic properties and decreasing of hepatic 
gluconeogenesis.  
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Bamosa et al. (2010), agreed with the previous study (Al-Hader et al., 1993) 
that showed a marked effect of Nigella sativa on blood glucose levels in 
alloxan diabetic rabbits, and also agreed with Labhal et al. (1997), who found 
an effect of Ns in controlling glucose homeostasis among sand rats. 
In 1987, Al Awadi et al. published a paper in which they demonstrated that 
there was no hypoglycaemic effect of Nigella sativa in streptozotocin diabetic 
rats. Furthermore, in 2004, Le et al. reported that Ns has no effect on glucose 
levels in normal rats. The different results for these studies could be due the 
different ways of extracting the Nigella seeds or to the different animal species. 
2.9.4. Effects of Nigella sativa on Diabetes and Blood 
Glucose 
Globally, millions of individuals suffer from the chronic illness of Diabetes 
Mellitus (DM), which has resulted in an interest in research into the factors that 
could help to treat the disease. In the late 1900s studies were carried out to 
test the effect of Nigella sativa (Ns) on various diabetic animals. Therefore, 
keyhanmaneshet al., (2014) suggested that plants such as Ns could be used 
to control diabetes. Furthermore, Al-Haderet al, (1993) also found a significant 
effect of the volatile oil of Ns seeds on insulin levels in diabetic rabbits, implying 
that Nscould be used as a treatment for hypoglycaemia.  
The few animals studies support the hypothesis of this thesis and also the 
clinical studies in humans sitting support the gap that using NS has a positive 
effect on blood glucose levels (see table 2.5). Furthermore, the clinical trial 
showing these results in humans has a robust study design and the literature 
review shows that there are mixing terms of animal outcomes and human 
outcomes. 
Although studies on animals may provide an indication as to what kind of an 
effect a particular substance (in this case Ns) would have on humans, the 
findings of such studies can be considered problematic when trying to 
understand the effect of Ns on humans, especially because the biological 
functions of the animals used were very different from that of human beings 
(Tekeogluet al., 2007). 
However, another way in which an understanding of the effect of Ns on 
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humans can be achieved is through the commonly used folk remedies. 
Although folk remedies and medical alkaloids have often been successful in 
healing different diseases, they are not based on any scientific findings. 
Despite this fact, the ingredients used within folk recipes and regimens (such 
as Ns) do provide an interesting subject for scientific research as it could help 
to develop an understanding of the beneficial healing ability of Ns and why it 
has been used as an effective treatment for many diseases (including DM) 
throughout history (Tariq, 2008; Ahmad et al., 2013).). In addition, Rchidet al, 
(2004) discovered that traditional Moroccan treatments for DM also made use 
of Ns, while Mohtashamiet al, (2011) also suggests that to treat and prevent 
diabetes and a large variety of other illnesses, traditional medicine has made 
use of a variety of Nigella sativa seed concoctions. 
Such findings lead to a series of controlled clinical studies whereby the effect 
of Ns was observed in humans. For example, Bamosaet al, (1997) gave 
healthy adults 2g/day of Ns seeds for 2 weeks and found a reduction in BGL. 
Bamosaet al, (1997) started with a small group, healthy students and for a 
short duration, because further research was needed to investigate the actual 
reduction in blood glucose levels. Further research then included patients with 
T2DM, such as the study of Bilal et al., (2009), who used a dose of 0.7g/day 
of Ns seeds for 40 days, and noticed a highly significant reduction in FBG 
levels on Type 2 diabetes patients. Furthermore, in a study by Bamosaet al, 
(2010) sufferers of Type 2 DM were given different doses of Nigella sativa 
seeds (1, 2 and 3g/day) as a complementary treatment to their existing anti-
diabetic drugs, to investigate the impact of Nigella sativa seeds on the 
glycemic control. Despite Bamosaet al, (2010) having improved their study 
since 1997 with a time duration of consuming the Nigella sativa seed powder 
to 3 months, however, still there is a limitation that the unspecific selection of 
the diabetic patients. Because of that, in 2015, Kaatabi et al. designed a study 
to compare their results with Bamosa et al., 2010. Therefore, the improvement 
in BGL levels were reduced over one year after using NS seeds powder 2g 
/day. The inclusion criterion was HbA1c > 7% and < 9%. The good effect of 
using 2g/day of NS powder was that of enhancing the antioxidant defence 
system for T2DM. 
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Kaatabi et al. (2015), have illustrated that Nigella sativa seed powder (2g a 
day) has postive effects on fasting blood glucose and HbA1c levels. In 
Kaatabi’s et al. study, there was no specific diet to follow for the diabetic 
patients and they also did not  use physical activity diaries because the study 
was over a long period. 
Although the factors measured all indicated a decrease in BGL, when 1g of 
Nigella sativa was ingested daily, the results were statistically insignificant. 
These results remained the same when 3g of the seed powder was ingested 
daily. The different doses of Nigella sativa powder administered in the 
research resulted in no negative effects in terms of the kidney or hepatic 
functions of the study subjects. Therefore, Bamosaet al, (2010) concluded that 
an intake of 2g of Nigella sativa seeds daily for 12 weeks, reduced BGL levels 
in Type 2 diabetic patients. The reduction in blood glucose level could be 
possible due to the reduction in gluconeogensis (GNG) in the liver. Thus help 
to avoid hypoglycemia in type 2 diabetes. It has been found that increasing 
the hepatic glucose production could increase the fasting blood glucose by 
increasing the GNG for diabetes patients. Bamosa 2010 
Two years later, another similar study was conducted by Najmiet al, (2012) to 
evaluate the effect of Ns seeds on fasting blood glucose (FBG), 2 hours 
postprandial (2hPP) blood glucose and glycated haemoglobin (HbA1c) in 
patients with poor glycaemic control. The results indicated that treatment with 
Ns significantly decreased the FBG, 2hPP blood glucose and HbA1c after 2 
months, which would be considered an improvement in glycaemic control for 
patients with Type 2 diabetes. 
Moreover, some studies extended the research of Ns by extracting oil from the 
seeds (NsO) and investigating the effect it had on humans. For example, 
Mohtashamiet al, (2011) found a statistically significant correlation between 
the ingestion of NsO and a reduction in fasting blood glucose levels of healthy 
adults. Furthermore, Hosseini et al, (2013) conducted a randomised trial of 
Type 2 diabetes patients in Iran, to investigate the effects of NsO on glycaemic 
status (FBG, PPBG and HbA1c), lipid profile, renal function and BMI. They 
(ibid, 2013) concluded that a dose of 5ml/day of NsO for 3 months, seemed to 
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improve glycemic control and BMI, while also observing a significant reduction 
in FBG, 2hPP blood glucose, HbA1c and BMI. Hosseini’s et al (2013) study 
has the weakness of not showing clearly how the data were handled. However, 
the data collection methodologies were presented in detail. Heshmati et al, 
(2015) also found that NsO caused a significant change in glycaemic profile 
(fasting blood glucose FBG, glycated haemoglobin HbA1c) after carrying out 
a study to investigate the effects on glucose metabolism in patients with Type 
2 diabetes. They (ibid, 2015) examined males and females aged between 30-
60 years old, who received Nigella sativa oil (NsO) 3g/day (of soft gel 
capsules) for 12 weeks and suggest that a diet supplemented with NsO may 
help to control glycaemic profile of T2DM patients. Hishmati et al (2015) 
discussed the findings from pervious research such as Bamosa et al (2010) 
and found that their findings concurred.   
2.9.5. Nigella sativa seeds on Blood Pressure and 
Antioxidants 
There have been several studies reporting the effe ct of Nigella sativa on Blood 
Pressure (BP) and artery disease. For example, Najmi et al, (2007) carried out 
a numerical study of the beneficial effect of Nigella sativa oil (NsO) on 
parameters of metabolic syndrome in patients with Type 2 diabetes, and 
showed that there was a significant change in BP as a result of a dose of 
5ml/day for 6 weeks. This study demonstrates particular strength in the 
selection and allocation of study participants. 
One year later, Dehkordi and Kamkhah, (2008), investigated the 
antihypertensive effect of Nigella Sativa seeds extract in Type 2 diabetic 
patients. In this study, the patients consumed 200 mg and 400 mg of NS/daily 
for 8 weeks and this resulted in a significant decline (p<0.05) of the systolic 
blood pressure (SBP) and diastolic blood pressure (DBP), when compared to 
the baseline after 2 months. Dehkordi and Kamkhah’s study selected suitable 
participants according to the inclusion criteria and presented their methods 
clearly. 
Five years after their study on NsO, Najmi et al, (2012) conducted another 
study whereby they measured the impact of 500mg/day of Nigella Sativa 
seeds on the BP of patients with metabolic syndrome over a period of 8 weeks. 
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BP measurements were taken at the baseline and then again at 2,4,6, and 8 
weeks. They (ibid, 2012) found a significant decrease in SBP, DBP, which they 
attributed to the antihypertensive effect of Ns.   
Furthermore, Fallah Hosseini et al, (2013) examined the effect of Nigella sativa 
seed oil (NsO) on SBP and DBP in healthy participants with a dose of 5ml 
daily during an 8 week period, and found a significant decline in both 
parameters (SBP and DBP) when compared to the placebo and baseline 
groups. They claimed that one of the reasons for the beneficial effects of 
Nigella Sativa on blood pressure was due to the lowering of arterial pressure 
(AP) and heart rate. (Eltahir et al, (1993); El Tahir and Ageel (1994), Fallah 
Hosseini et al, 2013). Fallah Hosseini’s study discussed and analysed their 
data clearly and in detail. 
Fallah-Hosseiniet al, (2013) also suggest that another possible reason for the 
decrease in BP was due to the effect of Ns volatile oil, which contained 
unsaturated fatty acids, such as oleic and linoleic acids (Ghosheh et al, (1999) 
and Doganet al., 2010), and flavonoids, which could have been the cause of 
a drop in the arterial pressure and heart rate. Earlier studies (e.g. Takeuchi et 
al., 2007; Miura et al., 2008 and Medina Remonet al., 2011), demonstrate that 
there is link between dietary oleic and linoleic acids intake and blood pressure. 
Furthermore, Fallah-Hosseiniet al, (2013) also support the findings of Khattab 
and Nagi (2007), who suggested that the decrease in BP may also have been 
caused by thymoquinone, one of the antioxidant active components found in 
NsO.  
Moreover, Galleano et al, (2010) explain that NsO is a rich source of 
polyphenols and flavonoids (a part of a phenolic family of compounds that 
have antioxidant properties), which are important in antioxidant activity and 
free radical properties. Carr and Frei (2000) and Fallah-Hosseiniet al, (2013) 
claim that it is these properties within NsO that cause a decline in the BP 
levels, which in turn leads to a decrease in the oxidative stress.   
Inhibit the oxidative stress by antioxidants activity and free radicals 
participating in impaired endothelial function are risk factors for hypertension 
(Carr and Frei ,2000; Fallah-Hosseiniet al, 2013) And the treatment with NsO 
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decreased the BPs was due to antioxidant activity of thymoquinone against I-
Name- induced hypertension (Kattab and Naqi 2007; Fallah-Hosseiniet al, 
2013) Nigella sativa is a rich source of antioxidants and flavonoids and 
polyphenols  
Nigella Sativa improve glycaemic control and Kaatabi et al, (2015) suggested 
that long duration of using NS supplementation as a treatment for diabetic 
patients will improve glucose homeostasis and raised antioxidant defence 
system in Type 2 diabetes patients. 
2.9.6. Effect of Nigella sativa on Cholesterol Levels 
Very few studies have been carried out to investigate the effect of Ns on 
cholesterol levels, and the studies that have been carried out in this area are 
mainly on animals. For example, Zaoui et al, (2002) tested Nigella sativa oil 
on diabetic rats and the effect it had on cholesterol levels over 12 weeks, and 
observed a decrease in the cholesterol level. Zaoui’s et al study has been 
shown a weakness in investigating the Nigella sativa’s effects only in diabetic 
rats and mice with no tests performed in control animals. 
Furthermore, Dahriet al, (2005) conducted a study on 24 eight-week old albino 
rats and observed the level of cholesterol after administration of Ns. Upon 
initiating the experiment, blood tests of the rats were taken, in order to 
measure cholesterol levels, and for 20 weeks they were given specific control 
and experimental nutritional regime. From this experiment it was concluded 
that serum HDL was elevated and LDL cholesterol was reduced.   
Kaatabi et al, (2015) undertook one of the few studies on humans (diabetic 
patients) to investigate the effect of Nigella sativa powder on lipid profile levels 
and showed a substantial reduction in cholesterol level, following an intake of 
2 grams of Nigella sativa powder daily for 12 weeks. The limitation of Kaatabi’s 
et al study was that all patients were not following a specific diet and making 
physical activity records. However, these limitations had only a slight effect on 
the study. A strong point was presenting the supporting information in tables 
and figures. 
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Summary  
Traditional Arab treatments of biological ailments have always originated 
from herbs. During experimental studies very few herbs have been 
investigated for the potential treatment of diabetes and those that have been 
carried out have based their findings on animal studies. Hence it has been 
concluded that traditional herbs that possess anti-diabetic effects may prove 
to be beneficial for individuals suffering from diabetes along with other 
hypoglycaemic medicines.  
Many experiments still have insufficient statistics, leading to disarray in the 
findings such as small sample size, decrease time of experiment, placebo 
group and lack of authority on subject. Hence, considering the lack of quality 
data and inference it is too early to assess and give a remark to the herbs 
with anti-diabetic potential. 
As shown in table 2.5 below, the previous intervention studies on human have 
highlighted a potential effect of Nigella Sativa seeds supplemented in diabetes 
Type 2. In addition, Nigella Sativa different types (oil, powder, extract and 
seeds) have a beneficial effect on blood glucose and improving glucose 
profile. In this study, it has been chosen Nigella sativa as a raw seeds because 
the other researchers have further examined the Ns as oil, powder and as a 
tea. There is a need for more research on Ns as a raw seeds it’s self. The 
methodologies of clinical trials (Randomised clinical trial, clinical trial, Double 
blind and Randomised clinical trial) could have influenced the results obtained 
(see table 2.5). 
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Table 2.5. Summary of the studies for Nigella sativa seeds 
Study paper Study 
population 
N=Sample Size 
Inclusion criteria Study design Period of 
intervention 
study 
Type and 
dose of NS 
Outcome  and 
Association 
(+P Value) 
Bamosa et al., 
1997 
{N=16 
9/6} 
  
  
Second year male 
medical students 
  
Saudi Arabia 
Clinical trial 2 weeks NS 
2g/day 
Sig change in FBG and 
TC (P<0.05) 
  
No significant decrease 
in TG (P>0.05) 
Najmi et al., 
2007 
{N=161 
80/81} 
  
40 – 60 years 
Metabolic 
Syndrome 
  
North India 
  
Randomised 
clinical trial 
  
  
6 weeks 
  
NSO 
(Extracted oli) 
5ml/day 
Sig change in FBG, HDL 
and LDL (P<0.05) 
  
No significant decrease 
in Weight, BP,  
(P>0.05) 
Dehkordi  and 
Kamkhah , 2008 
{N=108 
36/39/33} 
  
35 – 50 years 
Hypertension’s 
patients 
Double blind and 
Randomised 
clinical trial 
8 weeks Extract of NS 
(Extracted by 
water) 
200 mg/day 
400 mg/day 
Sig decrease ↓SBP and 
DBP (P<0.05)   
No significant change in 
weight, TG and 
HDL(P>0.05) 
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Najmi et al., 
2008 
N= 60 
30/30 
  
North India Clinical trial 6 weeks 5 ml /day 
NSO 
(Extracted oli) 
Sig reduction in FBG 
and Lipids and 
TC(P<0.05) 
Non sig TG, HDL and 
WC (P>0.05) 
Bhatti  2009 N= 10 
50 – 55 years 
Hyperlipidemic 
patients 
Pakistan 
Controlled trial, 
Non control 
2 months 1g/day 
Sig change in TG, TC, 
LDL and HDL (p<0.05) 
  
Bilal et al., 2009 N=41 
30 – 60 years 
T2DM 
Pakistan 
Controlled trial, 
Non-control 
40 days NSO 
(Extracted oli) 
0.7 g/day 
Sig. decline ↓FBS 
(P<0.001)   
Qidwai et al., 
2009 
{N=73 
39/34} 
≥18 years 
  
Pakistan 
Double blind and 
Randomised 
clinical trial 
6 weeks 1g/day 
No significant change in 
FBG, BMI , BP and Lipid 
profile (P>0.05) 
Bamosa et al., 
2010 
{N=68 
23/26/19} 
18- 60 years 
T2DM 
KSA 
Controlled trial, 
Non- control 
3 months NSP (powder) 
1,2 and 3g/day 
Sig reduction in FBG, 
2hPPBG, HbA1c 
(p<0.05)in group 
2.3g/day 
No significant change in 
group 1g/day (P>0.05) 
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Datau et al., 
2010 
{N=39  
19/20) 
  
30 – 45 years 
Obese Men 
(Indonesia) 
Double blind and 
Randomised 
clinical trial 
  
3 months 
  
NS 
1.5g/day 
Sig reduction in weight 
and WC (P<0.001) 
  
No significant change in 
BP, FBG, HDL and TG 
(P>0.05) 
Haque et al., 
2011 
{N=60 
30/30} 
  
40 – 60 year  
Anti-obesity therapy in 
Metabolic syndrome 
  
North India 
Randomised 
clinical trial 
  
6 weeks NSO 
(Extracted oli) 
5ml/day 
Non Sig in weight and 
WC 
Ibrahim et al., 
2011 
N=18 
  
23- 31 years 
  
Yemen 
Controlled trial, 
Non-control 
2 weeks 500 mg/day 
Sig reduction in FBG 
(p<0.05) 
No significant change in 
Lipid profile (P>0.05) 
Mohtashami et 
al., 2011 
{N=70 
35/35} 
  
25 – 60 years 
Healthy adults 
(Iran ) 
Randomised 
clinical trial 
  
2 months 
 NSO 
(Extracted oli) 
5ml/day 
Sig  change  in FBG, 2 
and  HbA1c (P<0.05) 
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Ahmed et al., 
2012 
{N=66 
41/25} 
  
  
  
  
T2DM 
Egypt 
Clinical trial 6 months NS tea bag 
5g/day 
Extract of 
N.Sativa ) 
Sig change in FBG, TC, 
LDL, TG and HDL   
(P<0.001) 
  
Elrehany et al., 
2012 {N=55 
40/15} 
  
35 – 65 years 
Patients with coronary 
artery disease and 
dyslipidemia 
Egypt 
Clinical trial 8 weeks NSO 
(Extracted oli) 
900 mg/day 
Sig change in BP, LDL, 
TG, TC and HDL  
(P<0.001) 
  
Kaatabi  et al., 
2012 
{N=71 
23/26/22} 
18 – 60 years 
T2DM 
KSA 
Controlled trial, 
Non-control 
3 months NSP (powder) 
1,2 and 3g/day 
Sig reduction in TC, 
TG,LDL and HDL 
(p<0.05)in group 
2.3g/day 
No significant change in 
group 1g/day (P>0.05) 
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Najmi et al., 
2012 
{N=80 
40/40} 
  
40 – 60 years 
Patients with poor 
glycemic control 
(North India ) 
Randomised 
clinical trial 
8 weeks NS 
500 mg/day 
Sig decreased in FBG, 
2hPPBG, HbA1c and 
LDL(P<0.001) 
  
No significant change in 
TG and HDL (P>0.05)  
Sabzghabaee et 
al., 2012 
{N=74 
37/37} 
  
≥18 years 
 
    
Randomised 
clinical trial 
  
4 weeks 
  
NS 
2g/day 
Sig decreased in TC, 
LDL and TG (P<0.001) 
  
No significant change in 
FBG and HDL (P>0.05)  
Shah et al., 2012 {N=159 
80/79} 
  
40 – 60 years 
Metabolic 
Syndrome 
  
Pakistan  
Clinical trial 6 weeks NS 
500 mg/day 
Sig change in FBG, HDL 
and LDL (P<0.05) 
  
No significant decrease 
in TG , TC, BP and 
weight (P>0.05)  
Fallah Hoseini et 
al., 
2013 
{N=70 
35/35} 
34 – 63 years 
Healthy adults 
(Iran ) 
Double blind and 
Randomised 
clinical trial 
8 weeks NSO 
(Extracted oli) 
5ml/day 
Sig change ↓SBP and 
DBP (P<0.001)  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Hoseini. et al., 
2013 
{N=70 
35/35} 
  
34 – 63 years 
T2DM 
Iran 
Double blindand 
Randomised 
clinical trial 
3 months   
NSO 
(Extracted oli) 
5 ml/day 
Sig reduction in FBG, 2 
hPPBG, HbA1c , BMI 
and TC (P<0.05) 
  
No significant change in 
HDL, TG and 
LDL(P>0.05) 
Najmi et al., 
2013 
{N=90 
45/45} 
40 – 60 years 
Metabolic 
Syndrome 
North India 
  
Randomised 
clinical trial 
  
8 weeks 
NS 
500 mg/day 
Sig decreased in SBP 
and DBP (P<0.001) 
  
Ibrahim et al., 
2014 
{N=37 
19/18} 
  
50 – 55 years 
Menopausal women 
  
Malaysia 
  
Randomised 
clinical trial 
  
2 months 
  
NS 
1g/day 
Sig decreased in TC, 
TG, FBG and 
LDL(P<0.05) 
No significant change in 
BP and HDL (P>0.05)  
Kaatabi et al., 
2015 
 N=114   T2DM CT 12 months NS 2g/day 
↓ FBG 
↓ HbA1c 
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2.10. Ajwa dates 
2.10.1. History of Ajwa dates 
Dating back to 5000 BC, and cultivated only in Al Medina Al-Munwarah, Saudi 
Arabia, the Ajwa date is a staple of Middle-Eastern cuisine and diet. During the 
course of Ramadan, Muslims all over the world, break their fast with the Ajwa 
date. High in natural fibre, with a soft, fine texture (Khalid et al., 2017), Ajwa 
dates provide a suitable amount of roughage to assist the ingestion process 
and maintain the balance of the digestive tract, whilst the high potassium 
content preserves and controls muscle contractions. Another key facet of Ajwa 
dates is the high iron content, which assists in the treatment and prevention of 
anaemia by increasing red-blood cell production (Ragab et al., 2013). Ajwa 
dates are also hugely beneficial throughout the maternity process; in enhancing 
the breast milk in lactating women, children are less susceptible to disease and 
infection through the consumption of Ajwa-enriched milk, than normal breast 
milk (Ragab et al., 2013).  
Originating in Saudi Arabia, Ajwa dates are among the most costly dates 
available, costing approximately 80SR, £16 and $21 for one kilogram. They are 
found in the Madinah region of Saudi Arabia and characterised by their 
softness, dryness and high cost. Health experts in Saudi Arabia claim that Ajwa 
dates contain anti-oxidant elements due to the flavonoid glycosides found in 
them, thus they have antioxidant and anti-inflammatory effects (Assirey, 2015). 
Furthermore, a cyclo-oxygenase inhibitory effect, comparable to that produced 
by anti-inflammatory medications such as ibuprofen, celebrex, aspirin and 
naproxen, has also been found to be produced by Ajwa dates (Zhang et al., 
2013). 
Moreover, fruits dates are certified as low in glycaemia on the glycaemic index 
as they have a value lower than 55, and a range between 29 and 55 (Al-
Mssallem. 2014). This index highlights a food’s capacity to increase blood sugar 
in relation to the carbohydrates present in the food. Such a trait increases the 
control of both lipids and glycaemia and is considered desirable as there is a 
correlation between a low glycaemic index and the diminished prevalence of 
cardiovascular disease, weight loss and diabetes. Whilst there is a considerable 
range witnessed in the glycaemic index of dates, and thus some dates are more 
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effective than others, Ajwa dates, in particular, are incredibly beneficial for the 
maintenance of the human body (Miller et al., 2002 and Alkaabi et al., 2011). 
Al-Khayri  et al., 2015 described the Ajwa date as a medium size and the colour 
of Ajwa is dark and should be consumed at tamar stage. There are 5 stages 
that take place over 7 months (see figure 2 .8below) for the growth of dates. 
Figure 2.9 (below) shows each of the stages of the ripening process from 
Hababouk to Tamar.  The softness, flavour, colour, appearance and nutritional 
value of the dates is dependent on the stage at which it is used. The Ajwa date 
is picked during the tamar stage, which results in a variation in its chemical 
composition and a reduction in the nutritional value (Al-Shahib and Marshall, 
2003 and Fadel et al., 2006).  
 
Figure 2.8. Dates stages (Baliga et al., 2011) 
 
Figure 2.9. Date growing stage (Baliga et al., 2011) 
 
 
 Hababou
k 
 This stage it take 4 to 5 weeks , the date immature post fertilization  
 Kimri 
 
It’s called green stage (take from 9 to 14 weeks ) the longest stage developing the fruit 
dates (dray and green colour) 80% moisture and 50% sugar (glucose and Fructose)  
 khalal 
 It’s called colour stage (takes for 6 weeks) change colour depending on the variety of dates 
physiologically mature  
 Rutab 
 
Texture become soft (soft ripe). It takes between  2 to 4 weeks (changing colour to brown 
or black)  
 
 Tamar 
 
Final stage in the ripening semi-dry. Dry dates will have nearly 50% each of sucrose and 
reduced sugar skin tend to soft flesh  
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2.10.2. Chemical composition and Nutritional facts of Ajwa 
dates 
Contemporary medical practice affirms that Ajwa dates aid in the prevention of 
cancer of the abdomen (Khalid et al., 2017). Ajwa dates contain a wider range 
of elements than other dates and consist of: calcium, sulphur, oil, iron, 
phosphorous, manganese, potassium, magnesium and copper(see table 
2.6).They are nutrition-rich and are made up of 60% sugar and 2% each of fat, 
minerals and proteins . (Hasan et al., 2010). 
The Ajwa date is one particular fruit that has a significant presence of 
polyphenolic such as (.Rutin 0.65 to 0.85 mg/100 g , Catachin 0.73 mg/100g 
and Caffeic acid 0.57 to 1.84 mg/100(Saleh et al., 2011; Hamad et al., 2015; 
Ahmed et al., 2016). In addition, Ajwa date has 283.43 milligrams of polyphenol 
per 100 gram serving. As a result, Ajwa dates are a key in the treatment of 
blood-related diseases. The presence of polyphenol compounds has a 
beneficial effect on glucose and lipid metabolism. (Jung et al., 2006).  
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Table 2.6. The composition for Ajwa dates (Phoenix dactylifera L) (per 100 g) (Assirey 
2015) 
 Ajwa date  
Sugar content of date flesh from cultivars (g/100 g dry weight).  
 
Ash 3.43 ± 0.01  
Lipid  0.47 ± 0.001  
Protein  2.91 ± 0.02  
Moisture  22.8 ± 0.1  
Total sugar  74.3 ± 0.2  
Reducing sugar 71.1 ± 0.5  
Sucrose 3.2 ± 0.03  
Glucose  51.3± 0.3  
Fructose  48.5 ± 0.2  
Minerals composition of date flesh in four cultivars (mg/100 g dry weight).  
 
Calcium 187 ± 0.5  
Phosphorus 27 ± 0.1 
Potassium  476.3 ± 0.4 
Sodium  7.5 ± 0.1 
Magnesium  150 ± 0.7 
 
Assirey (2015) and Khalid et al, (2016) reported that Ajwa dates are a rich 
source of dietary fibres, which are vital for the wellbeing of humans. An increase 
of an intake of dietary fibre could lead to a decrease in the cholesterol level, 
constipation and cancer. The Total Dietary Fibre (TDF) in Ajwa date stone was 
higher (26.4 to 33.9%) than the flesh of the Ajwa dates flesh (6.2 to 8.9%). 
 In addition, the Soluble Dietary Fibre (SDF) for the Ajwa date stone was 
between 13.5 to 22.5% and for Ajwa date flesh was between 6.2 to 13.5%, 
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whereas the Insoluble Dietary Fibre (IDF) for the Ajwa date flesh was 3.2 to 
4.6% and 11.2 to 12.8% for the Ajwa stone. 
Moreover, several studies (such as Al-Laith, 2009; Amoros et al, 2009; Al-Turki 
et al, 2010) have found that Ajwa dates are rich in polyphenols that are 
important in controlling cholesterol levels, which in turn decreases the chance 
of suffering from cardiovascular related diseases. Furthermore, Saleh et al 
,(2011) mentioned that there are different values of the total number of 
polyphenols of the Ajwa date when compared to Sukkari and Khalas dates. 
They (ibid, 2011) found that Ajwa dates had a water extract of 455.88mg/100g, 
while Sukkari dates contained 377.66mg/100g and Khalas dates had 
238.54mg/100g. Therefore, Ajwa dates had the highest value for the total 
amount of polyphenols. Hamad et al, (2015) and Saleh et al, (2011) explain that 
the reason for this is due to polyphenol concentration values varying depending 
on the method of extraction and how ripe the dates are (see table 2.7). Thus, 
the polyphenol value for Ajwa dates extract by aqueous was higher than 
alcohol.  
Table 2.7. The Ajwa date contain higher polyphenol content (Eid et al., 2013,Khalid 2016) 
 Dates growing stages  Polyphenol content 
Kirmri stage 290 mg/100 g 
Khalal stage 150 mg/100g 
Rutab stage 20 mg/100g 
Tamar stage 10 mg/100g 
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Ajwa dates are a type of fruit date palm (Phoenix dactylifera), which are a rich 
source of vitamins and minerals (iron, potassium, zinc, selenium and 
magnesium)(Ahmed et al., 2014). An Ajwa date provides essential amino acid 
as shown in table 2.8 and are also rich in iron, which is important for people with 
anemia. Further benefits of the Ajwa date is that it has been shown to enhance 
hemoglobin levels. (Alghamdi, 2017). 
Based of the varieties of nutrients present in Ajwa dates, recently many studies 
have used Phoenix dactylifera as a traditional medicine for treatment as it plays 
an important role in anti-diabetic activity  
Table 2.8. Amino acid content of Ajwa date flesh (mg/100 g dry weight). Assirey (2015). 
Amino acid (mg/100 
g)  
Ajwa 
Dates 
Amino acid (mg/100 
g) 
Ajwa 
Dates  
Aspartic acid  186 Valine 65 
Glycine  83 Leucine 57 
Histidine  26 Arginine 93 
 
 
Figure 2.10. The chemical composition of Ajwa dates  
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2.10.3. Ajwa dates and antioxidants  
Khalid et al (2017) evaluated a number of preclinical studies and reported that 
a dietary intake of Ajwa dates acts as a treatment for several illnesses such as 
(chronic disease and cancer) due to the presence of strong antioxidant, 
antimutagenic and hepatoprotective properties in the Ajwa date.  
Moreover, Ragab et al (2013) conducted a study from Al-Medina Al-Munawarah 
and focused on the significant attributes of the Ajwa extract, in particular as an 
antioxidant and its tissue protection abilities. They (ibid, 2013) found that Ajwa 
dates possesses significant antioxidant properties that assist in reducing and 
restricting lead-induced transitions in oxidative biomarkers in serum. The 
reason this occurs remains uncertain, but polyphenols, flavonoids and flavones 
are all offered as suitable solutions, as they exist in the Ajwa date (Ragab et al., 
2013). 
Several studies including Hasan et al (2010); Baliga et al (2011) and Hamad et 
al (2015) have found that tissue protection is afforded through ‘free-radical 
scavenging’ and the antioxidant aspect of the Ajwa date. They also found that 
the antioxidant nature of the extract from medicinal plants reduces the effects 
of metal toxicity – an aspect that is increasingly studied by researchers of 
phytotherapy. As a result, the extract could be used as a management tool in 
nutritional protocols surrounding lead poisoning. Ragab et al (2013) suggest 
that it is important to further elucidate the effects of the Ajwa extract, in order to 
fully comprehend the preventive and therapeutic benefits. Ragab’s et al study 
however, was designed to study animals and therefore cannot be compared to 
results in humans.  
2.10.4 Ajwa dates and Diabetes   
The present treatments for Diabetes are based on man-made medicines/ oral 
hypoglycaemic agents, which are effective, but have also been found to cause 
adverse effects and alter the metabolic and genetic pathways (Al-Alawi et al., 
2017). It is for this reason that the use of natural products (such as Ajwa dates) 
is a good approach to control diabetes, as they are less toxic and free from side 
effects. Miller et al (2003) conducted a study whereby they found that a diet 
including dates with yoghurt could have a beneficial effect on glycaemic and 
lipid control in diabetic patients. This study was conducted on healthy 
participants, hence the same batches of dates and yoghurt were used for all 
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participants. However, it wasn’t allowable for diabetic patients to eat the same 
amount of dates as the healthy subjects, which was 6 to 8 dates. Although the 
exact mode of action of dates in the control of diabetes is not fully known, it has 
been suggested that it might be due to an increase in the output of insulin and 
inhibition of glucose absorption, which is an effect that plants have shown to 
have on managing the function of pancreatic tissues (Malviya et al., 2010 and 
Fatima ,2012) 
Ajwa dates, like other plants, plays an anti-diabetic role as they contain the 
active component of the PDE antioxidant. A recent study (Michael et al., 2013) 
looked at flavonoid compounds from date fruits and showed that PDE plays an 
important role in the improvement of the different biochemical results in diabetic 
rats. Furthermore, Zhang et al (2015) claim that the strong antioxidant profile of 
the Ajwa fruit can play a strong anti-diabetic role by scavenging the free 
radicals. Moreover, Hussain Mallhi et al (2014) claim that the richness of 
flavonoids and phenols in Ajwa date extracts could be the reason for their anti-
diabetic activity, which can play a role in controlling diabetes as the phenolic 
compounds also modulate the secretion of insulin in the human body. Hasan 
and Mohieldein (2016) also found that consuming Ajwa seed extract by water 
(100g/L) had a significant reduction in the blood glucose level of streptozotocin 
diabetic rats due to the control of oxidative stress. However, the small sample 
size of Hasan and Mohieldein’s study were one of the limitations of their study. 
Their study (ibid, 2016) was an animal expiremintal study and this type of study 
is weak compared with the human trials. There is a further research is needed 
to test the hypothesis that Ajwa dates have good impact on blood glucose level 
on human.  
2.10.5 Ajwa dates and blood pressure  
The pressure of blood in the arteries fluctuates between heartbeats. It will be 
highest when the heart contracts and pumps blood throughout the body 
(Systolic Blood Pressure, SBP also known as the upper number), and lowest 
when the heart relaxes, while it fills with blood before pumping again (Diastolic 
Blood Pressure, DBP, also known as the lower number) (Amery et al., 2012).  
Hypertension can be defined as high blood pressure that causes a rise in the 
systolic blood pressure (SBP) and an increase in the level of diastolic blood 
pressure (DBP). The SBP is the upper number and a high level would have a 
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detrimental effect on human health (Lawes et al., 2008).  
The British Heart Foundation (BHF) reported that the normal and healthy level 
should be in the range (90/60 mmHg to 120/80 mmHg). Furthermore, Lawes et 
al (2008) highlight that patients with a high blood pressure (more than 140/90 
mmHg) have damage in the wall of their arteries, which leads to a higher risk of 
heart attack or heart diseases (such as stroke, clot and CVD). Most patients 
with hypertension (high blood pressure) do not know that they have the disease, 
which is why hypertension is named the “silent killer” as its symptoms 
(headache, dizziness and in some cases visual disturbances) remain unnoticed 
for years before diagnosis (Amery et al., 2012).  
Ekmekcioglu et al., 2016 reported that an increased dietary intake of potassium 
and decreased consumption of foods containing sodium, have a beneficial 
effect on hypertension patients. Ajwa dates contain important minerals such as 
potassium, which play a vital role in controlling high blood pressure (Assirey, 
2015). 
Summary  
In summary, the Ajwa date has a rich source of antioxidants and the highest 
amount of polyphenols when compared to other types of dates. Data analysis 
from the last few decades suggests that Ajwa dates have a potential to become 
an essential food ingredient for developing new bioactive functional food 
products targeted at various physiological functions of the human body. In 
addition, the Ajwa date is eaten at the tamr stage, whereas the highest 
nutritional value is at the kimri stage, which is why most studies used Ajwa seed 
extract rather than the flesh of the Ajwa date. Although recent animal studies 
have provided evidence for the effectiveness of Ajwa dates, there is a need for 
quantitative studies on humans, to provide a better understanding of the 
protective actions of Ajwa dates and the exact mode of action of Ajwa dates in 
the control of diabetes.  
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3.1. Introduction   
This chapter provides an overview of the research approach used for this study.  
Details of various factors such as, ethical considerations, the study design and 
duration, sample size and selection and methods of data collection will be 
explored. Thereafter, the validity and reliability of the study will be evaluated, 
followed by the statistical methods used and a justification of the choices made 
by the researcher to end the chapter.  
3.2. Ethical considerations 
Approval was given by the Manchester Metropolitan University (MMU) ethics 
committee on 2 April 2013, for the participation of (non-diabetic) volunteers as 
a healthy group. The research ethics committee of Al-Noor Specialist 
Hospital, Makkah, Kingdom of Saudi Arabia (KSA), granted official approval for 
the participation of patients with type 2 diabetes (Diabetic group) on 1 May 2015 
(See appendix 11) and request for the approval was submitted to the ethics 
research committee at MMU and approved on 16th May 2013. Patients were 
informed of the aims of the study and recruited after providing written consent 
to participate. 
3.3. Determination of sample size and study duration  
3.3.1. Sample size for main study   
Having considered the findings of studies in the field since 1997, it is evident 
that the sample size that showed significant validated results ranged between 
n= 16 to 159 (Bamosa et al., 1997; Bamosa et al., 2010; Shah et al., 2012 and 
Fallah Hoseini et al., 2013). These earlier studies noted that the sample size 
with the most improved change to control glucose profile and lipid profile ranged 
from n=60 to n=80 (Mohtashami and Entezari, 2016).  
Therefore, at the beginning of this study, 180 subjects were recruited with the 
intention of providing at least 150 volunteers for the research; 75 participants 
for the trial 1 (diabetic) group and 75 volunteers for the trial 2 (healthy) group. 
As expected, from the 180 participants who initially joined the study and who 
fitted the eligibility criteria, some failed to complete the therapy regime, hence 
dropping out from the study and some of them were barred by specific exclusion 
criteria (patients unwilling to continue the trial). By the end of the study, 75 
participants were randomly selected for the diabetic group and 75 participants 
were randomly selected for the healthy group. In total, 30 participants were 
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eliminated from the initial 180 volunteers, until the researcher had 150 
participants altogether (75 participants for each trial).   
As illustrated in figure 3.1, 15 patients failed to complete trial 1. There were 
various reasons for this including: n=7 failed to continue the study and n=8 of 
the diabetic patients were removed from the study. The details for those who 
left the study after recruitment at Al-Noor hospital are as follows: 3 failed to 
complete the study, due to 2 of them having cardiovascular disease (CVD) and 
one of them having lung cancer. The other diabetic participants (n=5) were 
eliminated because they missed FBG measurements.  The other seven diabetic 
participants who were eliminated stopped taking part in the study. 
From figure 3.2 below it can be seen that 15 participants were eliminated from 
trial 2: n=6 failed to complete the study due to missing measurements (FBG, 
2hPP) and n=9 of the healthy subjects were excluded from analysis. All patients 
were given a supplier of Ajwa dates it is sufficient to finish in 12 week, two 
patients (n=2) were eliminated because they consumed all the Ajwa dates 
supplied for the 12 week study within 1 month of the start. For those were 
assigned to the Nigella sativa seeds, C-NS (n=6), the reasons for their failure 
to complete the trial was that participants travelled abroad (n=3) at week 6 of 
the study, and the others (n=3) ceasing to follow the diet and eating NS.  
3.3.2. Study duration  
Initially, the choice of the study period was based on a previous study by 
Bamosa et al, (2010), which reported that there is a significant reduction in 
fasting blood glucose (FBG), two hours postprandial blood glucose (2hPP) and 
glycated haemoglobin (HbA1c) following 3 months of daily consumption of 
Nigella sativa seeds (2g/day). On the other hand, Datau et al, (2010) found that 
there was no significant decline in blood pressure and fasting blood glucose 
with a dose of 1g daily of Nigella sativa seeds. Although the study of Bamosa 
(1997) demonstrated that 2 weeks was sufficient to show a reduction in FBG 
after a daily consumption of Nigella sativa seeds, Kaatabi et al, (2015) 
suggested that a longer duration is needed to illustrate the beneficial effect of 
Nigella sativa seeds on glucose markers. Thus it was determined that a longer 
duration was needed to result in a beneficial outcome with regards to FBG, 
2hPP and HbA1c levels (Najmi et al., 2008 and Kaatabi, 2015). Therefore, 
based on the findings of the above mentioned studies, the researcher chose 
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the duration of this study to be to 90 days of treatment, with measurements 
being taken weekly.    
3.4. Trial 1 (Diabetic Type 2 Group) 
3.4.1. Study design and study population  
Ninety Saudi male and female type 2 diabetes patients were recruited for the 
study from Al-Noor Specialist Hospital in Mecca, KSA, between July and 
October 2015. Participants who met the inclusion criteria (Figure 3.1), were 
randomly allocated to one of the following three test groups, ensuring equal 
numbers in each group: group 1 consumed a modified diet for 12 weeks (group 
D-D)., second group were given Ajwa date daily in conjunction with a modified 
diet for 12 weeks (group D-AJ). Third group consumed 2g of Nigella sativa 
seeds daily plus modified diet for 12 weeks (group D-NS).The timeframe (over 
a period of 12 weeks) and study outline are detailed in Figures 3.1  
  
Figure 3.1. Study design and progression flow chart for Diabetic group 
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3.4.2. Recruitment and selection of participants 
Included in the diabetic group were patients with type two controlled and 
uncontrolled diabetes, either attending the outpatient diabetes clinic or admitted 
into Al-Noor Specialist Hospital. At the Al Noor hospital, the dietitian and the 
doctor who were responsible for the diabetic patients were with the researcher 
throughout the study to make sure that all the diabetic patients who took part 
were not placed under any risk (such as high blood glucose levels) by the 
modifcations the study required to their diets. The trial 1 participants (diabetic 
patients) were selected randomly using a randomised clinical trial (RCT). 
During the selection stage of the diabetic participants in Makkah, the researcher 
checked through and reviewed the hospital files of 300 patients. Patients who 
fitted the inclusion criteria and were thus eligible to participate, were invited to 
take part in the study. The dietician at Al-Noor hospital had more than 20 
appointments daily, which comprised of new patients and others on a follow up 
meeting. Most of the diabetic patients do regular test (BGL) before their 
appointment. Most patients brought this result with them to the meeting with the 
researcher, however some did not bring the result with them so the researcher 
asked the nurse for this data. This ensured that for all patient had an updated 
analysis result at the beginning of the research.  
Participants were recruited by approaching diabetic patients at the dietician 
clinic in the hospital. Patients attending the clinic appointments were presented 
with an outline of the study and information as to the possible benefits of Nigella 
sativa seeds and Ajwa dates with respect to their ability to control blood glucose 
levels. The patients were randomly allocated to one of the three groups, 
depending on the order in which they attended their follow-up appointment with 
the dietician. The researcher allocated the first attending patient to group D-D, 
the next patient to group D-AJ, and the next to group D-NS, and so forth, until 
all of the participants had been allocated to a group.  
 
The researcher explained the aim of the trial to the diabetic participants, in 
Arabic, and provided advice with regards to the dietary plan plus treatments 
with Nigella sativa seeds and Ajwa date respectively. Patients were fully 
informed about the purpose and duration of the study, and were reassured that 
they could leave the study at any time. The diabetic patients, who agreed to 
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participate in the study were asked to sign the Arabic version of the consent 
form (see appendix 13) and to read an information leaflet about the research 
and to fill out the questionnaire (demographic, lifestyle and diabetes sections) 
(See Appendix 12).  
They were also asked to adhere to the instructions given in relation to the 
modified diet (see appendix 15). The modified diet comprised of five meals, with 
a choice of seven varieties for each meal from which the participants could 
choose (see appendix 14). Each participant was also provided with either 
Nigella sativa seeds tubes or Ajwa dates, depending on their allocated group, 
during a meeting which lasted approximately 25 minutes (See appendix 16). 
All the diabetic participants were requested to perform self-monitoring of their 
blood glucose (SMBG) and to determine their FBG and 2hPP before the 
initiation of therapy, after Day 1 and Day 7, then weekly thereafter for 12 weeks. 
The SMBG readings were reliable up to 10 mg/dl (Schnell et al., 2015). In 
addition, the researcher reviewed the participant’s initial fasting blood glucose 
(FBG), two hours postprandial blood glucose (2hPP) and blood pressure (BP) 
measurements as well as their height and weight. 
 
The anthropometric measurements (weight and height) and body mass index 
(BMI) were taken for each patient before the initiation of treatment and after 12 
weeks. Measurements were carried out for the patients at baseline (Week 1), 
then subsequently at Weeks 4, 8 and 12 after starting the therapy. The 
measurements taken were blood pressure (BP), fasting blood glucose (FBG) 
and two hour postprandial blood glucose (2hPP).  
 
The follow up stage was very important as it provided the researcher with the 
opportunity to measure blood glucose levels, blood pressure and 
anthropometric measurements, as well as replace the Nigella sativa tubes and 
collect the blood glucose level records.  Follow-up meetings were scheduled at 
weeks 4, 8 and 12. The study participants were asked to record any changes 
with regard to their lifestyle or body weight, and instructed to inform the 
researcher if they consumed any other food not included in the modified diet 
designed by the researcher. 
Group D-NS was assigned consumption of the modified diet, plus 2g of Nigella 
sativa seeds daily, for 12 weeks. This dose was chosen as an effective dose for 
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the maintenance of blood glucose levels, following the findings of a study by 
Bamosa et al, (2010), who used different Nigella sativa seed doses (1g, 2g and 
3g), and found that a 2g/day dose was the most effective. These three doses 
were also used in other studies that looked at the effect of Nigella sativa seeds 
on patients with diabetes. Having considered the findings of previous research 
(e.g. Kaatabi et al., 2015), for this study it was decided that a dose of 2g/day 
would be used. 
At the end of the study, 75 participants with type 2 diabetes completed trial 1 
and had a full set of results. To summarise: 
● 25 participants consumed the modified diet for 12 weeks. 
● 25 participants consumed the modified diet, plus 2g of Nigella sativa seeds 
daily, for 12 weeks.  
● 25 participants consumed the modified diet, plus one Ajwa date every day, 
for 12 weeks. 
3.4.3. Inclusion and Exclusion criteria  
The following inclusion criteria were used to select the type 2 diabetes patients: 
● Male and female Saudis with type 2 diabetes. 
● Those with both poorly controlled and well controlled type 2 diabetes. 
● Those aged 18–60 years. 
● Residents of Mecca, to facilitate follow-up sessions. 
● Those who agreed to sign a consent form. 
Exclusion criteria for this study were as follows: 
● Pregnant women. 
● Those with type 1 diabetes. 
● Patients with chronic renal disease. 
● Patients with cardiovascular disease. 
● Patients who had consumed Nigella sativa seeds or any other herbal 
treatment to control their diabetes in the last 12 weeks. 
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3.5. Trial 2 (Healthy Groups) 
3.5.1. Study Design and study population  
Initially, the healthy group for this study consisted of 90 healthy (i.e. non-
diabetic) male and female participants recruited from Manchester student 
societies (MMU students, Asian/ Arab background) with the aim of registering 
75 healthy subjects for the study. They were split into three equal groups of 
30, the first group consumed a modified diet (C-D), the second group 
consumed the modified diet plus 2g of Nigella sativa seeds (C-NS) daily for 12 
weeks, and the third group consumed the modified diet, plus one Ajwa date 
(C-AJ), daily, for 12 weeks. Figure 3.2 shows the process for allocating the 
healthy participants who met the inclusion criteria. All the healthy participants 
were from an Asian or Arab background and were used to consuming AJ and 
Ns. The healthy subjects were willing to participate because eating Ns and AJ 
was part of their cuisine and traditional habit. 
Table 3.1. The study design for the clinical trial (SA) 
Group  Study 
population 
Age  Sample size  
(N) 
Study 
duration  
Controlled 
group (Non-
diabetic) 
In  
Manchester, 
UK, of  
Arab/Asian 
background 
 
18 – 60 years  
 
90  
 
12 weeks  
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Figure 3.2. Study design and progression flow chart for healthy (non-diabetic) group 
3.5.2.  Recruitment and selection of participants 
The non-diabetic (healthy) participant target population consisted of males and 
females originally of Asian descent (i.e. Gulf Arabs, Malaysian and 
subcontinental Asian (covers India, Pakistan and Bangladesh), aged 18–60 
years and living in Manchester. The trial 2 (healthy group) was selected using 
a randomised clinical trial (RCT) and the participants from the UK study gave 
consent to take part and were recruited randomly from MMU. Everyone who 
took part was a willing volunteer and the study had been passed by the Ethics 
committee. 
After initially recruiting 90 healthy participants, only 75 healthy male and female 
participants in the UK were actually included in the study, and were then split 
into three equal groups of 25 people. The first group consumed a modified diet 
(C-D), the second group consumed the modified diet plus 2g of Nigella sativa 
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seeds daily, for 12 weeks (C-NS), and the third group consumed the modified 
diet, plus one Ajwa date daily, also for 12 weeks (C-AJ). 
Due to the study being carried out at Manchester Metropolitan University 
physiology lab, and having received permission from the university to distribute 
a booklet containing information on the study, the best place to recruit non-
diabetic subjects, who were originally from an Asian or Arab background was 
the university’s Islamic societies and the local mosques.  
At the selection stage the researcher received calls and text messages from 
participants responding to adverts. The recruitment of participants for the study 
was achieved via flyers (see appendix 9 and10) and by sending emails through 
the university and by face to face interaction with students outside the 
university. After receiving positive responses from the participants stating that 
they were willing to join the trial, the researcher selected the healthy volunteers 
based on inclusion and exclusion criteria. Then the researcher invited the 
healthy subjects (via a telephone call or using Whatsapp) to visit the lab in order 
to take the initial measurements for weight, height and blood glucose levels.  In 
order to take the preliminary measurements such as FBG (Fasting blood 
glucose), weight and height, the researcher made an appointment with the 
healthy subjects, and asked them to fill out the questionnaire (demographic 
section and lifestyle section) and sign the consent form (See Appendix 2 and 
3). The participants were given the instructions of the study and a dietary plan 
to follow (See Appendix 4 and 8). Healthy participants were requested to follow 
a modified dietary plan and maintain normal physical activity throughout the 
trial. The subjects were provided dietary advice and instructions (See Appendix 
4 and 5) in order to complete the trial in a good way. The participants who were 
in the Ajwa group, were asked to avoid eating other types of dates while 
participants in the other 2 groups (Nigella sativa and modified diet) were asked 
to avoid eating Ajwa dates. Each of the participants met the researcher for about 
15 to 20 minutes, as documented in the time schedule (see Appendix 17)  
The possible benefits of Nigella sativa seeds and Ajwa dates on health were 
explained to the participants at the first meeting (see appendix 1). They also 
received training from a technical officer on how to self-monitor and measure 
their blood glucose levels (details mentioned in section 3.6.6). After the 
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induction meeting, the researcher contacted the participants once a week to 
record their fasting blood glucose, FBG (before meal) and two hours 
postprandial blood glucose, 2hPP (after meal) measurements. Regular 
meetings, four meetings over 12 weeks, took place between the researcher and 
the participants to ensure compliance and to address any problems.  
Participants were asked to perform SMBG (Self-Monitoring Blood Glucose) with 
respect to their FBG at home. The FBG and 2hPP results were collected by the 
researcher on a weekly basis. Physical activity was recorded daily to ensure 
that the data collected was valid and reliable.  
3.5.3. Inclusion and Exclusion criteria for the healthy group  
Selection criteria for the inclusion of non-diabetic or healthy subjects in the study 
were as follows: 
● Males and females from an Asian background, for example, Arab, Indian, 
Pakistan, Malaysian and Bangladeshi, also must be living in the UK. 
● Those aged 18–60 years. 
● Those who signed a consent form.   
● Those living in Manchester to facilitate follow-up sessions. 
● Non-pregnant women. 
● Healthy participants. 
● Participants had to agree to follow the diet and perform the measurements 
at home weekly (FBG and 2Hr-PP) 
Exclusion criteria:  
● Participants with T2DM, CVD or BP patients. 
● Participants with regular consumption of any type of dates. 
● Pregnant women. 
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3.6. Data collection and processing 
3.6.1. Questionnaire design for trial 1 and 2 
Initially, the researcher checked that the volunteers met the inclusion criteria 
and that they were happy to participate in the trial, and then they completed the 
questionnaire (Arabic version for intervention group and English version for 
controlled group). Regarding the diabetic patients, the questionnaire was read 
out for those who struggled to read. 
The questionnaire was designed to collect information from the volunteers and 
was divided into three sections: the first section was intended to gather personal 
background information, the second section gathered lifestyle data and the third 
section was only applicable to diabetics in order to collect medical health data. 
In addition, the questionnaire was designed with simple words written in English 
and then translated into Arabic. The participants were asked to complete a short 
questionnaire providing demographic information such as name, age, gender, 
marital status, smoking habits, diabetes status, age at diabetes onset, medical 
history and BMI. The designed questionnaire was pre-tested on 25 Arab 
volunteers who lived in the UK to identify apparent errors and was corrected to 
improve the clarity of instructions and remove irrelevant and unclear questions. 
“Informed consent” can be defined as the study participants agreeing to take 
part therein, based on the provision of clear information and their ability to easily 
understand it (Franck and Winter, 2004). Thus, the information in the consent 
sheet was explained to the participants, who confirmed that they understood 
the study procedure and requirements, then agreed to participate in the trial. In 
addition, details of the study, what the treatment involved, the benefits and 
potential side effects were outlined to the study subjects. Study subjects needed 
to be familiar with the purpose of the study, its possible benefits and whether or 
not it could be harmful. It is critical that simple language that is easy to 
understand was used in the consent form. The consent form and information 
sheet for this study were written in English and then translated into Arabic. 
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3.6.2. Dietary design for Trial 1 and 2 
Table 3.2. The DASH diet plan for 2000 calories a day for health conditions (High blood 
pressure patients) (NIH, 2003) 
Food group  Daily Serving Serving size  
Wholegrain 7-8  1 cup ready to eat cereal  
½ cup cooked rice  
Vegetables 4-5  1 cup raw leafy 
vegetables  
Fruit 4-5  1 medium fruit 
¼ cup dried fruit  
Low fat or fat free dairy 
food 
2-3  1 cup yogurt  
Lean meat and poultry  2 or less  3 ounce cooked lean meat 
(skinless) 
Nuts and seeds  4-5 per week ½  cup cooked dry beans  
1 teaspoon soft 
margarine  
Sweets 5 per week 1 tablespoon sugar 
Fats and oils  2-3  1 teaspoon vegetable oil 
The modified diet was designed by the researcher using the diabetes pyramid 
and the Dietary Approaches to Stop Hypertension (DASH) plan, which 
highlights the importance of sensible food selection. Figure 3.3 below details 
the formation of the food pyramid. The base group shows that eight to ten 
servings of starchy food should be eaten for every three to four servings of 
vegetables and two to four servings of fruit. As the dairy group contains high 
amounts of carbohydrate, which may affect blood glucose levels, two servings 
of dairy products should be consumed. The final group suggests a daily 
consumption of four to seven ounces of meat (NIDDK, 2007). The diabetes food 
pyramid in Figure 3.3 is designed for diabetics to choose food proportions 
easily. The food group at the base of the pyramid contains grains, starchy foods, 
vegetables and beans. More can be eaten from this group compared to the fats 
and sugars group at the top of the pyramid (NIDDK, 2014). 
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This diet is designed to control and monitor the blood pressure in the body. This 
diet plan is outlined in the Table 3.2 and is based on the intake of wholegrain, 
poultry, reduced amounts of fat, sugar and salt. In addition, this eating plan has 
rich sources of minerals such as potassium, magnesium and calcium. Diabetic 
patients are encouraged in their diet plan to have whole grains, fruit, vegetables, 
legumes and other rich sources of carbohydrates. However, it is essential to 
manage and count carbohydrate servings per day to ensure not too much gets 
consumed (Sacks et al., 2001; Liese et al, 2009). 
The modified diet created for the participants, is based on an average calorie 
intake of 1900 - 2000, also taking size, weight and exercise into consideration. 
As a whole, daily calorie consumption should total between 1900 to 2000 
calories for females and 2000 to 2500 calories daily for males. The UK 
government recommend that a daily calorie intake of 1900 to 2500 is suitable 
for men who do not undertake regular physical activity (NIDDK, 2007; DRVs, 
2011). As a result, the modified diet designed for the participants totalled 1600 
to 1800 calories; an additional 600 calories was made available for those 
volunteers who felt hungry or exercised daily. The modified diet was designed 
for both healthy and diabetic participants, so the food choices were a part of 
their traditional cuisine. All the male participants were verbally told that they 
were allowed some choices of certain snacks of an additional 600 calories per 
day if they were hungry. The rationale for the additional 600 calories designed 
for the male participants, who had 1700-1800 calories was that it was the 
midpoint of the recommended requirement needed per day (male 2000 to 2400 
calories). By adding an additional 600 calories, it allowed them to stay within 
the recommended daily consumption of calories, in order for the snack choices 
to be healthy. As for the female participants, they were told to only follow the 
modified diet of 1800 calories per day. 
The recommendation and dietary guidelines for diabetes patients state that 
carbohydrates should provide 45% to 65% of total energy in their diet. Fats 
should provide 25% to 35% of total energy and protein should provide 12% to 
20% of total energy (Geissler and Powers, 2005). Moreover, the modified diet 
was analysed by the WISP V3.0 intake analysis system to determine the 
percentages of macronutrients and micronutrients, and to ascertain the 
suitability of the modified diet. The analysis confirmed that the modified diet 
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would provide 50% of required energy from carbohydrates, 20% from protein 
and 30% from fats.  
Table3.3. Mean intake for the modified diet compared with the Guideline Daily Amounts 
(GDAs) 
Nutrient Mean daily intake GDA % of GDA 
Energy (kcal) 1600-1800            2000   76% 
Protein (g) 50.0 50.0 100% 
Carbohydrate (g) 205.0 260.0 79% 
Sugars (g) 83.0 90.0 92% 
Fat (g) 57.9 70.0 83% 
Saturates (g) 18.8 20.0 94% 
Fibre (g) 20.3 24.0 85% 
Sodium (mg) 1995 2400 83% 
Salt (g) 5.0 6 83% 
Table 3.3 shows a comparison of the modified diet and the GDAs, indicating 
that the modified diet provides slightly smaller amounts of some components 
but is sufficient for good nutrition.  
 
Figure 3.3. The Diabetes Food Pyramid (NIDDK, 2007) 
The diabetes food pyramid above indicates that the best sources of starch are 
bread, cereal, crackers, lentils, rice, pasta, potato and corn. The modified diet 
contains whole grain starch, which is considered to be beneficial for diabetic 
patients. It also contains an appropriate balance of carbohydrate, vitamins, fibre 
and minerals (NIDDK, 2007). Vegetables were also included in the modified 
diet, as this group contains multiple vitamins, minerals and fibre. Vegetables 
such as celery, tomatoes, carrots, lettuce and broccoli are also a good source 
of carbohydrates. A selection of fruits was included in the modified diet, because 
as with vegetables, they also contain a vast array of vitamins, minerals, 
carbohydrates and fibre (NIDDK, 2014). 
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The modified diet included apples, berries, orange, strawberries, bananas and 
fresh fruit juice. The dairy category provided a rich source of calcium, protein, 
carbohydrate, vitamins and minerals – the only caveat being that milk had to be 
low fat skimmed. The modified diet also included items from the top of the food 
pyramid: meat, eggs, salmon, fish, peanut butter, tuna, lamb, low fat cheese 
and chicken - all foods high in protein. Products from this group should be 
consumed in smaller quantities than foods from other groups (NIDDK, 2007). 
When consuming foods from this group, it is essential to pick the healthiest 
means of cooking meat and poultry; for example by grilling, steaming and stir-
frying, in order to significantly reduce the risk of cardiovascular disease in 
people with diabetes (NICE, 2014). British Nutrition Foundation (2016) reported 
that reheating cold starchy food such as potato, pasta, rice and bread could 
have an improvement in controlling BGL by reducing blood glucose.  
Table 3.4. The serving size daily from the Diabetes food pyramid (NIDDK, 2007) 
Food groups Serving daily  Portion size  
Starches  6-11 1/3 cup cooked rice, ½ 
cup pasta , ½ cup beans 
Vegetables  3-5 1 cup of raw vegetables, 
½ cup cooked vegetables  
Fruits 2-4 1 medium fresh fruit, ½ 
cup fresh fruit, ¼ cup 
dried fruit  
Meat and meat 
substitutes 
2-3 2 eggs, 2oz of fish, meat, 
4tbsp peanuts butter 
Milk and dairy product 2-3 1 cup of low fat milk, ¾ 
cup plain yogurt 
Fat and sweet  0-3 Butter, oil, 1 tbsp salad 
dressing, 6 nuts 
The Dietary Reference Values (DRVs) for nutrient intake recommend that, for 
the nutritional management of diabetes, the amount of fats (particularly 
saturated fats) in the diet should be limited. An accepted figure is that saturated 
fats should be equal to or less than 10% of total energy consumed (NIDDK, 
2014). Alongside this, cholesterol intake should be reduced to less than 300mg 
per day. Nutritional management assists in controlling blood glucose levels 
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hence reducing the risk factors associated with diabetes. (Geissler and Powers, 
2005). As a result, Geissler and Powers (2005) also state that the limiting of fats 
can help diabetic patients to control blood glucose levels because fats within 
the blood can block insulin from reaching the blood cells.  
3.6.2.1. Nutritional Analysis for Modified Diet 
Analyses of nutrition and food groups for the modified diet were conducted 
using NetWisp V3.0 (a product by Tinuveil Software), a dietary analysis 
software program that analyses and converts dietary intake measures and 
converts them into energy, macronutrients and micronutrients. All food 
composition data is supplied from HMSO/OPSI, McCance and Widdowson’s 
Food Composition Table, 5th and 6th editions and supplements. (Hassan, 2015 
and Murray et al, 2013) 
NetWISP V3.0 includes data from the following : Tillery Valley Foods (2008) 
,Calypso Soft Drinks Ltd (2008), Brakes Food Service (catering) products 
(2008), Nutricia (tube and sip feeds, 2008), Abbott (tube and sip feeds, 2006), 
Glycaemic Index of Foods (2005), Better Hospital Food (2005), Pasta and Pasta 
Sauces, Food Standards Agency (FSA) (2004), Catch-Up Project, FSA (2004), 
AOAC Fibre Content of Foods, USDA (2004), Non-milk Extrinsic Sugar Content 
of Foods, calculated by Registered Nutritionist (2003) (Murray et al., 2013). 
Nutrients for the modified diet were analysed. Energy in calories and 
macronutrients, such as carbohydrates, proteins and fat (total fat, cholesterol, 
saturated fatty acids, monosaturated and polysaturated fat) were also analysed. 
Micronutrients analysed included vitamins C, B12, D, A and B6, niacin, 
riboflavin, thiamin and carotene. Other nutrients analysed included sugar, non-
milk extrinsic, starch, fibre, chloride, selenium, sodium, potassium, 
phosphorous, magnesium, calcium, iron, copper, zinc and manganese (Murray 
et al., 2013; Institute of Medicine, 2011).The daily calorie consumption of a 
healthy adult should roughly be 2000 for women and 2500 for men (DRVs, 
2011). However, in Saudi Arabia the daily energy intake is between 1870 and 
2290 calories (Hamad, 2015).  
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3.6.3. Nigella sativa seeds preparation  
Nigella sativa seeds were given to the participants who were advised to 
consume 2g doses daily for 12 weeks. The Nigella sativa seeds, produced in 
India. The NS seeds were ordered once to ensure that the Ns were from the 
same batch (from Just Ingredients products company) to be used for both trials 
1 (diabetic patients) and 2 (healthy participants). It was ordered online by MMU 
staff and prepared in 2g aliquots to provide sufficient amounts for all participants 
in the NS groups for the entire duration of the trial. The Nigella seeds were 
weighed using a Mettler® PL3000 silicone weighing bowl, then each aliquot was 
placed in a small tube at the human physiology studio at MMU, as shown in 
Figure 3.4.It was advised that all participants chew the Nigella sativa seeds and 
not swallow them whole. For consistently it was requested for all participants 
should take Nigella seeds in the morning and record the time. 
 
Figure 3.4. A flow chart demonstrating the process followed when measuring out the 
Nigella sativa seed doses 
3.6.4. Ajwa dates preparation  
Ajwa dates, which are only grown in the city of AL-Madina, KSA, were provided 
to the relevant participants. The Ajwa dates were ordered online by MMU staff 
in one go, and the suppliers (Al-Madina Al-Menawara) were kept the same for 
T1 and T2 to ensure that the dates were from the same batch so that the Ajwa 
were from the same source.  
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The participants agreed to consume one Ajwa date in addition to a prescribed 
diet daily for 12 weeks to determine whether or not there was a beneficial effect 
on their blood glucose levels. Each participant was provided with a box of AJ 
dates containing enough dates (800g) and the researcher carefully explained 
that they should eat 1 AJ each day. At the end of each meeting (assessment 
meeting), they were asked them how many dates they had eaten and count the 
stones and collect them. Doing this allowed the researcher to identify the 
participants who did not follow the rules or the instructions given, and who had 
eaten all the AJ dates. For those who did not follow the guidelines provided, 
they were excluded. 
The nutritional information as displayed on the box, is shown below in Table 3.5 
and it appears from that this type of date is rich in fibre and carbohydrates. 
Table 3.5. The nutritional facts for Ajwa dates (serving size 100 grams) 
Nutrition information Amount per serving % Daily Value 
Calories  282  
Calories from fat 3  
Total fat  
Saturated fat  
Trans fat  
0g 0% 
Cholesterol  0mg 0% 
Sodium  2mg 0% 
Total Carbohydrate  75g 25% 
Dietary Fibre  8g 32% 
Sugar 63g  
Protein  2g  
Vitamin C  1% 
Iron   6% 
Calcium   4% 
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Figure 3.5. A flow chart showing the process for Ajwa dates  
As shown in figure 3.5 above, it was provided 1 box of Ajwa dates for each 
participants and each box contains 91 Ajwa dates (800 g) during 12 week. Ajwa 
dates labels shows that dates has rich in source of minerals such as calcium, 
manganese, copper, magnesium, iron, potassium and phosphorus. Also have 
volatile oils, rich in fibers, vitamin B6, folic acid, proteins and sugar. The 
researcher asked the participants to keep the stones for Ajwa dates. 
3.6.5. Anthropometric measurements for Trial 1 and 2 
Weight and height were measured by the researcher at baseline and then at 
week 12. Participants were asked to stand barefoot and upright, with their backs 
against the wall and a free-standing stadiometer was used to measure their 
height (WHO, 2013). Weight was measured using a standard weighing scale 
on a firm, level surface. Subjects had to wear light clothing and no shoes. After 
calibrating the scale, the weights of all subjects were recorded. This was 
completed before subjects had breakfast and weights were rounded to the 
nearest 0.1 kg. (CDC, 2009).  
BMI is a parameter used to measure body fat and define obesity. It is calculated 
as body weight (in kg) divided by the square of the height in metres (m²). The 
BMI classification ranges of normal weight is 18.5–24.9 kg/m², overweight 25.0–
29.9 kg/m² and obesity ≥ 30 kg/m². BMI is directly related to glucose intolerance 
in diabetes. (Ganong, 2005; Mann and Truswell, 2007).  BMI was used in this 
study because it has been proven to be a valid measurement of nutritional 
status, which has a strong relation with adiposity and leads to a high risk of 
diabetes (Narayan et al, 2007).  
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3.6.6. Blood glucose levels measurements (Trial 1and 2) 
Self-monitoring blood glucose (SMBG) should be a routine for diabetic patients 
in order to check the blood sugar level. Participants should also take FBG and 
2hPP readings twice a week. The expected target for blood glucose levels 
before consuming a meal should be between 70–120mg/dl (3.9 to 6.7 mmol/L) 
; an ideal level of glucose two hours after eating a meal should be less than 
180mg/dl(10.4 mmol/L). This monitoring can highlight aspects of 
hypoglycaemia (low blood sugar) and hyperglycaemia (high blood sugar) 
(Geissler and Powers, 2005 and IDF, 2009).  
Home SMBG devices  provide quick results accurately and can play an 
important role in controlling blood glucose levels (Guerci et al., 2003). Self-
monitoring is undertaken by pricking the side of the finger, using a sanitised 
lancet and then placing a drop of blood on a test strip. The control group tested 
blood glucose levels once a week, whilst the intervention group undertook the 
test twice a week; and both recorded the results on a specially designed form 
(IDF, 2009). 
 
Figure 3.6. The blood glucose concentration in type 2 diabetes and normal people over 
time (King, 2013) 
The line graph (3.6) above compares the concentration of blood glucose among 
type-2 diabetics and people who do not suffer from diabetes. The red line 
highlights a significant increase in blood glucose concentration in healthy 
people immediately after eating, peaking at 120mg/dl (6.7 mmol/L). After one 
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hour, there is a considerable decrease in blood glucose levels; after two hours, 
the concentration of blood glucose is relatively stable - below 100mg/dl (5.6 
mmol/L).  
Conversely, for patients with type 2 diabetes, the graph shows a rapid rise in 
blood glucose levels, peaking at 200mg/dl (11.1 mmol/L).  an hour after eating 
a meal and remaining high for around four hours, with blood glucose 
concentration slowly reducing until it stabilises (Geissler and Powers, 2005). 
The lowest level for diabetics is less than the highest level reached by the 
healthy participants. Both sets of data increase by 30% but the diabetics’ level 
does not fall back to the initial level, even after 5 hours. The blood glucose levels 
(FBG and 2hPP) of all participants were measured by the participants and they 
were recorded on the measurement sheet. In addition, the volunteers were 
asked to record the length of daily activity in the recording sheet. 
3.6.6.1 Blood glucose measurements (monitoring systems) 
Fasting blood glucose and 2 hours postprandial blood glucose levels were 
measured using the SD Codefree TM blood glucose monitoring system. This kit 
included the SD Codefree meter, blood glucose test strips, check strip, a 3V 
battery, self-test diary, test strip package insert, carrying case, user instruction 
guide, lancing device and lancets. Subjects are supposed to be familiar with the 
instructions of the SD Codefree TM blood glucose system. 
SD Codefree blood glucose test strips include an electrode which measures the 
glucose level. The glucose level is determined in the blood plasma, which is 
mixed with the reagent on the test strip. The chemical reaction produces a small 
electric current. The SD Codefree meter measures the current and the result is 
displayed on the meter in mg of glucose per dl (mg/dl). It is very important for 
participants to wash their hands with warm water in order to increase the flow 
of blood, then to dry the hands (SD Codefree guide). 
3.6.7. Glycated Haemoglobin A1c Measurement HbA1c (Trial 1) 
HbA1c is a measure of the blood glucose level in diabetic patients over a three-
month period. The HbA1c test, conducted by either a doctor or nurse, measured 
HbA1c using a DCA® Vantage Analyzer (made by Siemens), which indicates 
accurate results for diabetes and prediabetes. It is a simple four-step process 
where a finger prick blood sample is used and there is no need for patient 
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fasting. The same test kit is used for the diagnosis and management of diabetic 
patients. In addition, the results are available within six minutes.  
For this study, the doctor or nurse at the diabetes centre at Al-Noor Specialist 
Hospital obtained a whole blood sample from the patients by performing a finger 
prick, from which the small drops of blood were captured in a 1µl capillary 
holder. The capillary holder was then inserted into the HbA1c reagent cartridge 
compartment. Thereafter, the reagent cartridge was taken to the DCA® Vantage 
Analyzer, and the barcode on the cartridge scanned. Following adherence to 
the on-screen instructions, the cartridge compartment door was opened, and 
the reagent cartridge inserted into the cartridge compartment, then the door was 
closed. The results were displayed on the screen six minutes later and printed 
out.The DCA® Vantage Analyzer determines the HbA1c level in type 2 diabetes 
patients.  
Regular HbA1c testing is crucial for the optimum management of diabetes. 
Patients with type 2 diabetes need to control their blood glucose level, and this 
is achieved by maintaining a low-level HbA1c (the target/ideal is ≥ 6%). This 
decreases or prevents the development of complications associated with 
diabetes, such as foot, eye and kidney problems, not to mention cardiovascular 
disease (WHO, 2011). 
Table 3.6. HbA1c Classification (WHO, 2011) 
Haemoglobin A1c Interpretation of the result  
≥ 108 mmol/mol (12%) Very high  
86–108 mmol/mol (10–12%) High  
64–86 mmol/mol (8–10%) A little high  
≤ 53 mmol/mol (7%) (the target) Ideal, maintain this level 
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3.6.7.1. The Test Principle for HbA1c 
The intensity of the light transmitted through the cartridge optical window is 
analysed by the DCA Vantage AnalyzerTM
 
by using a spectrophotometer. Whole 
blood is added to the reagent cartridge, the cartridge is inserted into the DCA 
VantageTM
 
Analyzer, and then it takes 6 minutes to get meaningful results (see 
figure 3.7). The DCA Analyzer TM performs all measurements and calculations 
automatically. The screen displays HbA1c percentage at the end of the assay. 
Inside the cartridge, the following chemical reaction takes place. 
Measurement of total haemoglobin. To measure total haemoglobin potassium 
ferricyanide is used to oxidise haemoglobin in the sample to methaemoglobin. 
The methaemoglobin then mixed with thiocyanate to form 
thiocyanmethaemoglobin, the coloured species that is measured. The extent of 
colour development at 531nm is proportional to the concentration of total 
haemoglobin in the sample. Results are obtained by comparing the absorbance 
with results on a standard curve. 
 
Figure 3.7. DCA Vantage AnalyzerTM (Guide, 2008) 
3.6.8.Blood pressure measurements (Trial 1) 
The BP of the subjects was taken by the nurse while they were in a seated 
position, using an Omron® HEM-7113 Automatic Blood Pressure Monitor. BP 
was measured for the diabetic subjects at the beginning of the study, and every 
two weeks thereafter until completion of the study at 12 weeks. 
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Table 3.7. The classification of blood pressure (Lima et al., 2015) 
Blood pressure  Systolic blood pressure 
(mmHg) 
Diastolic blood pressure 
(mmHg) 
Normal ≤ 120 ≤ 80 
Prehypertension  120–139 80–89 
Stage 1 hypertension 140–159 90–99 
Stage 2 hypertension ≥ 160 ≥ 100 
 
3.6.8.1. Blood pressure mechanism (oscillatory blood pressure 
monitoring principle) 
Oscillatory devices present digital readings and operate on the principle that the 
flow of blood through an artery between systolic and diastolic pressure 
produces vibration in the arterial wall, which can be detected and transformed 
into electrical signals (Landgraf et al., 2010). This oscillometric technique has 
been used successfully in ambulatory blood pressure monitors and home 
monitors. The way oscillometric devices operate, such as the Omron, is that a 
cuff has to be inflated over the upper arm. At full inflation of the cuff, there would 
be no blood flowing through the artery. By contrast, when the cuff is deflated 
below the systolic pressure and the pressure on the artery is reduced, blood is 
allowed to flow. This sets up a vibration in the wall of the artery which is 
detectable (Appel et al., 2010). 
After the cuff pressure drops below the patient’s diastolic pressure, blood flows 
through the artery smoothly in regular pulses and without vibrations in the wall 
of the artery. Vibration occurs only where the pressure of the cuff is high enough 
for the blood to push the wall of the artery open so that it can flow through the 
artery. Vibrations are transferred from the wall of the artery into the transducer 
in the monitor through the air in the cuff. The transducer converts the 
measurements into electric signals. Oscillometric devices deflate at about 
4mmHg per second. This renders them slower sometimes than auscultatory 
aneroid devices but they are known to be more accurate (Landgraf et al., 2010; 
Ogedegbe and Pickering, 2010). 
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3.7. Validity and reliability  
Validity and reliability are the two measurements of quality in a quantitative 
study. ‘Validity’ is defined as the strength of the final result. Ensuring the validity 
and reliability of the data collected is important in quantitative research 
(Golafshani, 2003). 
The participants’ personal information was treated as confidential and was not 
disclosed beyond the research team. The researcher ensured that confidential 
information was kept secure. All the results were entered into Microsoft® Excel® 
and doubled-checked to reduce mistakes or data entry errors. 
To ensure validity and reliability in this study, patients in group D-NS (diabetics 
consuming Nigella sativa seeds) were seen at the dietician clinic once a month. 
Compliance, in terms of the correct amount of Nigella sativa seeds to be 
consumed daily, was ensured through a tube count, while the empty tubes were 
replaced on a monthly basis with new tubes. The healthy control group 
participants were seen at MMU once a month, where their empty tubes were 
also replaced with new tubes filled with Nigella sativa seeds (Zheng et al.,  
2014). 
Subjects in group D-AJ (diabetics consuming Ajwa dates) and group C-AJ 
(healthy controls consuming Ajwa dates) were seen monthly, for 12 weeks. 
Ajwa date stone counting was performed by collecting the date stones from the 
participants (n = 50). In addition, the researcher contacted the study subjects 
weekly by SMS, “Whatsapp|” messaging or by telephone call to remind them to 
measure their blood glucose (FBG and 2Hr-PP) and ensure that they were 
consuming the Nigella sativa seeds or Ajwa dates accordingly. 
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3.8. Compliance with appointments, measuring and diet 
All the participants (the intervention group in KSA and the control group in UK) 
adhered to the measurements (self monitoring blood glucose SMBG) and 
followed the modified diet. Nuti et al, (2015) suggests that, all volunteers should 
have regular measurements consistently every week (FBG, 2hBG and BP) and 
regular communication by phone with the researcher in order to increase 
adherence.Therefore, participants had regular meetings with the researcher 
and medical staff. Those participants who did not adhere to the instructions of 
the study were excluded from the trial. 
To make sure that literate patients understood the purpose of the study, the 
researcher emphasised the instructions and potential beneficial effects of 
Nigella Sativa seeds, Ajwa date and modified diet for the patients. The 
researcher encouraged the participants to record the measurements in the 
sheet (see appendix 7) to help the patients to remember to measure their SMBG 
at home. Participants from the Ajwa and Nigella sativa groups were provided 
with  a chart to help them organise their measurement times weekly 
(measurements box) and remind them to take their Nigella sativa seeds doses 
on time (Graham et al., 2016). It can help the patients to understand the purpose 
of the research if the instructions are reduced to several points and simple 
everyday language is used during each meeting, to ensure that they follow the 
diet recommendations clearly.  
Regarding the adherence to measurements (SMBG), regular communication 
with patients and participants was maintained with the researcher by sending 
reminders to their phone via Whatsapp or SMS to help them to remember to 
take measurements. It has been reported that regular contact can significantly 
and positively impact on adherence to the research study. In this study tubes 
counting for Nigella sativa seeds, counting Ajwa dates seeds, checking the 
measurements weekly and regular assessment of participant activity leads to 
good adherence (Atreja et al., 2005; Desroches et al., 2011; Gaffari et al., 2014 
and Graham et al., 2016). 
The initial treatment for patients with type 2 diabetes is to follow a healthy diet 
plan combined with achieving control of the blood glucose level by doing SMBG 
at home and undertaking regular physical activity. So, an increased adherence 
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to lifestyle changes and dietary plan can control and even prevent further 
complications associated with diabetes. 
For the patients, the new dietary plan and lifestyle changes can be very difficult 
for them to follow so they have difficulty in staying motivated and understanding 
fully the benefits in terms of the various food groups and having nutritional 
knowledge. For this reason, all the subjects were asked  to report or note any 
changes in their diet during the research to enhance their adherence to this 
regime (See appendix 10) (Atreja et al., 2005; Zweben et al., 2009). 
 
The modified diet was designed as a menu, where each meal in the menu had 
numerous choices. The participants could choose one option from each meal. 
They could consider how their choice complied with the dietary plan as a menu 
and they were given a variety of choices every day. (See appendix 15) Also, 
the dietary plan was designed using Saudi cultural routines in terms of eating 
patterns so, the participants were compliant with the plan and they accepted it 
because it conformed to Saudi cultural habits (Desroches et al, 2011; Gaffari et 
al, 2014).  
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3.9. Statistical analysis  
A randomised controlled trial was conducted, meaning the patients who have a 
particular condition (intervention) were compared to healthy participants who did 
not have that condition. The primary aim of the research was to investigate the 
effects of consuming Ajwa dates and Nigella sativa seeds on the following clinical 
measures: Fasting Blood Glucose, Two Hour Postprandial Blood Glucose, Blood 
Pressure, and Haemoglobin A1c. 
A statistical analysis was conducted to examine the effects of the consumption 
of three diets (the independent variables) on the repeated measures of five 
clinical observations (the dependent variables):  Fasting Blood Glucose (FBG), 
Two Hour Postprandial Glucose (2HPP), Systolic Blood Pressure (SBP), 
Diastolic Blood Pressure (DBP), and Haemoglobin A1c (HbA1c). Two trials 
were conducted.  Trial 1 had 75 participants with Type II diabetes (termed the 
diabetic patients). Trial 2 had 75 participants who were not diabetics (termed 
the healthy participants). The two trials were conducted over a time period of 
12 weeks.  Four repeated measures of each dependent variable were collected 
on Week 1 (baseline), Week 4, Week 8, and Week 12 (endpoint).  
Table 3.8 defines how the 75 diabetic patients and the 75 healthy participants 
were assigned into six equal sized groups, with 25 participants in each group. 
The three groups of diabetic patients were coded D-D, D-AJ, or D-NS. The three 
groups of healthy participants were coded C-D, C-AJ, or C-NS. The codes D, 
AJ, and NS indicated if the participants consumed a modified diet (D), a 
modified diet with Ajwa date (AJ), or a modified diet with seeds of Nigella sativa 
(NS).  
Table 3.8. Groups of Participants  
Trial Group  
 
Prescribed diet Number of 
participants 
1 D-D Modified diet 25 
1 D-AJ Modified with Ajwa Date 25 
1 D-NS Modified with Nigella seeds 25 
 
2 C-D Modified diet 25 
2 C-AJ Modified with Ajwa Date 25 
2 C-NS Modified with Nigella sativa seeds 25 
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The randomized controlled trial (RCT) is the gold standard research design 
underpinned by the concept of evidence based practice (Satake, 2015). An 
RCT is designed to determine if a prescribed treatment has a statistically and 
clinically significant effect on participants who have been randomly assigned 
into two or more mutually exclusive groups. These groups include the 
intervention/treatment groups, who are exposed to the prescribed 
interventions/treatments, and the control groups, who are not so exposed.  
Trials 1 and 2 were RCTs because the participants were randomly assigned 
into groups according to whether or not they received the prescribed diets. In 
experimental design terms, the healthy participants were a reference group, 
defined as a group of participants against which another group of participants 
(i.e. the diabetic patients) could be compared (Machin and Campbell, 2005).   
The characteristics of the diabetic patients and the healthy participants were 
summarised using descriptive statistics. The values of the mean (M) and the 
standard deviation (SD) were computed for three continuous variables: age, 
duration of diabetes, and Body Mass Index (BMI). One ways analysis of 
variance was conducted to determine if these variables were different across 
the D, AJ, and NS groups. Frequencies were computed for the four categorical 
variables: sex, marital status, smoking, and education.  Chi Square tests were 
conducted to determine if the frequencies were different across the groups of 
participants.  Differences were by p < .05 for the test statistics. 
The demographic and physical characteristics of the six groups of participants 
at the start of the study were summarized using frequencies for the categorical 
variables and descriptive statistics (M = mean, SD = standard deviation) for the 
quantitative variables.  Pearson’s chi-squared tests were used to determine if 
there were significant differences at the 0.05 level between the frequencies of 
the categories in each group (sex, marital status, smoking, education, and 
physical activity). One-way ANOVA was used to determine if there were 
significant differences at the 0.05 level between the mean age and Body Mass 
Index (BMI) of the participants in each group. 
 
Error bar charts were constructed to display the variations in the mean 
measures of Fasting Blood Glucose, Two Hour Postprandial Blood Glucose, 
Systolic Blood Pressure, Diastolic Blood Pressure, and Haemoglobin A1c ± 
95% confidence intervals (CI) in each group on four occasions during the 90-
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day study period, from Week 1 (baseline), through Weeks 4, 8 and 12 
(endpoint). 
The temporal changes in the clinical measures (Week 12 minus Week 1) were 
taken as the outcomes. The descriptive statistics changes (M ± 95% CI) were 
computed for each group.  Negative mean values indicated that the levels 
declined between Week 1 and Week 12. Sample t-tests were conducted to 
determine if the mean changes in Fasting Blood Glucose, Two Hour 
Postprandial Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, and 
Haemoglobin A1c between Week 1 and Week 12 were significantly different 
from zero at the 0.05 level in each group.  The effect sizes were indicated by 
Cohen’s d.  The interpretation of Cohen’s d was: 
● < 0.3 = small 
● Between 0.3 and 0.8 = moderate 
● > 0.8 = large. 
A matrix of correlation coefficients (Pearson’s r) was constructed to identify 
significant correlations at the 0.05 level between changes in the clinical 
measures from Week 1 to Week 12 (Fasting Blood Glucose, Two Hour 
Postprandial Glucose, Blood Pressure and HbA1c), and the selected 
demographic and physical characteristics of the 75 cases (age, BMI and 
diabetic history), which could potentially be associated with the symptoms of 
type 2 diabetes.   
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4.1. Introduction 
The results are presented in three main sections.  Section 4.2 presents the 
results for Trial 1, with the results of statistical tests to determine the effects of 
the three modified diets (see chapter 3) on the blood glucose profile and blood 
pressures of the diabetic patients.  Section 4.3 presents the results for Trial 2, 
with the results of statistical tests to determine the effects of the three prescribed 
diets on the blood glucose profile of the healthy participants. Section 4.4 
presents the combined results of Trial 1 and 2, to compare the effects of the 
three prescribed diets between the diabetic patients and the healthy 
participants.  Section 4.5 provides an overall summary of the results.     
4.2. Trial 1 (Diabetic Patients) 
4.2.1. Characteristics of Diabetic Patients 
Table 4.1 summarizes the baseline characteristics of the diabetic patients in 
Week 1. The majority of the patients (48, 64.0%) were female. They ranged in 
age from 25 to 60 years (M = 48.88, SD = 8.12). Their duration of diabetes 
ranged from 1 to 25 years (M = 6.39, SD = 4.64).  The majority (51, 68.0%) 
were married. The BMIs of the diabetics ranged from 21.67 to 47.38 kg/m2 (M 
= 27.67, SD = 3.79).  76% were classified as either overweight (36, 48.0%) with 
BMI = 25.0 to 30 kg/m2 or obese (21, 28.0%) with BMI > 30 kg/m2.   
The majority (50, 66.7%) of the diabetics did not smoke. The educational levels 
of the participants ranged from illiterate (9, 12.0%) to undergraduate (15, 
20.0%). The most frequent educational level was high school (25, 33.3%). The 
majority of the diabetics (45, 60.0%) reported that their frequency of physical 
activity was “Never”. Of those undertaken physical activity only (7, 9.3% ) 
achieved this daily. 
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Table 4.1. Characteristics of Diabetic Patients 
Characteristics Group Total 
D-AJ 
(n = 25) 
D-D 
(n = 25) 
D-NS 
(n = 25) 
Sex Female 16 17 15 48 
21.30% 22.70
% 
20.0% 64.0% 
Male 9 8 10 27 
12.0% 10.70
% 
13.30% 36.0% 
Age 
(Years)  
M 51.24 47.32 48.08 48.88 
SD 6.83 8.62 8.12 8.12 
Duration 
of 
Diabetes 
M 8.64 4.64 5.88 6.39 
SD 5.99 3.33 3.27 4.64 
Marital 
Status 
Married 18 17 16 51 
24.0% 22.7% 21.3% 68.0% 
Single 2 4 2 8 
2.7% 5.3% 2.7% 10.7% 
Divorced 
or 
Widow 
5 4 7 16 
6.7% 5.3% 9.3% 21.3% 
BMI  
(kg/m2) 
M 27.94 28.46 26.62 27.67 
SD 4.39 3.87 2.86 3.79 
Smoking No 17 18 15 50 
22.7% 24.0% 20.0% 66.7% 
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Yes 8 7 10 25 
10.7% 9.3% 13.3% 33.3% 
Education Illiterate 3 2 4 9 
4.0% 2.7% 5.3% 12.0% 
Primary  9 12 5 26 
12.0% 16.0% 6.7% 34.7% 
High  
School 
10 6 9 25 
13.3% 8.0% 12.0% 33.3% 
Under- 
graduate 
3 5 7 15 
4.0% 6.7% 9.3% 20.0% 
Physical 
activity 
Never 15 11 19 45 
20.0% 14.7% 25.3% 60.0% 
Once/wee
k 
3 7 3 13 
4.0% 9.3% 4.0% 17.3% 
Twice/wee
k 
5 3 2 10 
6.7% 4.0% 2.7% 13.3% 
Daily 2 4 1 7 
2.7% 5.3% 1.3% 9.3% 
Significance tests were conducted to determine if the characteristics of the 
diabetics were equivalent across the three groups. The frequencies of males 
and females did not vary significantly between the groups (χ2 (2) = 0.35, p = 
.841). ANOVA indicated no statistically significant difference in the mean age 
across the groups (F (2, 72) = 1.73, p = .184); however, there was a significant 
difference between their duration of diabetes (F (2, 72) = 5.44, p < .001).   
ANOVA indicated no significant difference in the mean BMI across the groups 
(F (2, 73) = 1.63, p = .202). Marital status did not vary significantly between the 
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groups (χ2 (4) = 1.99, p = .177). The frequencies of smokers and non-smokers 
did not vary significantly between the groups (χ2 (2) = 0.84, p = .657). The 
frequencies of the four educational levels did not vary significantly between the 
groups (χ2 (6) = .406, p = .379). The frequencies of the four levels of physical 
activity did not vary significantly between the groups (χ2 (6) = 7.99, p = .238). 
Statistical evidence is provided to conclude that all but one of the characteristics 
of the patients were equivalent across the three groups. The mean duration of 
diabetes in the D-D group was significantly lower (p < .05) than the mean 
duration of diabetes in the D-AJ and D-NS groups.  Consequently, the three 
groups were not equivalent in terms of their history of diabetes.  
Table 4.2 below presents a matrix of correlation coefficients (Pearson’s r) 
between the clinical measures at the baseline (week 1) and the age, BMI, and 
duration of diabetes of the patients.  These correlations could potentially be 
associated with the symptoms of Type II diabetes.  FBG was positively 
correlated with 2hpp (r = .887, p < .001) and HbA1c (r = .588, p < .001).  2hpp 
was positively correlated with DBP (r = .270, p = .019) and HbA1c (r =. 569, p 
< .001).  SBP and DBP were positively correlated (r = .440, p < .001). Age was 
positively correlated with HbA1c (r = .231, p = .048); BMI (r = .312, p = .006); 
and duration of diabetes (r = .253, p = .028).   
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Table 4.2. Correlations between Clinical Measures and Participant Characteristics 
 FBG 2hpp SBP DBP HbA1c Age BMI Duration 
FBG 1        
2hpp .887* 1       
SBP .083 .070 1      
DBP .188 .270* .440* 1     
HbA1c .588* .569* .199 .366* 1    
Age -.021 -.004 .042 -.124 .231* 1   
BMI  .038 .059 -.002 -.020 .001 .312* 1  
Duration .114 .151 -.048 .028 .199 .253* .162 1 
Note: * Significant correlation (p < .05), Note: FBG = Fasting Blood Glucose; 2hpp = 
Two Hour Postprandial Glucose; SBP = Systolic Blood Pressure; DPB = Diastolic 
Blood Pressure; HbA1c = Haemoglobin A1c; Age = Age of participant (Years); BMI = 
Body Mass Index (kg/m2); Duration = Duration of Type 2 Diabetes (Years) 
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Figure 4.1. Body Mass Index BMI of the diabetic participants 
Result in figure 4.1 shows that the BMI for Groups D-D, D-NS and D-AJ all 
decreased slightly over the 12 weeks of the study. All participants were 
categorized as overweight, BMI >25. The BMI was calculated using the patient’s 
information height and weight) taken by the nurse at the clinic.   
 
Figure 4.2. BMI (obesity level) of the diabetic participants 
Figure 4.2 illustrates that the total percentage of diabetic patients who were 
obese (n= 21, 28%) at the beginning of the study and it was decreased at the 
end with (n=18, 24%).  
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Figure 4.3. The correlation coefficient for BMI after treatment of dietary factors (Nigella 
sativa, Ajwa dates and modified diet group) of the diabetic participants and SBP   
The figure 4.3 above shows a matrix of correlation coefficient (Pearson’s r) 
between the BMI for the diabetic patients and the SBP measurement at the end 
of the treatment of Ns, AJ and modified diet. It has been shown that BMI for the 
AJ group has a strong correlation with SBP and there was significant decreased 
after 12 weeks of AJ intake (r = 0.186 , p < 0.05). This correlation indicated an 
association between the reduction in blood pressure and in the BMI after 
treatment with AJ dates for 12 weeks. However, there was a weak correlation 
between the decreased  BMI for the Ns and modified diet groups and SBP with 
r = 0.023 and r = 0.007 respectively.  
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Figure 4.4.The correlation coefficient for BMI after (12 weeks) treatment of dietary 
factors (Nigella sativa, Ajwa dates and modified diet) of the participants and DBP    
Figure 4.4 demonstrates the correlation between BMI and DBP for the diabetic 
group. BMI was positively correlated with DBP for Nigella sativa group (r = .211, 
p = 0.05) and the correlation is significant at the 0.05 level. However, there is a 
non-significant correlated between DBP and BMI for AJ and modified group with   
(r =0. 013, p  .293) and  (r =0.004, p  .338) respectively.   
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Figure 4.5. Measuring self-monitoring Blood Glucose (SMBG) 
The given figure 4.5 provides the percentages of the self-monitoring blood 
glucose levels that were taken in the homes of diabetic participants. Based on 
the bar chart above (figure 4.5), most of the diabetic patients (60%) never 
measured the blood glucose level at home, while 17% of the diabetic patients 
measured BGL once a week , 14% of the diabetic participants measured their 
BGL twice a week and only 9 % self-monitored their BGL daily. 
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Figure 4.6: Distribution of HbA1c in elderly diabetic patients who had long duration of 
diabetes  
 
Figure 4.6 shows the results from the analysis of HbA1c of patients with a long 
duration of diabetes to establish whether there could have been a possible link 
between the duration of diabetes and HbA1c levels. Only patient number 5 and 
8 had a little decline in the HbA1c after 12 weeks of consuming Ajwa who were 
elderly and had a long duration (10 years to 20 years) of T2DM. It can be seen 
from figure 4.6, the HbA1c at the baseline (before the treatments) of diabetic 
patients who had long duration (> 10 years) happened in older subjects, who 
had lower levels of HbA1c after 12 weeks of Ajwa dietary intake.  
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.  
Figure 4.7. Distribution of HbA1c in short-duration and long-duration sub-group for 
diabetic patients who had Ajwa date 
 
The figure 4.7 demonstrates the HbA1c levels for the diabetic patients who had 
short-duration diabetes subgroup (less than 10 years) and the sub-group (who 
had long duration and elderly members). It can be seen from the figure above 
that by taking away the elderly people who had long duration (>10 years) had 
a positive decline in HbA1c level and the mean of HbA1c for the sub-group was 
higher after 12 weeks from Ajwa dietary intake.   
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Figure 4.8. Distribution of HbA1c in elderly diabetic patients who had long duration of 
diabetes (Nigella sativa seeds) 
Figure 4.8 demonstrates the sub-group (who were elderly and had a long 
duration of DM). As is observed from the bar chart 4.8, five participants out of 
the whole Nigella sativa group, D-NS (n=25) had long duration (more than 10 
years) of diabetes. Only one patient (4) had an increase in the HbA1c levels 
after 12 weeks (8.5) of treatment with 2g/daily of Nigella sativa seeds. However, 
the other four participants showed a slight decrease in their HbA1c level after 
consuming Nigella sativa seeds for 12 weeks. 
 
Figure 4.9. Distribution of HbA1c in elderly diabetic patients who had long duration of 
diabetes (Modified diet) 
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The given bar chart above (4.9) shows the HbA1c level of older patients, who 
had long duration (>10 years) of DM and had the modified diet. As presented in 
the figure 4.9, only two patients of the sub group had a slight rise in their HbA1c 
level after 12 weeks of following the modified diet 
 
Figure 4.10. Distribution of FBG in elderly diabetic patients who had long duration of 
diabetes (Ajwa dates group) 
 The graph 4.10 shows the level of fasting blood glucose (FBG), for elderly 
participants who had long duration of diabetes (>10 years). Overall, most of the 
diabetic patients who consumed an Ajwa date daily showed an increase in their 
FBG levels at 12 weeks. Otherwise, only one patient had an improvement in 
the FBG levels from week 1(7.9 mmol/L) until week 12 (6.2 mmol/L). However, 
in some diabetic participants (4 and 6 ), the level of FBG is slightly low starting 
from 10 and 9 mmol/L at week 1 to 9.6 and 8.8 mmol/L at week 12 respectively. 
In conclusion, it seems that more than six patients from the elderly who had 
long duration of diabetes had an increase in FBG levels from week 1 until week 
12.  
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Figure 4.11. Distribution of FBG in elderly diabetic patients who had long duration of 
diabetes (Ajwa dates group) 
The graph 4.11 shows the level of 2 hours postprandial (2hPP) blood glucose 
levels, for elderly participants who had long duration of diabetes (>10 years). 
Overall, most of the diabetic patients who consumed an Ajwa date daily show 
an increase in the 2hPP levels at 12 weeks. Patient number 1 had an 
improvement in the 2hPP levels from week 1(8.8 mmol/L) until week 12 (7.6 
mmol/L). However, in some diabetic participants (2, 4 and 6), the level of 2hPP 
is slightly low starting from 8.2 , 10.9 and 9.35 mmol/L at week 1 to 8, 10.2 and 
9.2 mmol/L at week 12 respectively. In conclusion, it seems that six diabetic 
patients from the elderly, who had long duration of diabetes, had an increase in 
FBG levels from week 1 until week 12. 
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Figure 4.12. Distribution of FBG in elderly diabetic patients who had long duration of 
diabetes (Nigella sativa seeds) 
The graph 4.12 shows the changes in the fasting blood glucose level of diabetic 
participants who had long duration of diabetes (>10 years). There are five 
elderly patients, who consumed 2 g/daily of Nigella sativa seeds. , Patients 
number 1 and 3 had a decline in the FBG levels from week 1(6.6 and 20.8 
mmol/L) until week 12 (5.4 and 10.5 mmol/L) respectively. However, patient 
number 4 and 5 had a slight increase in FBG from week 1 (6.6 and 7 mmol/L) 
until week 12 (6.8 and 7.3 mmol/L).  
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Figure 4.13. Distribution of 2hpp in elderly diabetic patients who had long duration of 
diabetes (Nigella sativa seeds) 
The graph 4.13 demonstrates the changes in the 2 hours postprandial blood 
glucose of diabetic participants who had long duration of diabetes (>10 years). 
There were five elderly patients, who consumed 2 g/daily of Nigella sativa 
seeds. Patients number 1, 2, 3 and 4 had a decline in the 2hPP blood glucose 
level from week 1(9.4, 9.6, 22.4 and 7.9) until week 12 (8.2, 8.1, 12.4 and 7.3) 
respectively. However, only patient number 5 had a slight increase in 2hpp from 
week 1 (7.7 mmol/L) until week 12 (8.2 mmol/L).These data are confused by 
the results from patient 3 who seems on all these parameters to have a 
significantly worse condition than the other patients . Patient 3 however shows 
a significant improvement during the period of the study achieving values close 
to the other members of this cohort . 
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Figure 4.14. Distribution of FBG in elderly diabetic patients who had long duration of 
diabetes (Modified diet group) 
Figure 4.14 shows changes in fasting blood glucose (FBG) levels for week 1 
until week 12, for elderly diabetic subjects who had long duration of diabetes 
(>10 years). Patient number 2’s FBG level declined from week 1(11.9 mmol/L) 
to week 12 (9.4 mmol/L). However, patient number 1 had a slight rise from week 
1(4.2 mmol/L) until week 12 (5.3 mmol/L) but still maintained a fasting blood 
glucose level in the control average. Furthermore, in patient number 3, there is 
a small increase in week 4 (9.4 mmol/L) and 12 (8.8 mmol/L) while the starting 
FBG level was 8.5 mmol/L at week 1 and 8.4 mmol/L at week 8. 
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Figure 4.15. Distribution of 2hpp in elderly diabetic patients who had long duration of 
diabetes (Modified diet group) 
The figure 4.15 shows changes in 2 hours postprandial blood glucose levels for 
week 1 until week 12, for elderly diabetic subjects who had long duration of 
diabetes (>10 years). Patient number 2’s 2hpp declined from week 1(13.5 
mmol/L) until week 12 (10.5 mmol/L). However, patient number 1 had a slight 
increase from week 1(5.4 mmol/L) until week 12 (9.8 mmol/L) but the 2 hours 
postprandial blood glucose levels were still within the average of the expected 
2hpp levels. Furthermore, patient number 3 also had a slight increase in week 
4 (10 mmol/L) and 12 (9.8 mmol/L). However, patient 3 started with a 2hpp level 
of 10.9 mmol/L at week 1 and 9.6mmol/L at week 8. 
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4.2.2. Blood Glucose Profile of Diabetic Patients 
 4.2.2.1. Fasting Blood Glucose (FBG) in Diabetic Patients 
 
Figure 4.16 illustrates the variations in the mean levels of the repeated 
measures of Fasting Blood Glucose (FBG) ± 95% confidence intervals (CI) 
across the three groups of diabetic patients. The four repeated measures within 
each of the three groups were collected on Week 1 (baseline), through Weeks 
4 and 8, to Week 12 (endpoint). The mean FBG levels of all patients remained 
consistently greater than seven mmol/L throughout Trial 1, reflecting their 
continuing diabetic condition (because FBG levels greater than seven mmol/L 
or higher on two separate tests are indicative of diabetes).   In the D-AJ group, 
the mean FBG levels declined from 7.42 mmol/L in Week 1 to 7.27 mmol/L in 
Week 12. The mean FBG levels in the D-D group declined from 8.64 mmol/L in 
Week 1 to 7.71 mmol/L in Week 12. The mean FBG levels in the D-NS group 
declined from 8.24 mmol/L in Week 1 to 7.04 mmol/L in Week 12.   
 
Figure 4.16. Repeated measures of FBG in Diabetic Patients 
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Table 4.3 presents the results of repeated measures ANOVA. This analysis was 
conducted to determine the extent to which the mean FBG of the diabetic 
patients varied within (a) duration and the interaction between duration x group; 
and (b) between the three groups.  Applying p < .05 to reflect statistical 
significance, the results of ANOVA indicated that duration had a significant 
effect on the FBG levels (F (3, 216) = 13.24 (p < .001) but with a small effect 
size, indicated by Eta Squared (η2) = .155.  There was also a significant duration 
x group interaction (F (6, 216 = 2.20, p = .044) but with a smaller effect size (η2 
= .058).   The direction of the effect was consistent in all three groups (i.e., the 
FBG declined over time).   There was no significant difference between the FBG 
levels of the three groups (F (2, 72) = 1.36, p = .270) with an effect size η2 = 
.036which is not clinically significant (i.e., < .04).  
Table 4.3. Comparison of FBG across Duration and Groups in Diabetic Patients 
Effect Source of 
Variance 
df
1 
df2 F p Effect 
Size 
η2 
Within-subjects Duration 3 216 13.2
4 
<.001* .155 
 Duration x Group  6 216 2.20 .044* .058 
Between-
subjects 
Group 2 72 1.36 .270 .036 
 
Note: * Significant difference (p < .05) 
The conclusion is that no significant effects of the three dietary factors (i.e., the 
modified diet, the modified diet with Ajwa date, or the modified diet with Nigella 
seeds) could be detected between the FBG levels among the three groups of 
diabetic patients during Trial 1. The statistical evidence indicated, however, that 
the FBG levels did not remain constant, but fluctuated over time. There was a 
significant ordinal duration interaction, illustrated in Figure 4.14, because the 
FBG levels in the D-D and D-NS groups tended to decline more rapidly than in 
the D-AJ group. 
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4.2.2.2. Two Hours Post Prandial Glucose (2hpp) in Diabetic 
Patients 
Figure 4.17 illustrates the variations in the mean levels of the repeated measures 
of Two Hours Post Prandial Glucose (2hPP) ± 95% CI across the three groups 
of diabetic patients throughout Trial 1. In the D-AJ group, the mean 2hPP levels 
varied from 8.39 mmol/L in Week 1 to 8.29 mmol/L in Week 12. The mean 2hPP 
levels in the D-D group decreased from 9.96 mmol/L in Week 1 to 8.70 mmol/L 
in Week 12. The mean 2hPP levels in the D-NS group decreased from 10.25 
mmol/L in Week 1 to 8.29 mmol/L in Week 12. Two hours 2hpp above about 8 
mmol/L is indicative of diabetes. The 2hPP levels of all the patients remained 
above eight mmol/L through Trial 1, reflecting their continuing diabetic condition. 
 
Figure 4.17. Repeated measures of 2hpp in diabetic patients 
Table 4.4 presents the results of repeated measures ANOVA to determine the 
extent to which the mean 2hPP levels of the diabetic patients varied within (a) 
duration and the duration x group interaction; and (c) between the three groups 
of diabetic patients.  
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Table 4.4.  Comparison of 2hpp across Duration and Groups in Diabetic Patients 
Source of Variance df1 df2 F P Effect 
Size 
η2 
Duration 3 216 21.42 <.001
* 
.230 
Duration x Group 
Interaction 
6 216 4.44 <.001
* 
.110 
Group 2 72 1.51 .228 .040 
 
Note: * Significant (p < .05) 
The results of ANOVA indicated that time had a significant effect on the 2hPP 
levels (F (3, 216) = 21.42 (p < .001) but with a small effect size, indicated by η2 
= .233.  There was also a significant duration x group interaction (F (6, 216 = 
4.44, p = <.001) with a smaller effect size (η2 = .110).  This interaction was 
ordinal, because the direction of the changes in the mean values was consistent 
in all three groups (i.e., the 2hPP consistently declined over time).  There was 
no significant difference between the 2hPP levels of the three groups (F (2, 72) 
= 1.51, p = .228) with aninsignificant effect size (η2 = .040).   
The conclusion is that the diets consumed by the three groups of diabetic 
patients did not have any significant effects on the differences between the 
mean 2hPP levels during Trial 1. The significant interaction indicated that the 
decline in 2hPP over time was more rapid in the D-D and D-NS groups than in 
the D-AJ group.  
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4.2.3. Glycated Haemoglobin (HbA1c) in Diabetic Patients 
Figure 4.18 displays the variations (Mean ± 95% CI) in two repeated 
measures of Haemoglobin A1c (HbA1c) in each of the three groups of diabetic 
patients at the baseline and endpoint of the trial (Week 1 and 12).  
 
Figure 4.18. Repeated measures of HbA1c in diabetic patients 
In the D-AJ group, the mean HbA1c declined from 7.83% in Week 1 to 7.79% 
in Week 12. The mean HbA1c in the D-D group decreased from 7.96% in Week 
1 to 7.83% Week 12. The mean HbA1c in the D-NS group decreased from 
8.17% in Week 1 to 7.96% in Week 12. The mean HbA1c levels were 
consistently elevated above the normal level expected in healthy persons (5%) 
and were typical of the levels of HbA1c observed in diabetics (over 7.0%).   
Table 4.5 presents the results of repeated measures ANOVA to determine the 
extent to which the mean HbA1c levels of the diabetic patients varied within (a) 
duration and the (c) the duration x group interaction); and between the three 
groups of diabetic patients.  
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Table 4.5. Comparison of HbA1c across Duration and Groups in Diabetic Patients 
Effect Source of 
Variance 
df1 df
2 
F P Effec
t 
Size 
η2 
Within-subjects Duration 1 72 3.2
2 
.077 .043 
 Duration x Group  2 72 0.4
3 
.653 .012 
Between-
subjects 
Group 2 72 0.2
2 
.805 .006 
 
The results of ANOVA indicated that time had no significant effect on the HbA1c 
levels (F (1, 72) = 3.22 (p = .077) with a very small effect size (η2 = 043).  There 
was no significant duration x group interaction (F (2, 72 = 0.43, p = .653) with 
an even smaller effect size (η2 = .012).  There was no significant difference 
between the HbA1c levels of the three groups (F (2, 72) = 0.22, p = .805) with 
a clinically insignificant effect size (η2 = .006).  
The conclusion is that the different diets consumed by the three groups of 
diabetic patients had no significant effects on the differences between the mean 
levels of HbA1c of the patients during Trial 1.  Furthermore, time also had no 
significant effects.  
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4.2.4. Blood Pressure in Diabetic Patients 
 4.2.4.1. Systolic Blood Pressure (SBP) in Diabetic Patients 
 Figure 4.19 illustrates the variations (Mean ± 95% CI) in the repeated measures 
of SBP across the three groups of diabetic patients in Weeks 1, 4, 8, and 12.  
 
Figure 4.19. Repeated measures of SBP in diabetic patients 
In the D-D group, the mean SBP varied from 143 in Week 1 to 139 in Week 12. 
The mean SBP in the D-AJ group decreased from 133 in Week 1 to 129 in Week 
12. The mean SBP the D-NS group declined more rapidly from 140 in Week 1 
to 128 in Week 12. A systolic blood pressure of 140 or higher, on repeated 
measurements, is considered hypertension, or high blood pressure. The upper 
bounds of the 95% CIs were above 140 in Week 1 and 2, implying some 
patients had hypertension, but thereafter the upper bounds of the CIs were 
below 140, implying that hypertension was relieved. Referring to figure 4.3 it 
can be seen that there is a positive relation between BMI and reducing the blood 
pressure due to the decrease the BMI obesity level during 12 weeks at the end 
of the study especially for Ajwa group    
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Table 4.6 presents the results of repeated measures ANOVA. Time had a 
significant effect on the SBP (F (3, 216) = 9.16 (p < .001) but with a small effect 
size (η2 = .233).   There was also a significant duration x group interaction (F 
(6, 216) = 3.17, p = .005) with a smaller effect size (η2 = .018).  The duration x 
group interaction was disordinal.  Figure 4.17 displays that the changes in the 
SBP were not consistently in the same direction in the three groups. The mean 
SBPs declined rapidly over time in group D-NS, decreased followed by an 
increase in group D-D, but remained consistently low in group D-AJ. The 
significant difference between the SBP of the three groups (F (2, 72) = 6.08, p 
= .004) with an insignificant effect size (η2 = .144) could not be interpreted 
because the effects of diet on SBP in Trial 1 were inconsistent.  
Table 4.6. Comparison of SBP across duration and Groups in Diabetic Patients 
Effect Source of 
Variance 
df1 df2 F P 
Within-subjects Duration 3 216 9.61 <.001* 
 
Between-subjects 
Duration x Group  
Group 
6 
2 
216 
72 
3.17 
6.08 
.005* 
.004* 
Note: * Statistically significant (p < .05) 
 
4.2.4.2. Diastolic Blood Pressure (DBP) in Diabetic Patients   
 Figure 4.20 illustrates the variations (Mean ± 95% CI) in the repeated measures 
of Diastolic Blood Pressure (DBP) in the three groups of diabetic patients in 
Weeks 1, 4, 8 and 12.  In the D-AJ group, the mean DBP declined from 83 in 
Week 1 to 77 in Week 12. The mean DBP in the D-D group varied from 82 in 
Week 1 to 81 in Week 12. The mean DPB in the D-NS group declined from 87 
in Week 1 to 79 in Week 12. A diastolic blood pressure of 90 or higher, on 
repeated measurements, is considered to indicate hypertension, or high blood 
pressure; however, all of the repeated of DBP measures were less than 90.  
The results of repeated measures ANOVA are presented in Table 4.7. 
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Figure 4.20. Repeated measures of DPB in diabetic patients 
Table 4.7. Comparison of DBP across duration and Groups in Diabetic Patients 
Effect Source of 
Variance 
df1 df
2 
F P Effect 
Size 
η2 
Within-subjects Duration 3 21
6 
14.2
6 
<.00
1* 
.295 
 
Between-
subjects 
Duration x Group  
Group 
6 
2 
21
6 
72 
3.56 
2.61 
.005* 
.080 
.094 
.068 
Note: * Significant (p < .05)  
 
Duration had a significant effect on the DBP (F (3, 216) = 14.26 (p < .001) with 
a moderate effect size (η2 = .295).   There was also a significant duration x 
group interaction (F (6, 216 = 3.56, p = .005) with a small effect size (η2 = .094).  
This interaction was disordinal because figure 4.18 shows that DBP tended to 
decrease rapidly in the D-NS group, decrease less rapidly in the D-AJ group, 
but remain relatively constant in the D-D group.  There was no significant 
difference between the DBP of the three groups (F (2, 72) = 2.61, p = .080) with 
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a very small effect size (η2 = .068).  The conclusion is that the disordinal 
interaction meant that the effects of diet on the DBP of the three groups of 
diabetics were inconsistent. The 2 groups taking supplements show a decline 
whilst those on the diet alone did not. It might be claimed that the 2 supplements 
produced a reduction in DBP, which was not seen in diet only patients. It would 
appear that supplementing the modified diet plus (Ajwa and Nigella) dose have 
effect on DBP. Referring to figure 4.4 it has been shown that there is correlation 
between reduced BMI level and blood pressure (DBP). The reduction in DBP 
for the groups D-NS and D-AJ is greater than for the D-D due to the high level 
of BMI in the modified diet group. 
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 4.3. Trial 2: Healthy Participants 
4.3.1. Characteristics of Healthy Participants 
Table 4.8 summarizes characteristics of the healthy participants. The majority 
of the 75 healthy participants (47, 62.7%) were female, and they ranged in age 
from 20 to 60 years (M = 33.77, SD = 9.02). About one-half of them (37, 49.3%) 
were married. Their BMIs ranged from 18.61 to 37.02 kg/m2 (M = 25.53, SD = 
3.92).  Over half were classified as either overweight (29, 38.7%) with BMI = 
25.0 to 30 kg/m2 or obese (10, 13.3%) with BMI > 30 kg/m2.   The majority (49, 
65.3%) did not smoke. The educational levels of the participants ranged from 
primary (3, 4.0%) to postgraduate (18, 24.0%). The most frequent educational 
level was undergraduate (36, 48.0%). Over one third of the healthy subjects 
(26, 34.7%) reported that their frequency of physical activity was “Daily”. The 
least frequent level of physical activity (12, 16.0 %) was two or three times a 
week.  
 
Statistical tests were conducted to determine if the characteristics of the healthy 
were equivalent across the three groups. The frequencies of males and females 
did not vary significantly between the groups (χ2 (2) = 1.48, p = .477). ANOVA 
indicated no significant difference in the mean age across the groups (F (2, 72) 
= 1.73, p = .184). ANOVA also indicated a significant difference in the mean 
BMI between the groups (F (2, 72) = 3.83 p = .026). Marital status also varied 
significantly between the three groups (χ2 (4) = 19.11, p = .001). 
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Table 4.8. Demographic and Contextual Characteristics of Healthy Participants 
Characteristics Group Total 
C-AJ 
(n = 25) 
C-D 
(n = 25) 
C-NS 
(n = 25) 
Sex Female 14 15 18 47 
18.7% 20.0% 24.0% 62.7% 
Male 11 10 7 28 
14.7% 13.3% 9.3% 37.3% 
Age 
(Years)  
M 30.72 30.12 40.48 33.77 
SD 6.74 4.99 10.49 9.02 
Marital 
Status 
Married 11 11 15 37 
14.7% 14.7% 20.0% 49.3% 
Single 14 14 4 32 
18.7% 18.7% 5.3% 42.7% 
Divorced or 
Widow 
0 0 6 6 
0.0% 0.0% 8.0% 8.0% 
BMI  
(kg/m2) 
M 24.08 25.48 27.03 25.53 
SD 4.10 2.63 4.37 3.92 
Smoking No 16 21 12 49 
21.3% 28.0% 16.0% 65.3% 
Yes 9 4 13 26 
12.0% 5.3% 17.3% 34.7% 
Education Primary 0 0 3 3 
0.0% 0.0% 4.0% 4.0% 
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High School 4 1 13 18 
5.3% 1.3% 17.3% 24.0% 
Under-
graduate 
14 15 7 36 
18.7% 20.0% 9.3% 48.0% 
Post- 
graduate 
7 9 2 18 
9.3% 12.0% 2.7% 24.0% 
Physical 
activity 
Never 2 0 15 17 
2.7% 0.0% 20.0% 22.7% 
Once/week 10 4 6 20 
13.3% 5.3% 8.0% 26.7% 
Two to  
Three /week 
4 5 3 12 
5.3% 6.7% 4.0% 16.0% 
Daily 9 16 1 26 
12.0% 21.3% 1.3% 34.7% 
 
The frequencies of smokers and non-smokers also varied significantly between 
the groups (χ2 (2) = 7.18, p = .028). The frequencies of the four educational 
levels also varied significantly between the groups (χ2 (6) = 26.50, p <.001). 
Furthermore, the frequencies of the four levels of physical activity varied 
significantly between the groups (χ2 (8) = 40.21, p < .001).The differences 
between the three groups could potentially influence their blood glucose profiles 
and blood pressures, thereby confounding the impact of the three prescribed 
diets.  
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Figure 4.21. Body Mass Index BMI of the participants 
 
Figure 4.21 above illustrates that of the 75 participants in the non -diabetic 
group, one third of them (C-D) had an average BMI of 25.5kg/m2 before the 
study, which is considered to be overweight (since it is between 25-30 kg/m2 ), 
but after the study this same group had an average BMI of 24.9, which is 
considered normal (since it is between 20-25 kg/m2 ). The participants who 
followed the modified diet supplemented with Nigella sativa seeds (C-NS) had 
an average BMI of 27 kg/m2  before the study, which came down to 26.7 
kg/m2  after the study. Furthermore, those who followed the modified diet 
supplemented with an Ajwa date appeared to have an average BMI before and 
after the study, 24 and 24.8 kg/m2 respectively.   
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Figure 4.22. BMI (obesity level) of the Healthy participants 
Figure 4.22 shows that 10 of the healthy participants (13%) were obese at the 
baseline at the study. By the end of the 12 weeks, after following either the 
modified diet, or the supplemented diet with either Nigella sativa seeds or Ajwa 
dates, the number of non-diabetic participants considered obese fell by 2 to 
11%. 
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4.3.2. Blood Glucose Profile of Healthy Participants 
4.3.2.1. Fasting Blood Glucose (FBG) in Healthy Participants 
Figure 4.23 illustrates the variations in the mean levels of the repeated 
measures of Fasting Blood Glucose (FBG) ± 95% confidence intervals (CI) 
across the three groups of healthy subjects during Trial 2.  
 
Figure 4.23 Repeated measures of FBG in healthy subjects 
The mean FBG levels were consistently less than 5.6 mmol/L indicative of 
healthy individuals who did not have diabetes. In the C-AJ group, the mean 
FBG levels varied from 5.13 mmol/L in Week 1 to 5.15 mmol/L in Week 12. The 
mean FBG levels in the C-D group varied from 4.96 mmol/L in Week 1 to 5.09 
mmol/L in Week 12. The mean FBG levels in the C-NS group varied from 5.36 
mmol/L in Week 1 to 5.06 mmol/L in Week 12.   
Table 4.9 presents the results of repeated measures ANOVA.  There was no 
significant difference in the FBG levels within duration (F (3, 216) = 1.98 (p = 
.117) with nonsignificant effect size (η2 = .027). There was no significant 
duration x group interaction (F (6, 216 = 1.73, p = .155) with a very small effect 
size (η2 = .049). There was no significant difference between the FBG levels of 
the three groups (F (2, 72) = 0.68, p = .501) with an effect size that was not 
significant (η2 = .019). 
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Table 4.9. Comparison of FBG across Duration and Groups in Healthy Subjects 
Effect Source of Variance df1 df2 F p Effect 
Size 
η2 
Within-subjects Duration 3 216 1.98 .117 .027 
 Duration x Group  6 216 1.73 .115 .040 
Between-
subjects 
Group 2 72 0.68 .501 .019 
 
The conclusion is that the two dietary factors consumed by the three groups of 
healthy subjects did not have any significant effects on the differences between 
their mean FBG levels during Trial 2.  The mean FBG levels remained constant 
over duration, and the changes in the FBG levels over duration were the same 
in the three groups, as illustrated in Figure 4.21. 
4.3.2.2. Two Hours Post Prandial Glucose (2hpp) in Healthy Subjects 
Figure 4.24 illustrates the variations in the mean levels of the repeated 
measures of 2hpp ± 95% CI across the three groups of healthy subjects during 
Trial 2. The 2hpp levels of all the patients remained below eight mmol/L 
between Week 1 and Week 12, indicating that they did not have diabetes.  In 
the C-AJ group, the mean 2hpp levels varied from 5.66 mmol/L in Week 1 to 
5.64 mmol/L in Week 12. The mean 2hpp levels in the C-D group varied from 
6.27 mmol/L in Week 1 to 6.43 mmol/L in Week 12. The mean 2hpp levels in 
the C-NS group varied from 6.10 mmol/L in Week 1 to 5.60 mmol/L in Week 12. 
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Figure 4.24. Repeated measures of 2hpp in healthy subjects 
Table 4.10 presents the results of repeated measures ANOVA. The results 
indicated that duration had no significant effect on the 2hpp levels (F (3, 216) = 
1.39 (p = .245) with an effect size that was not significant (η2 = .019).  There 
was, however, a significant duration x group interaction (F (6, 216 = 4.44 p < 
.001) with a small effect size (η2 = .119). There was also a significant difference 
between the 2hpp levels of the three groups (F (2, 72) = 13.33, p <.001) with a 
moderate effect size (η2 = .270).  
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Table 4.10. Comparison of 2hpp across Duration and Groups in Healthy Participants 
Effect Source of 
Variance 
df1 df2 F P Effect 
Size 
η2 
Within-subjects Duration 3 216 1.39 .245 .019 
 Duration x 
Group  
6 216 4.84 <.001* .119 
Between-
subjects 
Group 2 72 13.3
3 
<.001* .270 
 
Note: * Significant (p < .05) 
The duration x group interaction was disordinal, because the directions of the 
changes in the 2hPP levels over duration were not the same in the three groups. 
As illustrated in Figure 4.22, the 2hPP levels in the C-AJ group tended to remain 
relatively constant, whereas the 2hpp levels in the C-D group tended to 
increase, whilst in the C-NS groups the 2hPP levels tended to decline over 
duration. Because the interaction was disordinal, and the effects were both 
positive and negative, the significant differences between the three groups were 
not interpretable.  
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4.4. Comparison of Diabetic Patients and Healthy Participants 
4.4.1. Participants Characteristics (Trial 1 and Trial 2)   
The demographic and physical characteristics of the six groups of participants 
are summarized and compared in Table 4.11. The majority of the participants 
(95, 63.3%) were female.  The frequencies of males and females in each group 
did not vary significantly across the six groups (Pearson’s Χ2 (5) = 1.866, p = 
.867). The participants ranged in age from 20 to 60 years (M = 41.33, 95% CI 
= 38.49, 43.16). ANOVA indicated a significant difference in the mean age 
between the six groups (F (5, 144) = 34.17, p < .001).  The ages of the three 
diabetic groups (M = 47.32 to 51.24 years) were significantly higher than the 
ages of the three control groups (M = 30.12 to 40.48 years). 
The majority of the participants (88, 58.7%) were married. The marital status of 
the participants varied significantly across the six groups (Pearson’s Χ2 (10) = 
40.255, p < .001). The diabetic group contained the highest frequencies of 
married, widowed, and divorced participants. The health group contained the 
highest frequencies of single participants. 
 The BMIs of the participants ranged from 18.61 to 47.38 kg/m2 (M = 
26.85, 95% CI = 26.15, 27.56).  The majority of the participants were classified 
as overweight (65, 43.3% with BMI = 25.0 to 30 kg/m2) or obesity (31, 20.7% 
with BMI > 30 kg/m2).  ANOVA indicated a statistically significant difference in 
the mean BMI between the six groups (F (5, 144) = 5.186, p < .001). The mean 
BMIs of two case groups: D-AJ (M = 28.53 kg/m2) and D-D (M = 29.08 kg/m2) 
were significantly higher than mean BMIs in the other four groups (M = 24.08 to 
27.04 kg/m2). 
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Table 4.11. Characteristics of Six Groups of Participants 
Characteristic                                                                  Group Total 
 C-AJ C-D C-NS D-AJ D-D D-NS  
Sex Female 14 15 18 16 17 15 95 
 
9.3% 
10.0
% 
12.0
% 
10.7
% 
11.3
% 
10.0
% 
63.3
% 
Male 11 10 7 9 8 10 55 
 
7.3% 6.7% 4.7% 6.0% 5.3% 6.7% 
36.7
% 
Age 
(Years)  
Mean 30.7
2 
30.1
2 
40.4
8 
51.2
4 
47.3
2 
48.0
8 
41.33 
SD 
6.74 4.99 
10.4
9 
6.83 8.62 8.12 
11.37 
Marital 
Status 
Married 11 11 15 18 17 16 88 
 7.3% 7.3% 10.0
% 
12.0
% 
11.3
% 
10.7
% 
58.7
% 
Single 14 14 4 2 4 2 40 
 9.3% 9.3% 2.7% 1.3% 2.7% 1.3% 26.7
% 
Divorced 
or 
Widow 
0 0 6 5 4 7 22 
0.0% 0.0% 4.0% 3.3% 2.7% 4.7% 14.7
% 
BMI  
(kg/m2) 
Mean 24.08 25.48 27.04 28.53 29.08 26.92 26.85 
SD 4.10 2.63 4.37 5.16 4.33 3.51 4.37 
Smokin
g 
No 16 21 12 17 18 15 99 
10.7% 14.0% 8.0% 11.3% 12.0% 10.0% 66.0% 
Yes 9 4 13 8 7 10 51 
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6.0% 2.7% 8.7% 5.3% 4.7% 6.7% 34.0% 
Educati
on 
Illiterate 0 0 0 3 2 4 9 
0.0% 0.0% 0.0% 2.0% 1.3% 2.7% 6.0% 
Primary  0 0 3 9 12 5 29 
0.0% 0.0% 2.0% 6.0% 8.0% 3.3% 29.3
% 
High  
School 
4 1 13 10 6 9 43 
2.7% 0.7% 8.7% 6.7% 4.0% 6.0% 28.7
% 
Under- 
Graduate 
14 15 7 3 5 7 51 
9.3% 10.0
% 
4.7% 2.0% 3.3% 4.7% 34.0
% 
Post- 
Graduate 
7 9 2 0 0 0 18 
4.7% 6.0% 1.3% 0.0% 0.0% 0.0% 12.0
% 
Physica
l activity 
Never 2 0 15 15 11 19 62 
1.3% 0.0% 
10.0
% 
10.0
% 
7.3% 
12.7
% 
41.3
% 
Once/we
ek 
10 4 6 3 7 3 33 
6.7% 2.7% 4.0% 2.0% 4.7% 2.0% 
22.0
% 
Twice/we
ek 
2 2 2 5 3 2 16 
1.3% 1.3% 1.3% 3.3% 2.0% 1.3% 
10.7
% 
2 or 3 
times/we
ek 
2 3 1 0 0 0 6 
1.3% 2.0% 0.7% 0.0% 0.0% 0.0% 4.0% 
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Daily 9 16 1 2 4 1 33 
6.0% 
10.7
% 
0.7% 1.3% 2.7% 0.7% 
22.0
% 
C-AJ (Control group consumed Ajwa date), C-D (Control group consumed Modified diet), C-NS 
(Control group supplemented with Nigella Seeds), D-AJ (Diabetes group consumed Ajwa 
dates), D-D (Diabetes group followed a modified diet) D-NS (diabetes group supplemented with 
Nigella sativa seeds) SD (standard deviation) BMI (Body mass Index) 
A total of 51 (34.0%) of the participants were smokers. The frequencies of 
smokers and non-smokers in each group did not vary significantly across the 
six groups (Pearson’s Χ2 (5) = 8.111, p = .150). The educational levels of the 
participants ranged from illiterate (9, 6.0%) to postgraduate (18, 12.0%). The 
most frequent educational level (51, 34.0%) was undergraduate. The 
frequencies of the educational levels in each group varied significantly across 
the six groups (Pearson’s Χ2 (20) = 88.878, p <.001). The frequencies of the 
most highly educated participants (undergraduates and postgraduates) were 
higher in the healthy groups than in the diabetic groups.  
The levels of physical activity of the participants ranged from “Never” (62, 
41.3%) to “Daily” (33, 22.0%). The frequencies of the physical activity levels in 
each group varied significantly across the six groups (Pearson’s Χ2 (20) = 
78.422, p <.001).  Higher levels of physical activity were more frequent among 
the healthy subjects than the diabetic. Lower levels of physical activity were 
more frequent among the cases than the controls. 
 4.4.2 Blood Glucose Profile (Trial 1and2)  
The results of repeated measures ANOVA using the data collected in Trial 1 
and Trial 2 indicated that there were no significant differences between-subjects 
in the blood glucose profiles of the three groups of participants who consumed 
the two types of dietary factors. Consequently, the data for the three groups 
were pooled, in order to compare the blood glucose profiles of diabetic patients 
and healthy participants.  
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4.4.2.1 Fasting Blood Glucose (FBG) 
Figure 4.25 illustrates the variations in the mean levels of FBG ± 95% CI in the 
three groups of healthy participants remained below 8 mmol/L between Week 
1 and Week 12, indicating that they did not have diabetes. In contrast, the mean 
levels of FBG among the diabetic patients started above 8 mmol/L between 
Week 1 and Week 12, reflecting their diabetic condition.   In both the healthy 
participants and the diabetic patients, the FBG levels tended to decline with 
duration. In the healthy participants, the mean FBG declined from 5.51 mmol/L 
in Week 1 to 5.10 mmol/L in Week 12. In the diabetic patients, the mean FBG 
declined from 8.10 mmol/L in Week 1 to 7.34 mmol/L in Week 12. 
 
Figure 4.25. Comparison of FBG in healthy participants and diabetic patients 
Table 4.12 presents the results of repeated measures ANOVA to determine the 
extent to which the mean FBG varied within (a) duration and the duration x 
health status interaction, and (b) between the healthy participants and the 
diabetic patients (termed the health status).  
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Table 4.12. Comparison of FBG in healthy participants and diabetic patients 
Effect Source of Variance df
1 
df2 F p Effect 
Size 
η2 
Within-subjects Duration 3 444 13.56 <.001* .084 
 
Between-subjects 
Duration x Health 
Status  
Health Status 
3 
1 
432 
148 
9.21 
128.4
1 
<.001* 
<.001* 
.059 
.465 
Note:  * Significant (p < .05) 
The variations in FBG with duration were significant (F (3, 344) = 13.56, p < 
.001) with a small effect size (η2 = .084). There was a significant duration x 
health status interaction (F (3, 342) = 9.21, p < .001) with a smaller effect size 
(η2 = .059).  This interaction was ordinal, because Figure 4.23 reflects that the 
mean levels of FBG declined with duration in both the healthy participants and 
the diabetics. The effect of health status was  significant (F (1, 148) = 128.41, 
p < .001) with a moderate effect size (η2 = .483); however, the duration x health 
status interaction effect indicated that the decline of FBG was most rapid among 
the diabetics 
4.4.2.2 Two Hours Post Prandial Glucose (2hpp) 
Figure 4.26 illustrates the variations in the mean levels of 2hpp ± 95% CI in the 
three groups of healthy participants remained below 8 mmol/L between Week 
1 and Week 12, indicating that they did not have diabetes. In contrast, the mean 
levels of 2hpp among the diabetic patients remained above 8 mmol/L between 
Week 1 and Week 12, reflecting their continual diabetic condition.  In the healthy 
participants, the mean 2hPP declined from 6.01 mmol/L in Week 1 to 6.89 
mmol/L in Week 12. In the diabetic patients, the 2hpp declined from 9.53 
mmol/L in Week 1 to 8.42 mmol/L in Week 12.  
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Figure 4.26. Comparison of 2hpp in healthy participants and diabetic patients 
Table 4.13 presents the results of repeated measures ANOVA to determine the 
extent to which the mean 2hpp varied within (a) duration and the duration x 
health status interaction; and (b) between the diabetic and healthy participants 
(termed health status for the purpose of this analysis).  
Table 4.13. Comparison of FBG in Healthy Participants and Diabetic Patients 
Effect  Source of Variance df
1 
df2 F p Effect 
Size 
η2 
Within-
subjects 
duration 3 444 20.37 <.001* .121 
 
Between-
subjects 
Duration x Health 
Status  
Health Status 
3 
1 
432 
148 
14.53 
138.34 
<.001* 
<.001* 
.089 
.483 
 
Note: * Significant (p < .05) 
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 The variations in 2hPP with duration were significant (F (3, 444) = 20.37, P 
<.001) with a small effect size (η2 = .121).  There was a significant duration x 
health status interaction (F (3, 432) = 14.53, p < .001) with a smaller effect size 
(η2 = .089).  This interaction was ordinal, because Figure 4.24 reflects that the 
2hPP levels declined with duration in both the healthy participants and the 
diabetic patients. The effect of health status was significant (F (1, 148 = 138.34, 
p < .001) with a moderate effect size (η2 = .483).  In conclusion, the decline in 
2hPP indicated that the decline in 2hPP was more rapid among the diabetic 
patients.  
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4.5 Summary 
 There is no significant effects of the specific dietary intake (i.e., the 
modified diet, the modified diet with Ajwa date, or the modified diet with 
Nigella seeds) which could be detected in the FBG levels between the 
three groups of diabetic patients. However, Fasting Blood Glucose levels 
declined between Week 1 and Week 12 in groups (D-D with modified 
diet and D-NS with Nigella seeds).  
 The diets consumed by the three groups of diabetic patients (Trial 1) did 
not have any significant effects on the differences between the mean 
2hPP glucose levels. However, Two Hour Post Prandial Glucose levels 
declined rapidly between Week 1 and Week 12 in groups (D-D with 
modified diet. and D-NS with Nigella seeds) 
 The different dietary factors (modified diet, Ajwa and Nigella seeds) 
consumed by the three groups of diabetic patients had no significant 
effects on the differences between the mean levels of HbA1c of the 
patients. However, HbA1c levels declined significantly over duration 
between Week 1 and Week 12 in group D-NS (with Nigella seeds), the 
effect size was large, and there were no significant changes in HbA1c 
among the other two groups.  
 The significant difference between the blood pressures of the three 
groups of diabetic patients with non-significant effect could not be 
interpreted because of a disordinal duration x group interaction, which 
meant that the effects of dietary factors on the blood pressures of the 
diabetic patients were inconsistent. Furthermore, Systolic Blood 
Pressures (SBP) and Diastolic Blood Pressures (DBP) declined over 
duration between Week 1 and Week 12 in group D-NS (with Nigella 
seeds). The DBP declined over duration between Week 1 and Week 12 
also in group D-AJ (with Ajwa Date).  
 There was no significant difference between the FBG or 2hPP levels of 
the three groups of healthy participants (Trial 2).  
 The between- subject interaction effects with duration were the most 
significant outcomes of the trials. The FBG, 2hPP, HbA1c, and blood 
pressures declined more rapidly in diabetic patients than in healthy 
participants; however, the effects were only small to moderate.  
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5.1. Introduction 
This study aimed to assess the impact of consumption of Nigella sativa seeds 
or Ajwa dates in conjunction with a defined modified diet or the modified diet 
alone on the Blood Glucose Levels (BGL) of diabetic patients with Type 2 
diabetes and a control group of healthy volunteers. The study was divided 
between 2 populations. A randomised clinical trial (RCT) study was carried out 
in the Kingdom of Saudi Arabia and was used in the United Kingdom. 
The healthy population was divided into three groups: the first group (C-D) were 
placed on a modified diet for 12 weeks, the second group (C-AJ) consumed the 
same modified diet plus 1 Ajwa date early morning (between 6am to 11am) for 
12 weeks, the third group (C-NS) consumed the modified diet plus 2g/day of 
Nigella sativa seeds early morning (between 6am to 11am) for 12 weeks.  
The diabetic group was focussed on adult patients with a confirmed diagnosis 
of Type 2 diabetes. The diabetic group was divided into three groups; each 
group was placed on a modified diet for 12 weeks. Group 1 acted as a control; 
groups 2 and 3 had their modified diet supplemented with either 1 Ajwa date 
(per day) or Nigella sativa seeds (2g/day) respectively.  
The hypothesis of this study was that supplementing a basic diabetic diet with 
Nigella sativa seeds or Ajwa dates would significantly improve the control of 
BGL in Type 2 diabetic patients. By supplementing the diet with Ajwa dates or 
Nigella sativa seeds, there would be an increase in the nutrients and calories 
available and this difference may be the cause of any differences between the 
groups observed by the researcher.  
Routine measurement of blood glucose levels is an important part of diabetes 
management. Hence, the BGL was measured in the early morning before any 
food or drink had been consumed and then again 2 hours postprandial. This 
was considered important as the changes in this response were taken to be an 
indication of differences in the response to the different diets. Moreover, the 
healthy groups had their BGL measured once a week, and the measurements 
have been used by the researcher to help with this project. The research 
procedure for the diabetic groups required patients to measure their BGL more 
than twice a week using Self-Monitoring Blood Glucose (SMBG) meters. 
(Chapter 3 for details of the method). 
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The main findings of this research is that diabetic patients who followed a 
dietary plan plus Nigella sativa seeds showed a rapid decrease of BGL (FBG 
and 2hPP), which was significantly greater than the control achieved in a 
comparable group taking only a modified diet. The findings also suggest that by 
using a dietary supplement of Ajwa dates, BGL remained stable throughout the 
12 week period.    
5.2. Trial 1 (Diabetic Subjects) 
           5.2.1. Demographic and Lifestyle Data  
           5.2.1.1. Age and Duration of Diabetes in the Diabetic groups 
The demographic data shows that the diabetic participants ranged in age from 
25 to 66 years. The Ajwa group, which was 40 to 66 years, was higher in age 
than the Nigella sativa and modified diet groups with the ages of participants 
ranging from 36- 61 and 25-62 years respectively. Previous research (AlBakr et 
al., 2013) has reported that old age has a significant correlation with 
uncontrolled Type 2 diabetes. Furthermore, Memish et al (2014) also show that 
there is an increased risk of development of Type 2 diabetes in old age. This 
could explain why many of the diabetic participants fell within the old age 
category (>50 years (Karlin et al., 2016). Moreover, due to the fact that there 
are more instances of Type 2 diabetes in women compared to men in Saudi 
Arabia (SA) (Memish et al., 2014), this could also explain why 65% of the 
diabetic participants were female.   
 
The time since initial diagnosis of the diabetic patients in the Ajwa group (D-AJ) 
ranged from 5 – 25 years, 1- 9 years for the group on the modified diet (D-D) 
and 5-10 years for the group on the modified diet plus Nigella sativa seeds (D-
NS). Furthermore, previous research on Type 2 diabetes (e.g. Memish et al., 
2014) revealed that a long duration of diabetes is related to increase HbA1c 
levels and enhanced the risk factors related to Type 2 diabetes such as high 
blood pressure.  Bahijri et al, (2016), also found that long duration of diabetes 
and age can lead to a rise in BGL, leading to a change in HbA1c, which supports 
the finding in this study that the Ajwa dates group (D-AJ) showed an increase 
in fasting blood glucose (FBG) and HbA1c levels in the older members of the 
Ajwa group (D-AJ), who had a long duration diabetes (>10 years).  
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As part of this study, a subgroup was extracted from each of the diabetic groups 
(D-D, D-AJ and D-NS) to represent the patients who had a long duration of 
diabetes (10 > years) and were elderly (>50 years), which was one of the factors 
that influenced blood glucose profile (FBG and 2hPP) and HbA1c levels (see 
chapter 4). One of the possible reasons for why the average in HbA1c did not 
decrease, could be because some of the individuals had high values of HbA1c 
(above 8%), FBG and 2hPP that was poorly uncontrolled. Moreover, only three 
out of nine patients had an improvement in HbA1c after 12 weeks of consuming 
Ajwa dates (see figure 4.4 ).However, those who were elderly and had long 
duration of diabetes in the Nigella sativa seeds group (D-NS) showed a 
decrease in HbA1c, FBG and 2hPP BGL levels at the end of the study 
compared to the baseline (the beginning of the study),  
As for those patients who were elderly and had a long duration of diabetes but 
only consumed the modified diet alone (D-D), there was a slight increase of 
HbA1c, FBG and 2hPP BGL levels after 12 weeks. 2 out of the 3 patients who 
were from the D-D group, with a long duration of diabetes and elderly had well 
controlled BGL (HbA1c, FBG and 2hPP) than those from D-AJ and D-NS. 
It can be seen from the graph (4.5)(see chapter 4) that the Ajwa dates seems 
to have an effect in diabetic people who have recently been diagnosed (short 
duration of diabetes < 10 years) The separation of the long duration diabetic 
patients (diagnosed > 10 years ago) from the short-duration diabetic patients 
(diagnosed < 10 years ago) reveals the difference in the effect of Ajwa dates in 
the two groups. Over the 12 week period of the study there is a slight fall in the 
HbA1c levels in the short-duration group whilst there is a rise in the HbA1c 
levels in the long-duration diabetes group. The division of the group into short 
< 10 and long > 10 years since diagnosis is essentially arbitrary hence it might 
be more reasonable to make the separation at another boundary such as <5> 
years. This has not been done as part of this study because the numbers are 
not considered sufficient for statistical analysis. However the theoretical 
justification for a differential effect of Ajwa dates is that the effect may be slight 
and related to insulin sensitivity/insensitivity (falling/rising) as the diabetes 
develops. Thus Ajwa dates have an effect in early diabetes when insulin 
sensitivity is still high but the effect is loss as insensitivity develops. This would 
also be consistent with the date flesh having low levels of an activity component 
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which is possibly present at higher levels in the seed also explaining why 
studies using ground seed or extracts of seed apparently show a greater effect. 
It is possible that a more detailed analysis of the data obtained in this study 
might assist In clarifying this but is probable that the better option would be to 
recommend further studies which attempt to relate activity of Ajwa to the 
duration of diabetes also biochemical analyses of the seed and the flesh of the 
date is needed to attempt to identify the specific active materials.  
5.2.1.2. Smoking status 
The percentage of the diabetic participants who were smokers was 33.3% 
(n=25), most of whom were male. Willi et al, (2007) concluded that the risk of 
diabetes is higher for heavy smokers. Moreover, Wannamethee et al, (2001) 
found that smoking could significantly increase the risk of diabetes and the 
complications associated with Type 2 diabetes such as failing to a healthy diet 
or to take adequate exercise.  
The percentage of female smokers compared to male smokers from the diabetic 
participants was very low (n=9, 12%), which may be reflective of the Saudi 
culture as highlighted by the findings of Al-Nozha et al ,(2004).   
5.2.1.3. Education Levels for Diabetic patients 
The current study has shown that Nigella sativa seeds have the greatest effect 
on BGLs compared to the other two treatments. The Nigella sativa seeds group 
(D-NS) for diabetic participants had the least number of participants with a low 
level of education compared to the two other diabetic groups (D-AJ and D-D). 
21.3% (n=16/25) of the D-NS group were identified as having a higher level of 
education, which is a significant point of discussion in light of earlier research. 
The findings of Maty et al ,(2005) could be used to understand why the D-NS 
showed a greater effect on BGL, since they highlight the observation that high 
education levels play an important role in positive adherence to treatment and 
controlling BGLs.  Furthermore, Bamosa et al, (2007) showed that low 
education levels had a strong correlation with risk factors for Diabetes Mellitus. 
Sharaf ,(2013) and Al-Banny et al, (2015) came to the same conclusions, 
suggesting that higher levels of education may reduce relative risk factors, such 
as smoking, not following a dietary plan and decreased physical activity, which 
are more common in less educated patients . In addition, they found that a 
higher level of education improved the knowledge of Diabetes Mellitus and 
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health education for diabetic patients and found a correlation between high 
education levels and lifestyle modifications such as encouraging patients to 
follow a balanced diet (a low sugar and salt intake and increasing consumption 
of fruit and vegetables). 
The results of this study show that 34.7% (n=26/75) of the total trial 1 group of 
diabetic participants were not educated beyond the primary school level.  This 
low level of education may explain why some participants experienced difficulty 
in understanding their disease and how to independently follow the instructions 
given to them as part of the self-management programme and nutrition support 
plan.  
Similarly, illiteracy in diabetic patients could also have had a detrimental effect 
on understanding the disease and that may increase the risk of complications 
that relate to Type 2 diabetes such as hypoglycaemia. The incidences of 
illiteracy in diabetic participants in all groups (D-D, D-AJ and D-NS) were low 
(n=9, 12%), all of whom were from the elderly female category. This could be 
due to the fact that elderly women in SA are less likely to be educated  as 
historically women were socially discouraged from education (Elamin and 
Omair, 2010). Such participants were completely dependent on other family 
members keeping track of their BGL during the day.  
5.2.1.4. Physical activity  
As outlined in the literature review, Tuomilehto et al ,(2001) and Ramachandran 
et al ,(2006) found that there was a positive correlation between lifestyle 
modifications and diabetes prevention. Lifestyle changes such as dietary 
modification and increased physical activity can reduce the relative risk for the 
development of Type 2 diabetes. 
The physical inactivity of the Saudi population is a major public health concern, 
especially for diabetic patients. The findings of the current study revealed that 
60%, n=45/75 of all the diabetic participants were inactive, while 34% of them 
had up to a primary level of education (see table 4.1). This does not support the 
findings of Al-Nozha et al, (2007), who mentioned that the level of physical 
activity correlated with the education level of patients; those who had a lower 
level of education were more likely to be inactive. In addition, the findings of this 
study also suggest that lack of physical activity may also be due to other factors 
such as people’s culture. Furthermore, Al-Nozha et al, (2007) also found that 
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females were less physically active than males. This could be due to the fact 
that there are a limited number of environments in which females can be 
physically active (such as health centres or gymnasiums), and any such 
facilities that do exist are expensive.  
Moreover, most of the elderly diabetic participants of this study had low levels 
of physical activity. The researcher’s information gathered at the initial meetings 
with such participants imply that this could be because of the hot weather 
conditions in SA, which makes it difficult for them to be physically active 
outdoors during the day. Another possible explanation for this trend could be 
the inability of elderly people to exercise frequently due to other health 
conditions.     
5.2.1.5. Body Mass Index (BMI) 
The results of the present study show that the BMI of all the participants ranged 
from 18 to 47kg/m2, with the average being 26.8kg/m2. Despite patients being 
randomly assigned to the different group which should have ensured that pre-
existing factors did not influence the study it can be seen that the BMI of the 
Ajwa group is different.  
Memish et al, (2014) and Al-Daghri et al, (2011), found that an increase in BMI 
leads to an increase in HbA1c levels and a BMI of more than 26 – 30 may 
increase the risk factors of Type 2 diabetes. Consistent with the findings of 
Memish et al, (2014) and Bahijri et al, (2016), this study found that the 
participants with a higher BMI in D-AJ group had higher levels of HbA1c. 
This study showed that the BMI for the 2 diabetic participant groups following 
the specific supplementary diets assigned to each group (Nigella sativa seeds 
and Ajwa dates), declined after 12 weeks. This supports the findings of Hoseini 
et al, (2013) who concluded that Nigella sativa intake produced a significant 
reduction on BMI. However, there are numerous studies illustrating that Nigella 
sativa has a non-significant effect on BMI. (Qidwai et al., 2009; Haque et al., 
2011 and Shah et al., 2012).  
The contradictory findings of other studies may be reflective of the fact that they 
each used a different dosage of Nigella sativa and were carried out over 
different duration. For example, Qidwai et al, (2009) used 1g/day for six weeks, 
whereas Haque et al, (2011) used 5ml of Nigella sativa oil/day for six weeks 
and Shah et al., 2012) used 500mg/day for the same duration. Although Hoseini 
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et al’s (2013) study used the same dosage of Nigella sativa as Haque et al, 
(2011), their study (ibid,  2013) was carried out over a period twice as long as 
Haque et al’s (2011).   
All the studies which concluded that the BMI reduction was insignificant as a 
result of using Nigella sativa were carried out over a period of six weeks. 
Whereas the studies, including this one, which were carried out over a longer 
duration (12 weeks), found a significant reduction in BMI. Therefore, it is 
important to consider the differences in the dosages of Nigella sativa used as 
well as the duration of each of the studies. One of the reasons why the findings 
of Hoseini et a,l (2013) are consistent with the findings of this present study 
could be because both these studies allowed 12 weeks of Nigella sativa intake 
in order for a significant reduction in BMI to be observed.  
5.2.1.6. Measuring Blood glucose level SMBG 
Many research studies (Rubin et al., 1989; Hirsch et al., 2008; Durán et al., 
2010) have concluded that self-monitoring blood glucose is one of the most 
effective ways of self-managing type 2 diabetes. This is because it allows the 
patient to be aware of their own BGL, giving them the opportunity to change 
their behaviour, resulting in better control of the BGL through dietary restraint. 
The fact that 60% of the diabetic participants of this study, did not do the Self-
Monitoring Blood Glucose measurements at home is reflective of the findings 
of Huri et al, (2010), who found that patients preferred to do the measurements 
at the hospital, as it was easier for them to have a health professional, such as 
a nurse, do the measurements for them; despite having all the tools to measure 
BGL at home. The possible reasons for this could have been a fear of pain 
associated with the tests and difficulties in reading the results, especially for the 
illiterate participants.  
As demonstrated in chapter 4, there was a fluctuation in the BGL (FBG and 
2HPP) of all three diabetic groups over the 12 week period. Among the reasons 
for this could be due to 60% of participants taking their BGL measurements at 
the hospital rather than at home. Therefore, the frequency of monitoring their 
BGL was dependent on the frequency of their hospital appointments, which in 
some cases were monthly.  
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Summary  
In summary, it is important to consider the demographic and lifestyle data 
discussed above when analysing the results of this study because it is possible 
that this data may influence the BGL and blood pressure. It would appear that 
the level of education is a key factor for people in SA, including those with 
diabetes, in influencing their lifestyle choices. This is because there is a strong 
positive correlation between low levels of education and lifestyle modifications 
such as reducing smoking, increasing physical activity and frequently 
measuring BGL in order to be able to manage the disease. 
5.2.2. Discussion of individual parameters in the Diabetic group 
5.2.2.1. Fasting Blood Glucose Levels (FBG) 
The results in the present study suggest that the FBG level for trial 1 (diabetic 
group) D-NS and D-D groups declined over the 12 weeks of the study. However, 
the FBG level of the D-AJ group remained constant over the 12 weeks of the 
study. Over the duration of this study, the researcher observed that time had a 
significant effect on the FBG level, with P (<0.001), within the diabetic groups.  
The data shows that the Ajwa date group (D-AJ) started with a significantly 
lower mean FBG than the other 2 groups and that the levels in these 2 groups 
(D-D and D-NS) falls only into the range in which the Ajwa date group remain, 
suggesting that the FBG in the Ajwa group was already under control. The 
possible explanation for the fact that the BMI appears to be reduced more in 
the Ajwa group and the diet group. (Figure 4.1) is that the Nigella seeds provide 
some additional nutrition.  
In the present study, a reduction in FBG was observed in Type 2 diabetes 
patients, who had a diet supplemented with 2g of Nigella sativa seeds (D-NS). 
This supports the findings of Bamosa et al, (1997), who studied the effect of 
different doses of Nigella sativa seeds on blood glucose in healthy volunteers 
in SA. They (ibid, 1997) found that 2g of Nigella sativa seeds resulted in a 
significant decrease (P<0.05) in FBG after inclusion in the diet for 2 weeks. The 
findings of this study are also consistent with previous research on patients with 
Type 2 diabetes, (Bilal et al., 2009; Bamosa et al., 2010; Ahmed et al., 2012; 
Najmi et al., 2012 and Hoseini. et al., 2013) all of which show a significant effect 
of Nigella sativa on FBG. Furthermore, Bamosa et al ,(2010) found that 1g of 
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Nigella sativa seeds had no significant effect on FBG levels over a 3-month 
period, which was in contradiction to the findings of Ibrahim et al (2014), who 
used the same dose of Nigella sativa seeds, and found a significant effect on 
FBG over a 2-month period. One of the reasons for the inconsistency in their 
results could be due to the fact that the participants used for each of the above 
mentioned studies, had an impact on the overall result. When comparing these 
studies, it is essential to consider the fact that Ibrahim et al, (2014) only studied 
the effect of Nigella sativa seeds on menopausal women aged 50-55, whereas 
Bamosa et al, (2010) studied males and females aged between 18-60.  
Based on the previous research (outlined in chapter 2) on Nigella sativa seeds 
and their effect on FGB, there does not appear to be a consistent trend in the 
amount of Nigella sativa seeds given and the effect on FBG. For example, 
Datau et al’s (2010) result of a non-significant change in FBG (p>0.05) leads to 
further speculation. This may be because their study was based on obese men 
but it was not clear as to whether or not they also had Type 2 diabetes, hence 
it may or may not be comparable with other studies in diabetic patients. 
Therefore, the duration of studies, the dose of Nigella sativa used, and the 
status of participants are all essential factors to be considered when comparing 
studies. 
There is a lack of studies that observe the effect of Ajwa dates on FBG levels 
in humans. Despite the report of Hasan and Mohieldein (2016), who found that 
there was a significant decrease in FBG in diabetic rats when given 10 ml of 
Ajwa date seed extract, this is not a justification for adding Ajwa dates to the 
diet. The reason being that they used an extract of Ajwa date seeds which 
clearly is significantly different biochemically from the flesh of the date hence 
the properties are significantly different. Care should be taken when examining 
pervious study because of variation in the materials actually used. References 
show that rather than the flesh of the date many studies used the seeds either 
ground or as an extract and of course with different method of extraction being 
used, all of which results in different material which produce different results. 
5.2.2.2. Blood Glucose Levels (2hPP) 
Over the 12 weeks of the present study, there were significant changes 
(P<.001) in the 2 hour postprandial BGL of all diabetic groups. The statistical 
difference (see chapter 4, figure 4.2) shows a clear fall in both parameters from 
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a mean of 9.96 mmol/L in week 1 for D-D to a mean of 8.70 mmol/L in week 12, 
and from a mean of 10.25 mmol/L in week 1 for D-NS to a mean of 8.29 mmol/L 
in week 12.  In contrast, the group consuming the modified diet supplemented 
with Ajwa dates (D-AJ) did not show a fall over the study period but 
unexpectedly this group started the study with a value of 8.39 and although 
there was variation, week 4 = 8.50, week 8 = 8.23 and week 12 = 8.29, remained 
constant throughout the study.  
The D-AJ group coincidently had low values for FBG and HbA1c at the 
beginning of the study, which resulted in the average 2hPP BGL of the D-AJ 
group being already as low as the other 2 groups became (D-D and D-NS). 
Although it is possible to interpret this difference in figures as being a result of 
selecting participants for the Ajwa group, rather than randomly assigning them, 
the study design (outlined in chapter 3) clearly shows that this was not the case, 
as patients were assigned to each of the groups (D-D, D-AJ and D-AJ) 
depending on their time of arrival to the diabetes clinic, at different days 
throughout the period of collecting diabetic participants. One possible reason 
for the significant difference in the baseline readings, could be due to the 
unbalanced nature of the groups due to being randomly assigned to each of the 
three groups. Thus, the significant fall in 2hPP BGL in the D-D and D-NS groups 
only brought their values down to the level of the D-AJ group.   
Previous research (e.g. Rahman, 2007; Bandeira et al., 2012 and Hasan and 
Mohieldein, 2016) suggests that the presence of flavonoids and antioxidants in 
the Ajwa date could reduce the oxidative stress by an antioxidant enzyme, 
leading to a reduction in BGL. However, this was not the case from the results 
of this study. Thus care should be taken when considering these results, as 
after 8 weeks and 12 weeks the results appear to show a fall in both these 
parameters when compared to the week 1 and week 4 data (figures 4.2 in 
chapter 4 ), suggesting that this fall could be an anomaly. Furthermore, this 
could also be because the basic results show that the D-AJ group had mean 
values, which appear to be lower than the mean values on all data of the other 
2 groups (see 2hpp figure 4.2 for trial 1). One possible reason for no reduction 
in BGL for the Ajwa group, could be due to the reduction of most polyphenols 
(natural antioxidants) at the tamar stage of the growth of dates (details 
mentioned in chapter 2) 
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In addition, the significant fall in 2hPP BGL for the D-NS found in this study also 
support the earlier study of Bamosa et al, (2010), who showed that 2hPP blood 
glucose level were affected by treatment with Nigella sativa seeds. Also in 
support of the above results, Najmi et al, (2012) demonstrated that Nigella 
sativa with 500 mg a day for 8 weeks had a significant effect on the 2hPP blood 
glucose in diabetic patients.  
5.2.2.3. Glycated Haemoglobin HbA1c  
The current study found a reduction in HbA1c levels in the D-NS group with a 
dose of 2g per day of Nigella sativa seeds after 12 weeks compared to the 
baseline (the starting value). These findings are consistent with many previous 
studies (Bamosa et al., 2010; Mohtashami et al., 2011; Najmi et al., 2012 and 
Hoseini et al., 2013), which found that Nigella sativa ingestion is associated with 
improvements in the HbA1c levels and that a Nigella sativa supplement could 
have a positive impact on patients with Type 2 diabetes, dependent on the 
doses and duration of treatment. According to Bamosa et al’s (2010) clinical 
trial analysis of 68 Type 2 diabetes patients, a study duration of 12 weeks taking 
a dose of 2g/day produced a significant reduction in HbA1c levels. They (ibid, 
2010) suggest that the effect of Nigella sativa seeds on the levels of insulin 
resistance may improve the function of B-cells leading to a reduction in HbA1c. 
In contrast, patients who followed a modified diet (D-D) or a supplemented 
modified diet with an Ajwa date (D-AJ), showed no significant change in HbA1c 
levels. Research on the Ajwa date is very limited and there is a lack of studies 
carried out on humans to test the effectiveness of the Ajwa date flesh and their 
effect. Thus, this study aimed to address this gap in research by using the Ajwa 
date flesh as a supplement to the modified diet for one of the control groups (D-
AJ).  
However, studies have been carried out to test the effect of Ajwa date seeds 
(e.g. Khalid et al., 2016) and their extracts (e.g. Baliga et al., 2011). Another 
such study was that of Hasan and Mohieldein (2016), who tested the effects of 
Ajwa date seeds extract on diabetic rats and demonstrated a significant 
decrease in blood glucose levels after 8 weeks at a dosage of 10 ml/day. The 
treatment also produced a significant decrease in the rats’ HbA1c levels as well 
as producing enhanced insulin levels and improving glycaemic control.  
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The part of the Ajwa date used in each of these studies is vital to consider. A 
possible explanation for the positive effects of the Ajwa date seed extract could 
be due to the presence of flavonoids and phytoconstituents, which could be the 
reason why Ajwa dates seeds had an anti-diabetic activity( Kalantaripour et 
al,(2012) and Said et al, (2014). Therefore, although the findings of this study 
show that there was no significant change in HbA1c levels for D-AJ, this could 
have been anticipated, since it could be seen to be in agreement with the 
conclusions of  previous research, which found a positive effect of the date 
seed/extract rather than the flesh. The findings of Khalid et al, (2016) also 
highlight that Ajwa date seeds contain more proteins, crude fat and crude fibre 
when compared to the flesh. 
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Summary  
In summary, when comparing all three diabetic groups, the D-NS group showed 
the most change in FBG and 2hPP. This could be because treatment with 
Nigella sativa may cause a reduction in gluconeogenesis in the liver, which 
leads to a decrease in FBG (Fararh et al, 2004). Moreover, a possible reason 
for the reduction in the FBG level and HbA1c in patients consuming Nigella 
sativa is that it may cause an inhibition in the intestinal absorption of glucose 
and this may lead to an improvement in glucose tolerance (Meddah et al, 2009). 
In addition, according to Alsaif (2008) and Abdelmeguid et al, (2010), Nigella 
sativa also has a beneficial effect on pancreatic B-cells as it causes an increase 
in blood insulin levels and lowers blood glucose levels.  
Furthermore, Ajwa dates seeds had more polyphenols (as form of antioxidants) 
than Ajwa date flesh (Khalid et al., 2016), which cause a decrease in oxidative 
stress, leading to a decline in FBG and HbA1c. Despite this fact, the FBG and 
the 2hPP levels of the D-AJ group remained constant. This could be due to the 
lack of adherence of participants to the recommended diet or not having an 
Ajwa on a daily basis. The limited amount of research on the effect of Ajwa 
dates on diabetes makes it difficult to speculate further on the reasons for this 
finding.  
Furthermore, another explanation for why the results of the D-AJ were 
significantly different from the other groups could have been due to the lack of 
compliance to modified the diet, and the participants in D-AJ not following the 
dietary intake of an Ajwa date daily. It can be difficult for the researcher to follow 
and understand the compliance of the participants throughout the study.  
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5.2.2.4.Blood Pressure (Diastolic and Systolic Blood Pressure) 
One of the major risk factors for Type 2 diabetes is hypertension, for this reason 
the participants’ blood pressures were measured on a weekly basis for the 12 
weeks of the study. There was a rapid fall in systolic blood pressure (SBP) 
between week 1 and week 12 for the Nigella sativa seeds diet group (D-NS). 
There was an initial fall in SBP from week one and week four results for both D-
D and D-AJ. These results changed significantly for all 3 groups over the 12 
week study period with P<.004. A possible reason for why this occurs could be 
as a result of the change from normal to the modified diet, but may have been 
masked by nutrients in the 2 supplements, or due to lack of compliance to the 
diet.  Furthermore, the D-D results for weeks 4,8 and 12 show a gradual rise, 
which possibly show that the initial change to a modified diet was good but that 
there was a gradual loss of effect or possibly due to the patients are not 
"sticking" to the diet.  
In contrast the Ajwa group showed a smaller fall but there was no subsequent 
rise. 
Interestingly the average diastolic blood pressure (DBP) rapidly declined in two 
groups, the D-AJ and D-NS, from week one (83 and 87) until week 12 (77 and 
79) respectively. However, there was a slight initial decline from week one (82) 
to week four (81) but then the average DBP for the modified group (D-D) started 
to rise in week 8(82) and fall again in week 12 (81) and did not change 
significantly. A possible reason for that could be because the modified diet had 
less effect on DBP. Moreover, those who consumed the modified diet plus Ajwa 
and Nigella sativa seeds showed a greater effect on DBP than those who only 
followed the modified diet alone.  
These findings support earlier studies that found a relationship between dietary 
intake of Nigella sativa seeds and reduction of blood pressure (SBP and DBP) 
(Dehkordi and Kamkhah, 2008; Elrehany et al., 2012; Fallah Hoseini et al., 2013 
and Najmi et al., 2013). Dehkordi and Kamkhah, (2008) randomly split 108 
patients suffering from mild hypertension, into 3 groups, using a double blinded 
clinical trial with 200 mg and 400 mg daily of Nigella sativa extract for 8 weeks. 
Despite the use of an extract of Nigella sativa seeds from northern Iran, and a 
difference in dose and duration to this study, they (ibid, 2008) also found that 
the intake of Nigella sativa extract had a significant decrease on blood pressure 
(P < 0.05).  
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More recent studies also support the positive effect of Nigella sativa on blood 
pressure. A clinical trial in Egypt by Elrehany et al, (2012) recruited 55 patients 
with coronary artery disease and dyslipidemia, who they treated with a dose of  
900 mg of Ns seeds daily for 8 weeks and found that there was a significant 
change in blood pressure (P <0.001). Furthermore, Najmi et al, (2013) suggest 
that the use of Nigella sativa seeds in patients with metabolic syndrome had a 
positive impact on blood pressure and concluded that following administration 
of NS seeds for 8 weeks at a dose of  500 mg daily, there was a highly significant 
decline (P<0.001) in blood pressure.  Despite the use of NS oil, the findings of 
Fallah Hoseini et al, (2013) are in agreement with the conclusions of Elrehany 
et al’s (2012) study. They (ibid, 2013) reported on the effect of NS oil on the 
blood pressure of healthy subjects in Iran, with 5 ml daily for 8 weeks, and 
showed a significant decrease in both systolic and diastolic blood pressure  
Elrehany et al, (2012) and Najmi et al, (2013) both used a dose of Nigella sativa 
seeds, 900 mg and 500 mg respectively, but Fallah Hoseini et al, (2013) used 
5 ml of the oil. When comparing studies that used seeds and oil, it is important 
to discuss key differences between these substances, which may have an 
effect. Firstly, oil is an extract from the whole seed so it will take more than 5g 
possibly 10 or more grams of seed depending on the percentage oil which can 
be extracted. Secondly, the difference in chemical composition between the oil 
and the whole seed could suggest that the active ingredient is not oil soluble 
and in fact exists in higher concentrations in the pulp left following oil extraction. 
Many researchers (for example El Tahir et al., 1993; Al Tahir and Ageel, 1994; 
Dogan et al., 2010 and Fallah Hoseini et al., 2013) suggest that the reason for 
the reduction in blood pressure in patients using Nigella sativa seeds, as part 
of a modified diet, is that the seeds contain anti-oxidants in the form of 
unsaturated fatty acids, such as oleic and linoleic acids and polyphenols 
(Mahmmoud and Christensen ,2011) 
Miura et al, (2008) conducted an international cross-sectional epidemiological 
study of 4680 males and females aged between 40 and 59 years, and 
compared the effects of macro and micronutrients on blood pressure. They 
conducted a 24 hour dietary recall for each person and found that linoleic acid 
was one of the main dietary polyunsaturated fatty acids (PUFA). Their 
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conclusions support the theory that including linoleic acids intake in a dietary 
plan may have a beneficial effect on controlling blood pressure.  
Among the reasons presented in the literature, for the lowering of blood 
pressure, are that Nigella sativa is a rich source of polyphenols and flavonoids, 
which have antioxidant activity, particularly thymoquinone, and also has free 
radical scavenging properties (Khattab and Nagi, 2007; Fallah Hoseini et al., 
2013). Another possible explanation for the improvement in blood pressure 
measurements, from studies using Nigella sativa oil, could be that the volatile 
oil present in Nigella sativa oil may cause a decrease in arterial pressure (El 
Tahir and Ageel, 1994). Based on previous studies by Khattab and Nagi (2007) 
and Fallah Hoseini et al, (2013) the findings of this study suggest that the 
reduction in blood pressure is due to Nigella sativa seeds being a rich source 
of antioxidant such as thymoquinone. 
Interestingly, the correlation between a decline in blood pressure and Nigella 
sativa seeds intake is reported to be related to a decreased angiotensin-
converting enzyme activity (Mohtashami and Entezari, 2016). In addition, 
Andriambeloson et al, (1998) and Khattab and Nagi (2007) reported that Nigella 
sativa is rich in flavonoids, which lead to an increase in nitric oxide, causing a 
fall in blood pressure. Furthermore, Jaarin et al, (2015) claim that treatments 
using Nigella sativa seeds may have an anti-hypertension effect on patients due 
to lowering of cardiac oxidative stress. 
On the other hand, there are several studies that found that there was no 
improvement in blood pressure using Nigella sativa (Najmi et al., 2007; Qidwai 
et al., 2009; Datau et al., 2010; Shah et al., 2012 and Ibrahim et al., 2014). A 
randomised clinical trial study by Najmi et al, (2007) of 161 metabolic syndrome 
patients given a daily dose of 5 ml of Nigella sativa oil for 6 weeks, found that 
there was no significant change in blood pressure. This could be because when 
comparing 5 ml of NsO with 2g of Nigella sativa raw seed it is important to note 
that the 5ml of oil is likely to have less effect than 2g of raw seeds. The reason 
for this can be explained as a result of the dose ratios between oils and the 
actual seed. If the density of the oil is assumed to be 1.0 then 5 ml is equivalent 
to 5g of seed if the yield of oil is 100% (i.e. the density of the oil is the same as 
the seeds). More realistically, the yield of oil from seed is approximately 30% 
(Gholinezhad and Abdolrahimi, 2014), thus 5ml of oil is equivalent to 
approximately 16g of whole seed, which suggests that as 2g of seed works, that 
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the oil is far less effective. A dose of approximately 16g would make the dose 
used in Najmi et al, (2007)’s study 250% higher than the dose used in this study, 
making it above the range of Nigella sativa that is recorded to be effective (as 
mentioned in chapter 2). 
Furthermore, Qidwai et al, (2009) conducted a study for the same duraion (6 
weeks) with 73 adults in Pakistan, who were randomly given 1g of Nigella sativa 
seeds daily. Despite the fact that Najmi et al, (2007) used 2.5 ml of Nigella sativa 
oil twice a day and Qidwai et al, (2009) used seeds, both found that there was 
no significant effect (P>0.05) on blood pressure over the same duration. 
It was later shown by Datau et al, (2010), that even at a longer duration, Nigella 
sativa seeds at a dose of 1.5 g/day did not reduce blood pressure. Datau et al 
,(2010) conducted a double blinded, randomised control trial on 39 obese men, 
to whom Nigella sativa seeds were given daily, for 3 months. At 3 months, the 
blood pressure levels were not significantly improved (p>0.05). Two years later, 
a similar study was done by Shah et al, (2012), whereby a clinical trial was 
conducted of 159 metabolic syndrome patients given 500 mg daily of Nigella 
sativa seeds for 6 weeks, and there was no significant difference in blood 
pressure. This is also consistent with the findings from another study involving 
37 randomly selected menopausal women (aged 50-55), who followed a diet 
including 1g of Nigella sativa seeds powder per day for 2 months (Ibrahim.R.M 
et al., 2014).  
The findings of this study contradict the findings of the above mentioned studies. 
Among the reasons for this could be the fact that none of the above studies that 
looked at the effect of Nigella sativa on blood pressure, used Type 2 diabetes 
participants. This is a very important factor to consider as one of the 
complications related to patients with Type 2 diabetes is hypertension. 
Therefore, any changes in BP would be more clearly observable in patients with 
Type 2 diabetes.  
Furthermore, another possible reason for the non-significant change in BP 
found in the previous studies, could have been because of the different doses 
of Nigella sativa used. This study used a dose of 2g/day of raw Nigella sativa 
seeds, which was higher than any of the doses used in the above mentioned 
studies. Therefore, the dose of Nigella sativa, may have an impact on the 
change in the BP.  
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In addition, another possible reason for the non-significant change observed in 
previous research could also be due the fact that in all of the previous studies, 
Nigella sativa was just added to the normal diet of participants rather than a 
modified diet. The findings of this study may differ from the results of previous 
research due to the fact that participants were instructed to follow a modified 
diet (for details see chapter 3) and the adherence to the modified diet of the D-
NS group was high. Therefore, the decline in BP may reflect the effect of the 
Nigella sativa seeds more accurately over the 12 weeks of the study. The 
findings of this study suggest that the use of a modified group alone (D-D) could 
cause a change in SBP. However, it would appear that the use of Nigella sativa 
seeds as a supplement to a modified diet had a greater impact on SBP when 
compared to just a modified diet alone.  
The DBP on the D-AJ group also decreased significantly. One of the reasons 
for this could be because Khalid et al, (2016) noted that Ajwa also contain 
antioxidant activity, polyphenols, flavonoids and antiviral activities. Khan et al, 
(2014) found that Ajwa dates have a phenolic component of 7.3 mg/kg and free 
radical scavenging activities, which could cause a fall in blood pressure in 
people who consume Ajwa dates.  
Khalid et al, (2016) also reported that Ajwa date flesh have a higher amount of 
potassium (4.8 mg/100 g) than Ajwa date seeds (4.7 mg/100 g). This is 
significant because most of the studies on Ajwa have used the seed or extract 
from the seed, whereas this study used the flesh of the Ajwa. Therefore, it is 
not surprising that the DBP for the D-AJ decreased significantly as this could be 
due to the higher level of potassium in the flesh when compared to the seed. 
In addition, Assirey (2015) reported that the Ajwa date is a rich source of 
potassium. Ajwa dates contain less sodium than potassium making the balance 
beneficial, which could be the reason for the improvement in blood pressure 
level of hypertension patients. Chang et al. 2006 reported that the balance of 
sodium/potassium (1/16) ratio is a very important aspect of a healthy diet, as 
well as a reduction in the salt intake, which should be less than (6 g/day) 
(Assirey, 2015). Du et al. 2014 claims that a balance of sodium and potassium 
intake is nutritional and health-wise the best option. They (ibid, 2014) state that 
this balance can be reached by adding high potassium foods to one’s diet (such 
as white beans, sweet potato, winter squash, milk, avocado, spinach and 
salmon).  
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The SBP remained consistently low in the Ajwa group (D-AJ), but there was no 
significant decrease in the SBP. A possible explanation for this, could be due to 
the different types of antioxidants activity present in Ajwa date flesh compared 
to Nigella sativa seeds. Another possible explanation could be due to the 
difference in concentration of antioxidant activity in Ajwa and Nigella sativa. If 
Ajwa dates have less antioxidant activity then it may explain why they have no 
significant effect on SBP. 
Moreover, the reduction in SBP for diabetic patients could be due to the 
decrease in BMI after consuming Ajwa dates for 12 weeks (see chapter 4, 
figures (4.3 and 4.4). 
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Summary  
The present study illustrates a significant improvement in the blood pressure of 
diabetic patients (p<0.05) in the Nigella sativa seeds 2g/day group (D-NS). In 
contrast only the DBP falls in those patients consuming Ajwa dates (D-AJ). 
However, there was no significant decline in the SBP and DBP in participants 
on the modified diet regime, indicating that the effects observed were due to the 
dietary supplements. Thus there might be significant nutritional advantages in 
including both these supplements in a modified diet. 
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5.3. Trial 2 (Healthy Subjects)  
5.3.1 Demographic and Lifestyle Data 
The demographic data illustrates that the healthy participants ranged in age 
from 20 to 60 years. Generally, the results of trial 2 show that the BMI of all 
healthy participants ranged from 18.61kg/m2  to 37.02 kg/m2  (with the average 
being 25.53 kg/m2 ) and that most of the healthy subjects were overweight. 
(Malik et al., 2013 and Memish et al, 2014), reported that an increase in BMI 
leads to an increased risk of obesity and a BMI of over 30 could increase the 
risk factors associated with type 2 diabetes. Despite the BMI level being higher 
in the Nigella sativa group (C-NS) when compared to the modified diet group 
(C-D), there was still a reduction in the FBG in the C-NS.  
There is a reduction in the BMI level at the baseline for the whole trial 2 group, 
after following the modified diet over the 12 weeks. However, the Nigella sativa 
group had the same modified diet plus 2g/day of Ns and showed a decrease in 
FBG over the 12 weeks.  
In trial 2, there was a reduction in weight for all healthy participants compared 
to the measurements at the baseline (See figure 4.18). Datau et al, (2010) 
mentioned that Nigella sativa (1.5 g daily for 3 months) caused a significant 
(P<0.001) reduction in body weight in obese men aged from 30 to 45 years. 
Similarly, Ibrahim et al, (2014), also reported that a dose of 500 mg of Nigella 
sativa seeds powder daily for 8 weeks, in women aged from 45 to 60, caused a 
slight decrease in the body weight but it was not statistically significant. 
However when the 8 weeks of dietary intake of Nigella sativa seeds powder 
was over, there was a dramatic increase in body weight (ibid, 2014). Moreover, 
Dehkordi and Kamkhah (2008) reported that there was no significant decline in 
body weight after treatment with Nigella sativa seeds extract with 100 mg and 
200 mg daily for 8 weeks.  
Previous research (Memish et al.,2014) has reported that a high BMI (being 
obese)  has a significant correlation with incidences of  Type 2 diabetes. 
Furthermore, Chen et al, (2013) also show that there is an increased risk of 
CVD in people with a BMI within the obese range. At the baseline 13% of the 
healthy volunteers were obese with a BMI > 30 kg/m2 , after 12 weeks of 
following a specific diet, the percentage of healthy subjects that fell within the 
obese range fell to 11% (see figure 4.19). However, 11% from the healthy 
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subjects need to manage their weight as they are at risk of developing type 2 
diabetes. 
Most of the healthy participants had a high level of education (72%), which was 
most likely due to the fact that healthy participants were recruited within close 
proximity to a university. This could explain why 77.3% of the healthy 
participants were active. Bassuk and Manson (2005), reported that being active 
could reduce the risk of having type 2 diabetes and cardiovascular disease. 
Sharaf (2013), found that a high level of education (university level) leads to an 
increase in awareness of physical activity. Midhet et al, (2010) reported that the 
level of high school education or lower of Saudi’s, leads to physical inactivity 
and an unhealthy dietary intake. However, the Saudi’s who had a high level of 
education (undergraduate and postgraduate) demonstrated a healthy dietary 
intake and were physically active Midhet et al., 2010. 
Within the trial 2 group, the BMI for the C-D appeared to decline after 12 weeks 
compared to the other 2 groups. This may be due to additional nutrients 
provided by supplement which obscured the fall in BMI which might have 
occurred.  
All of the healthy participants had good BMI which is probably the results of 
physical activity. This supports the findings of Hawley (2004) and Fareed et al, 
(2017) who concluded that being active had a significant effect on BMI. Previous 
studies (Hodge et al., 2004 and Mohan et al., 2009) have also mentioned that 
following a dietary plan including wholegrain, fibre and a reduced intake of red 
meat is associated with a decreased risk of type 2 diabetes. Furthermore, 
Muraki et al, (2013) also reported a relationship between a dietary intake of 
whole fruit, such as apple, blueberry and grapes and a decreased risk of type 2 
diabetes. 
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5.3.2 Discussion of individual parameters in healthy groups 
5.3.2.1 Blood Glucose Levels (FBG and 2hPP) 
There was an observable decrease in the FBG levels of the healthy participants, 
who followed the modified diet supplemented with 2g/day of Nigella sativa 
seeds (C-NS). This result supports the findings of a previous study by Bamosa 
et al, (1997), who examined the effect of 2g/day of Nigella sativa seeds on 
adults for 2 weeks and found a significant decline in FBG levels. This could be 
due to the mechanisms by which NS has its effect on the reduction of BGL as 
mentioned in the trial 1 (diabetic group) section. Furthermore, Mohtashami et 
al, (2011) mentioned that using a dose of Nigella Sativa oil (5ml) daily for 2 
months had a significant P(<0.05) effect on the FBG of healthy adults.  
However, in-group C-D, following only the modified dietary plan, and C-AJ, 
following the modified diet with an Ajwa date, a non-significant fluctuation was 
observed in glucose levels (fasting blood glucose, FBG) in healthy participants 
after 12 weeks. This could imply that the Ajwa dates do not have an effect on 
the FBG levels of healthy people. Moreover, another possible explanation for 
this finding may be a lack of adherence to the treatment or diet.   
The C-AJ results began significantly lower than the other 2 groups. The C-NS 
group values fell significantly but the end point was remarkably close to the 
values of the C-AJ group suggesting that the C-AJ was selected specifically 
rather than the volunteers being randomly assigned and that the AJ group were 
the healthy group with specific advantages compared to the other groups. Also 
the modified diet group showed no reduction in values but this group is also 
higher than any value observed in the other groups. Although there was a 
significant difference (P<.001) in the 2hPP blood glucose levels, between all the 
healthy groups, the Nigella sativa seeds group (C-NS) showed a rapid decrease 
in 2hPP but the modified diet (C-D) and Ajwa date (C-AJ) groups did not have 
a noticeable decrease in the 2hPP BGL. As discussed earlier in trial 1, this could 
be due to the active component (Thymoquinone), found in NS, which could 
reduce the BGL.  
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5.4.Trial 1 and Trial 2 
In this study, both the diabetic group (Trial 1) and the healthy group (Trial 2) 
had a fall in fasting blood glucose (FBG) from week 1 (8.10 and 5.5 mmol/L) to 
week 12 (7.34 and 5.1 mmol/L) respectively, with a significant decrease within 
both trial groups over the 12 weeks (P <.001). Furthermore, the difference in 
the mean of the 2hPP levels in the 3 groups of healthy participants was below 
8 mmol/L and the variation in the mean of the 2hPP levels in the 3 diabetic 
groups was above 8 mmol/L. This simply due to the fact that the healthy group 
already had a low value and hence any fall would probably be small i.e. as 
observed. 0.4mmol/L, whereas the diabetic groups began with an unhealthy 
high value which made it possible to have a large fall from the unhealthy high 
value to a normal value. However the fall is only to 7.34mmol/L which is still 
high but it is a fall of 0.8mmol/L. So in both cases the fall is approximately 
10% of the original value which may allow the statement that the fall in 2hPP 
is equivalent in both groups. 
 There was a significant decline in 2hPP levels over the 12 weeks within both 
trial 1 and trial 2 groups (P <.001). One possible reason for why there were 
different results in the FBG and 2hPP BGL could be due to the different places 
of recruitment (the trial 1 group was recruited in SA and the trial 2 group from 
the UK). It is expected that the healthy participants (Trial 2) being more active 
and having a lower BMI than the diabetic group (Trial 1), and therefore the 
results for the diabetic group should be more significant than those seen in the 
healthy group. It is important that being physically active and following a 
modified diet is more effective than following a modified diet alone. 
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Summary 
Generally, the healthy groups in trial 2 had a high level of education and 
physical activity that lead to a decrease in the BMI after 12 weeks of specific 
dietary intake. The Nigella sativa group for the healthy participants (C-NS) had 
a fall in FBG and 2hPP from week 1 to week 12. However, the modified diet 
alone (C-D) appeared to produce a statistically non-significant reduction in both 
parameters, FBG and 2hPP blood glucose levels, whilst the modified diet plus 
Ajwa dates (C-AJ ) started and finished at a level which did not change and was 
equal to the final value compared to the other 2 groups in this trial whose values 
fell but began higher than those of the Ajwa group and only fell to a level 
equivalent to the level of the Ajwa group. Suggests that the Ajwa date group 
were at the lowest achievable level throughout the study whilst the other two 
cohorts were initially abnormal and improved. 
There was a significant difference between the 2hPP levels of the three (C-D, 
C-AJ and C-NS) groups (p <.001).The reason for this is not understood and 
need further examination.  
Overall, it is clear from this study that the consumption of a supplemented of 
modified diet reduced FBG and 2hPP.Clearly the diabetic groups had 
significantly higher mean values of BGL than the healthy groups, which is in line 
with expectation, but although the diabetic group of volunteers were randomly 
assigned to the three test diets, it is clear that the means at week one are 
different between them 3 diet groups. Despite this, there was a significant 
decreased in FBG and 2hPP BGL in diabetic patients (trial 1) when compared 
with the healthy participants (trial 2).     
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5.5. General Discussion  
The aim of this study was to investigate whether a modified diet supplemented 
with either Nigella sativa seeds or Ajwa dates had an effect on markers of 
diabetic control. 
Recent research (Memish et al., 2014) has revealed that Saudi Arabia is one of 
the countries in the middle east with the highest incidences of Type 2 diabetes. 
As a result of the current global Type 2 diabetes epidemic, there is great interest 
in the contribution of dietary factors to the prevention of this disease. Some 
studies have shown that a plant based diet has proactive effects against the 
development of metabolic complications such as insulin resistance. These 
beneficial effects have been related to the presence of polyphenolic 
compounds, which possess a wide range of biological properties including 
antioxidant and insulin sensitizing activities. Additionally, growing evidence has 
demonstrated that diets rich in polyphenolic compounds may also regulate and 
improve glucose and lipid metabolism. Accordingly, diet modification 
programmes can be employed as an alternative approach to control the risk of 
Type 2 diabetes (Jung et al., 2006). In order to reduce the high prevalence of 
T2DM in SA, Albakr et al, (2013) proposed that diabetes clinics around the 
country should encourage patients to practice self-management and provide 
practical training for those who are poorly educated or illiterate. For example, 
providing the appropriate skills that help them to improve the glycaemic control 
by testing the blood glucose level at home. Furthermore, Tourkmani (2014) 
reported that there is a need to promote health education by publishing flyers 
and brochures about the risk factors of T2DM, thus improving general 
knowledge about diabetes type 2. 
Food environments could make a positive contribution to a healthy lifestyle 
(eating healthy) for type 2 diabetes patients. Larson et al, (2009) claim that 
people who had many choices of supermarket and fewer fast food restaurants 
in their neighbourhood had healthy intake habits and less risk of developing 
T2DM and obesity. In order to encourage Type 2 diabetic patients in the KSA 
to improve their diet and lifestyle, they should be encouraged to increase the 
intake of traditional Saudi foods such as, Harees, Hassawi rice, dates and 
Margoog, which are a rich source of iron, fibre and whole grains (Al-Mssallem, 
2014). The findings of this study suggest that the healthy traditional Saudi foods, 
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such as rice and whole grains (Al-kanhal et al., 1994 and Alhadd et al 2007) 
should be included in the diet of patients with Type 2 diabetes. Furthermore, 
being active for at least 30 minutes per day as well as providing a health 
education could also help to reduce the incidence of T2DM in SA and make an 
important contribution to the control of Type 2 diabetes, by reducing blood 
glucose levels. Sidawi et al, (2014) reported that by providing facilities such as 
gym centres, sidewalks and cycling lanes, the lifestyle habits of the Saudi 
population could be improved. 
There are numerous different sources of polyphenolic compounds, with fruits 
such as dates and plants such as Nigella sativa seeds being rich sources (Saleh 
et al., 2011; Rajab et al., 2013). Qadori, 2011 have shown that Nigella sativa 
has a beneficial effect on diabetes because it contains antioxidants (such as 
Thymoquinone) and has a hypoglycaemic effect and can reduce the risk of Type 
2 diabetes.  
Ajwa date is a soft dry fruit that grows on palm trees in Saudi Arabia (Al-Madina 
Al-Menawrah). Ajwa dates contain essential vitamins such as vitamin A, fibres 
and minerals such as phosphorus, iron, magnesium, and calcium. However, 
currently there is insufficient scientific evidence on the relevance of Ajwa dates 
as a beneficial dietary factor, with only few studies that show that it is a rich 
source of natural antioxidants (such as Phoenix dactylifera) (Saleh et al., 2011; 
Rahmani et al., 2014 and Rajab et al., 2013). Accordingly, in order to identify 
the significant effects of the Ajwa date, there needs to be further studies carried 
out on humans. An important point to beware of in designing such studies is it 
is normal to eat the flesh of the date not the stone but some workers have used 
ground stone or stone extract in their studies which complicates the problem. 
Studies should be separated into those which used date flesh and those which 
used ground stone or stone extract simply because of the biochemical 
differences between stones and flesh. There is now a drink based on ground 
date stones available in the SA which might be a useful source of the active 
ingredients present in the stone and of value to diabetic patients although the 
effects of preparation of the drink on the “active” ingredients has not been 
studied. 
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Ajwa dates have been used for many years, and many people have tried to 
grow them in different countries and different soils. However, the chemical 
composition for Ajwa dates is completely different to the original Ajwa dates that 
come from Al-madinah Al-menawrah due to the soil, geographic and other 
environmental factors. Ajwa dates are a rich source of fibre (soluble and 
insoluble) and, as mentioned in chapter 3, they were originally grown in Al-
madinah Al-menawrah but can now be grown around many Saudi cities. Only 
5% of the Ajwa dates on the market are grown in Al-madinah, 95% of AJ dates 
are grown in Haeel city, Qassium city, Makkah and Jeddah. Those grown in Al-
Madinah have a different chemical composition and smaller size compared to 
those from Haeel and Qassium. The variation in AJ dates depends on genetic 
variability among the cultivars (Ibrahim, 2013; Khalid et al., 2016). The date 
palm research centre of excellence in Saudi has the information for all types of 
dates around Saudi and the researcher can use it for their research. However, 
the consumers cannot tell by eye, which AJ is grown in al-Madinah. The AJ 
dates grown in al-Madinah can only be distinguished by the information 
provided on the food labels regarding where they are sourced. Thus, food 
labeling on AJ dates are an important to help reduce the adulteration of the 
dates available on the market.  
Nigella sativa is an herbaceous plant, the seeds of which have been widely and 
traditionally used in the Middle East, North Africa and India for the treatment of 
several illnesses such as asthma, coughs and fevers. Alherz et al ,(2012) 
concluded that Nigella sativa seeds have numerous nutritional benefits as they 
contain proteins, fats and carbohydrates. In addition, they are rich in potassium, 
phosphorus, sodium and iron but low in calcium and zinc (ibid, 2012). In this 
study the inclusion of Nigella sativa seeds in the diet appears to be beneficial 
and is therefore recommended. 
Nigella sativa seeds are grown around the world (Mediterranean countries, 
North Africa and Asia) and each have a different chemical composition, 
bioactive components, and biological activities due to environmental factors 
such as the soils and the plants’ genetic makeup. The variation in Nigella sativa 
within species is inherent by chemical traces (Dubey et al., 2016; Ahamad 
Bustamam et al., 2017). 
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Ajwa and Ns are both natural bioactive products, which contain a rich source of 
nutrients such as fibre, natural antioxidants, vitamins and minerals. Therefore, 
since the researcher did not extract a specific component from either of the two 
dietary supplements, all the possible mechanisms that could be responsible for 
the reduction in BGL should be discussed.  
One of the reasons why there may have been a reduction in the BGL could be 
due to the presence of soluble dietary fibre (SDF) and insoluble dietary fibre 
(IDF) in both Ajwa and Ns (as mentioned in chapter 2). Such fibres play an 
important role in reducing the absorption of glucose, which may have helped to 
control the BGL as Chandalia et al (2000) found that a high intake of fibre 
showed a positive impact on glycaemic control.  
Furthermore, soluble dietary fibre could be a possible reason for lowering the 
blood glucose and cholesterol levels in the body. The possible mechanism for 
lowering the blood glucose level is that after eating a meal that has a good 
source of soluble dietary fibre (SDF), the fibre β-glucan increases the viscosity 
of the small intestine in the gastrointestinal tract (GI), which could delay 
carbohydrate digestion. In turn, this helps to reduce blood glucose levels as the 
β-glucan slows down the glucose absorption (Lattimer and Haub, 2010). 
Moreover, the intestinal viscosity could reduce bile acid absorption and then 
increasing the bile secretion causing a reduction in LDL cholesterol levels. This 
effect occurs due to the soluble fibre interacting with bile acids.  
It has been conclusively shown that a daily intake of 5g β-glucan (soluble fibre) 
has a positive decline of 2 hour postprandial glucose, insulin and LDL 
cholesterol levels (Lattimer and Haub, 2010). The IDF helps people who are 
suffering from constipation due to the bulking effect of passing food quickly into 
the stomach and intestine (Threapleton et al, 2013). Furthermore, IDF helps 
people to control their weight (Burton-Freeman et al., 2017) while soluble fibre 
has a greater effect on BGL than insoluble fibre.  
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In addition, the presence of potassium in Ajwa dates could also be used to 
explain the results on blood pressure, as it has been found to have a positive 
impact on pressure in the arteries and blood vessels. NHS (2017) suggests that 
the daily average intake of potassium for an adult should be 3,500mg and that 
consuming certain foods that are rich in potassium (such as bananas, dried 
apricots, raisins, potatoes and Ajwa dates) could regulate blood pressure by 
improving kidney function. (Geleijnse et al, 2003). 
It is very important to control the blood glucose level and blood pressure 
because that helps to prevent kidney malfunction. Including potassium in the 
diet could be very helpful for diabetic patients to manage and keep the 
potassium levels normal and could prevent the development of low potassium 
levels (hypokalemia) and high potassium level (hyperkalemia), which could 
cause a heart attack (National Kidney Foundation, 2017). Regulating insulin for 
type 2 diabetes could also help to regulate potassium levels for diabetic 
patients. Reducing the insulin levels in diabetic patients could lead to increased 
potassium levels in the cells and in the blood (Nguyen et al., 2011). Diabetic 
nephropathy (DN) is a disease that is common in diabetic patients, who had a 
kidney malfunction and that is one of the diabetes complications. To reduce the 
risk of DN, potassium levels should be within a normal range (3.5-5.0 
milliEquivalents per liter (mEq/L).(Lim, 2014). 
One potential mechanism by which polyphenolic compounds could have 
beneficial effects on insulin sensitivity is by increasing nitric oxide (NO) 
production in the endothelium of the vascular system, which can increase tissue 
and organ blood flow and improve glucose uptake and metabolism (Quiñones, 
2003). Thus, increasing NO bioavailability may be associated with beneficial 
effects on insulin sensitivity and carbohydrate metabolism.  
The present results provide helpful guidance as to which are the most beneficial 
dietary factors that Type 2 diabetes patients can use to control their blood 
glucose. 
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Chapter 6 Conclusion  
6.1. Limitations of the Study 
6.2. Suggestions for Future Studies 
6.3. Conclusion 
6.4. Public Health Recommendations  
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6.1. Limitation of the Study 
The trials (diabetic and healthy groups) were conducted in different countries, 
hence the measurements were taken in different places, which could have 
caused a difference in results for trial 1 (diabetic) and trial 2 (healthy) subjects. 
It would have been better to have had the same clinic carry out all the 
measurements. In addition, the social, economic and cultural differences of the 
participants (from UK and SA) may also have had an effect on the results. For 
example, it was found that the healthy subjects were more active than the 
diabetic subjects. This could have been due to the fact that the healthy 
participants were all from the UK. The weather in the UK is different from that 
of SA, and as a result, the level of PA may have differed, as the lifestyle in the 
UK is generally much healthier. Furthermore, food portion sizes are larger in SA 
when compared to the UK, and eating habits differ, such as whole families 
eating from a single large plate in SA, making it difficult to measure a single 
portion of food. Therefore, compliance with the modified diet could have been 
better assessed, possibly through the use of a dietary sheet to make sure that 
all participants followed the same diet.  
Another limitation of this study was that the lifestyle questionnaire alone was 
not enough to measure the PA. Arm and waist circumference may have been a 
better method to observe this factor.   
Studies (Arredondo et al, 2012 and Sylvia et al, 2014) have found that devices 
such as armbands, heart-rate monitors, pedometers and accelerometers are 
among the many alternative ways to measure physical activity. In addition, there 
are other methods to measure the PA like self-report questionnaires, self-report 
activity diaries and direct observation. Some of these methods are difficult to 
get ethical approval, for example direct observation. However, after a pilot study 
of 15 participants who live in the UK, found that some of them found it difficult 
to write the activity type and time, and that they did not fill in the self-report 
activity diaries, the researcher decided to use a questionnaire. Therefore, a 
limitation of this study was that the assessment of the PA was not critical and 
accurate. For Saudi’s participants it was not useful for them to write the activity 
diaries.  
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In the future, the PA should be measured by  armband devices to be more 
accurate. The variation between the two cultures (KSA and UK) would also be 
a problem when using the self-report diaries to measure PA, because the two 
cultures are different and the 2 trials cannot be compared,as the devices for 
measuring PA would be different. For the validity and reliability should be all the 
analysis in the same lab.  
In the future, it would be better if the same clinic carries out all the clinical 
biomarkers and testing of all the participants. This could be a standardised 
methodology for both participants to make sure all the measurements have 
been addressed in the same clinic lab.  
This study could have been improved in a number of ways. Firstly, trial 2 
participants (healthy individuals) should have had their blood pressure 
measurements (DBP and SBP) and HbA1c levels taken in the same hospital (in 
the same way as the diabetic participants). This would have provided more 
information by which the two trials could have been compared. Secondly, in 
order to get a more accurate result, the trial 1 intervention groups (Type 2 
diabetic patients) should have all had a poorly controlled HbA1c level, for 
example 7+ %, rather than using any random Type 2 diabetes patients. Thirdly, 
there were more female participants than male participants in trial 1 and trial 2, 
thus resulting in a non-representative sample, which may have implications for 
the general conclusions of the study, as they may not apply to a group of only 
male participants. Fourthly, this study only addressed the blood glucose level, 
HbA1c and blood pressure of diabetic participants only. Finally, the participants 
from each of the trials were from two different countries (SA and UK). Therefore 
the measurements were not carried out for participants from both trials in the 
same place. It would have been better for the researcher to have recruited 
healthy participants who attended the same nutrition clinic as the diabetic 
participants, in order to be able to follow the measurement records from all 
participants. 
One of the possible limitations of this study is that there was no way for the 
researcher to measure patient’s compliance with the modified diet since 
patients did not provide feedback on their compliance with their prescribed 
diets. Therefore, future researchers of similar studies, may want to consider 
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methods to check compliance by using a biomarker of compliance such as 
blood or urine samples.   
6.2. Suggestions for Future Studies 
This study is the first of its kind to have reported on the effect of Ajwa on the 
BGL of Type 2 diabetes patients. There is a lack of scientific research on the 
benefits of the Ajwa dates on humans, thus further research is required. 
Furthermore, future studies in this field could also focus on establishing whether 
or not there are any observable benefits of Ajwa date seeds, since most studies 
on humans, including this one, only focus on the Ajwa date. Due to the lack of 
observable effects of the Ajwa date on BGL from this current study over the 12 
weeks, future research could investigate the impact of Ajwa date seeds on BGL 
in Type 2 diabetes patients. 
Another factor that future research in this field could consider, is to use Nigella 
sativa in different forms, such as in capsules or in the form of powder as well as 
the raw seeds, and measure its impact on BGL in Type 2 diabetes patients. A 
comparison between these different forms of Nigella sativa may help to broaden 
the understanding of which form of Nigella sativa is most effective.  
Moreover, several questions remain to be resolved with regards to the dose of 
Nigella sativa seeds that have the most observable effect on BGL of Type 2 
diabetes patients. A further suggestion for future research would be to 
investigate the effect of different doses of Nigella sativa such as 1.5g/day, 
2g/day and 2.5g/day on lipid and glucose profile in Type 2 diabetes patients.The 
reason for these suggested amounts is due to the fact that Bamosa et al (2012), 
studied the effects of 1g, 2g and 3g/day of Nigella sativa seeds, and found that 
1g/day had no significant effect on BGL, 2g/day had a significant effect and 
3g/day had no observable effect on BGL. Therefore, it may be beneficial to 
reduce the gap between the different doses from 1g (as in Bamosa et al’s (2012) 
study) to 500 mg in order to be able to see which dose of Nigella sativa  seeds 
has the most observable effect on BGL 
A suggested study design for this may include a randomised clinical trial of 90 
participants with Type 2 diabetes and a HbA1c level of  >7% (45 male and 45 
female). These 90 participants should be placed on a modified diet and divided 
into 3 equal groups (30 participants in each group -15 male and 15 female) 
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namely A, B and C. Each group should then be given one of the 3 doses of 
Nigella sativa seeds in the form of capsules (1.5g, 2g and 2.5 g) daily for 120 
days. BGL measurements should then be recorded weekly for each of the 
groups and HbA1c levels should be recorded at the start and end of the study.     
Finally, future research could also compare the impact of Ajwa date seeds with 
Nigella sativa seeds, in order to see whether there are any significant effects in 
the BGL of Type 2 diabetes patients. This is because there are currently no 
studies that have compared these two seeds.  
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6.3. Conclusion  
This current study aimed to determine the effect of dietary factors on blood 
glucose levels in healthy people and Type 2 diabetic patients by giving them a 
dietary supplement of either 1 Ajwa date per day or 2g/day of Nigella sativa 
seeds. In summary, Type 2 diabetes can be effectively controlled by taking 
medicine, applying dietary modifications and completing regular physical 
activity. As discussed previously, patients with Type 2 diabetes should follow a 
healthy diet and be active at home and outdoors as these lifestyle changes are 
important to consider to avoid the complications of the disease. In addition, 
there are many factors that can also contribute to the control of blood glucose 
levels, such as the awareness of Glycaemic Index (GI). Foods with a low GI are 
broken down at a slower rate by the body, so they are less likely to induce a 
sudden increase in blood sugar concentration, and are thus the most ideal foods 
to consume for those aiming to maintain stable blood glucose levels. 
Furthermore, eating a diet that is rich in fibre and has a low GI can reduce the 
risk of cardiovascular disease and diabetes. The combination of these factors 
can play a significant role in managing the condition and have an immensely 
beneficial impact on the lives of those suffering from Type 2 diabetes.  
The most obvious finding to emerge from this study is that consuming 2g/day 
of Nigella sativa seeds for 12 weeks, appear to be the most effective dietary 
supplement in order to help lower BGL levels (Fasting blood glucose (FBG), 
after 2 hours postprandial 2HPP and HbA1c) and blood pressure. Therefore, 
there is benefit in using traditional plant treatments from natural resources to 
aid in the management of the disease. Furthermore, daily supplementation of 
2g/day of Nigella sativa seeds for 12 weeks also lowered weight and BMI in 
both the control and intervention groups. The results from this project will 
provide helpful guidance as to what the most beneficial dietary factors are for 
controlling blood glucose levels in Type 2 diabetes patients. 
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6.4. Public Health Recommendation  
 
● Throughout the study, it was difficult to persuade the diabetic participants 
to be active outdoors due to the hot weather in SA. This suggests that 
there is a need to improve the education programme for diabetic patients 
in order to increase the awareness of the importance of physical activity.  
● All the diabetic patients should register at a local diabetes clinic and be 
educated in diabetes programmes.  
● Encourage the use of the treatments with traditional plants and herbs 
such as Nigella sativa seeds, which have a beneficial effect on the blood 
glucose levels of patients with Type 2 diabetes. 
● All Type 2 diabetes patients should  be given a list of traditional Saudi 
foods with their GI in order to help them to be able to easily identify 
healthy foods with a low GI so that they can control their BGL. 
● Increase the dietary intake of fibre, whole grains, and foods with low 
Glycaemic Indices (GI).  
● Encourage the recording of blood glucose levels using Self Monitoring 
Blood Glucose (SMBG) meters on a daily basis in order to impact dietary 
intake to help control the blood glucose level and improve the HbA1c. 
● Following a diet plan and changing lifestyle will be helpful for controlling 
the disease and prevent the complications that are related to Type 2 
diabetes. 
● Enhancing the awareness of risk factors and SMBG by increasing the 
health education programs in SA for diabetic patients. 
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Appendix 1 
Research Participants Information Sheet 
Study title: The control of type 2 diabetes with specific references to dietary 
factors  
Invitation Paragraph  
We would like to invite you to take part in a research study.  Before you decide 
you need to understand why the research is being done and what it would 
involve for you.  Please take time to read the following information carefully.  
Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
What is the purpose of this study? 
The primary aim of the current study is to investigate the regulatory effects of 
consumption of Ajwa date and Nigella sativa seeds on glucose levels in type 2 
diabetic patients. The secondary objective is to investigate whether these 
dietary factors may have potential beneficial effects in controlling diabetes 
complications and improving insulin sensitivity.   
What is the foods , device or procedure that is being tested? 
In this research I will test the first group in the UK and I divided into two 
groups: first group they have to be healthy and they will receive Ajwa dates, 
Nigella sativa and the second group (diabetic patients) will receive the same 
modified diet and dietary food. 
Why have I been invited to take part? 
You have been invited to join our study because I will investigate the benefit of 
Ajwa dates and other dietary intake such as Nigella seeds. Furthermore, many 
people will involve in this study to help diabetes patients.  
Do I have to take part? 
Your participation is voluntary. I would like you to consent to participate in this 
study as we believe that you can make an important contribution to the 
research.  If you do not wish to participate you do not have to do anything in 
response to this request.  We are asking you to take part in the research 
because the benefits from this study will help the diabetic to control the blood 
glucose level and we believe you can provide important participation to us that 
may be relevant to the evaluation of this study.  
You will be given a copy of this information sheet and your signed form to 
keep.  You are free to stop taking part at any time during the research without 
giving a reason. If you decide to stop, this will not affect the care you receive. 
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What will happen to me if I take part? 
If you are happy to participate in the research we will ask you to read this 
information sheet, sign the consent form and return it to us.  When we receive 
this a member of the evaluation team will contact you to discuss your 
participation in the evaluation.  At that point we can confirm your participation 
and make arrangements for you to meet the researchers.   
That the first group will take Ajwa dates, cherry, nigella seeds  for three 
months every day with modified diets and they can choose the amount of 
Ajwa dates 1 , I will bring that dates because it will bring Ajwa dates from 
Saudi Arabia. In addition, every week I will meet you and the blood test should 
take every week after 2 hours of eating dietary intake. According to blood 
glucose level test, the participants will test it by finger-picking devices and 
lancets, it gives us an accurate result of your blood glucose level. 
 
Figure 1: Ajwa Dates  
The second group (diabetic patients) will take, Ajwa dates and Nigella seeds  
every day for 12 week. In addition, home blood glucose test will do it twice a 
week.   
What are the possible disadvantages and risk of taking part? 
There is no risk of eating fruits. 
What are the possible benefits of taking part? 
The information you provide can contribute to the future development of the 
treatment  for diabetes type 2 and the result can help us to know which one of 
the following dietary intake is better for diabetes type 2 .  
However, we cannot promise the study will help you but the information we 
get from this study will help and improve the treatment of people with diabetes 
type 2. 
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What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. 
 
Will my taking part in the study be kept confidential? 
All information you provide to us will be kept confidential and we will follow 
ethical and legal practice.  Only members of the research team will have 
access to it.  
What will happen to the results of the research study? 
All information provided by you will be stored anonymously on a computer with 
analysis of the information obtained undertaken by the researcher based at 
Manchester Metropolitan University.   
Who is organising and funding the research? 
The sponsors of this study will pay Saudi Embassy (Ministry of High Education 
in Saudi) for including you in this study. 
Further information and contact details: 
Researcher: Reham Algheshairy 
Email: 10981715@stu.mmu.ac.uk 
Direct supervisor: Christopher Smith  
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Appendix 2 
CONSENT FORM 
Title of Project: The control of type 2 diabetes with specific 
references to dietary factors 
Name of researcher: Reham Algheshairy 
 
Please initial box 
 
1. I confirm that I have read and understand the 
information sheet dated……….. for the above study.  
I have had the opportunity to consider the 
information, ask questions and have had these 
answered satisfactorily.  I acknowledge the risks 
associated with the study and they have been 
explained to me. 
 
2. I understand that my participation is voluntary and 
that I am free to withdraw at any time without giving 
any reason, without my medical care or legal rights 
being affected. 
 
3. I agree to take part in the study. 
_______________________  ____________        ____________________ 
Name of participant  Date   Signature 
 
 
_______________________ ____________         ____________________ 
Name of person  Date   Signature 
taking consent 
When completed, 1 for participant; 1 for researcher site file; 1 (original) to be kept in medical 
notes 
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Investigation of the control of type 2 diabetes with specific references to dietary 
factors 
 
Hello everybody, 
My name is Reham Algheshairy and I am studying a PhD in Nutrition and Food 
Science at Manchester Metropolitan University, I am undertaking a piece of 
research work which is requires studying this diet and dietary factors on diabetic 
patients.  
This diet is designed to provide sufficient vitamins and 
minerals for good health .In addition, this diet has been 
designed to gather information to control blood glucose 
level on Saudi people with type 2 diabetes and those 
who are healthy people in the UK. 
All information provided during this study will be kept strictly confidential, and 
no information will be used for any other purposes other than those intended. 
 
 
Reham Algheshairy  
07453306855 
reham_goshiry@hotmail.com 
10981715@mmu.ac.uk 
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Name:___________________ Date of Birth:_______________ Current 
weight:_______             height:_________ 
Address:______________________________________________________
________ 
Contact number:_______________________ 
Section A: personal background information 
1.  Are you: (please tick one box) 
Male                   Female 
 
2. Age: 
18 – 30     31 – 40      41 – 50    Over 50 
 
3. Are you smoking  
Yes                    No 
 
4. Educational Status: 
Undergraduate        Post- graduate degree (i.e. Master and PHD                             
5. What is your marital status? 
Single 
Married  
Married with children 
Divorced 
Widowed 
Other: specify ---------------------------------------------------------- 
Section B: Lifestyle 
1. Do you smoke? 
 Yes                               No 
 
2. Do you do Physical exercise? 
 Yes                                No 
 
3. How often do you do physical exercise? 
Never        
Only during the holidays    
2 to 3 times a month             
Once a week                         
 2 or 3 times a week      
 4 to 6 times a week              
 Daily 
Section C: Diabetes people  
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1. Do you have a machine to measure your blood glucose level? 
 Yes                               No 
 
2. Do you test your blood glucose level? 
Daily         
Once a week 
2 to 3 times a week                                          
 4 to 6 times a week              
Monthly  
 
3. Do you take a pills for diabetes? 
 Yes                               No         Don’t know 
4. Do you get insulin injections? 
 Yes                               No         Don’t know 
5. Do you take pills for high blood pressure? 
 Yes                               No         Don’t know 
6. Do you take pills for cholesterol? 
 Yes                               No         Don’t know 
 
7. Age of diabetes onset? 
____________________         
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Appendix 4 
1600-1800 Calorie Diet Plan 
 
(A)Menu for breakfast: choose one option from group A 
 2 sliced brown toast 144  + cream cheese 2tbsp  + 1cup of low fat milk 330cals  
 1 slice of brown bread  144 + 55g or ¼ cup cottage cheese 50 + 1 cup of orange 
juice 360cals 
 2 tbsp of hummus + 2slice of brown bread  + 1 cup of low fat milk  355cals 
 1 boiled egg  + 2slice brown toast   +1 tomato  + 1cup of low fat milk 350cals 
 1cup semi-skimmed  milk  + ¾ cup of bran flakes cereal + 1 apple  200cals 
 1 cup of salad  + 2 slice of turkey smoked  + 2 slice of brown bread + 1cup semi-
skimmed  milk  100 = 342cals 
 1 Small chapatti  + 30 g of low fat cream cheese   + 1 apple 326 cals 
(B) Menu for lunch: choose one option from group B 
 1 cup of green salad  + 1 cup of brown rice  + grilled breast chicken 60 gram 
415cals 
 A cereal bowl of salad with dressing  + 1cup of pasta with tomato sauce with 
beef  468cals 
 1 cup of green salad with Italian dressing  + grilled fish 60g  + 1cup of rice  
485cals 
 2 slice of brown bread  + 1 cup of cooked beans with beef and tomato  + 1cup 
of green salad 609cals 
 60 g of grilled steak  + 1 cup of caesar salad  low fat dressing+ 1 slice of brown 
toast 500cals 
 1 cup of salad  + 1cup of okra with beef and tomato sauce  +2 slice brown 
bread  572cals 
 1 cup of salad  +1cup of jew’s mallow cooked with chicken  +1cup of rice  
445cals 
(C) Menu of Snack: choose one option from group C 
 One portion of fruit (apple or banana or handful of grapes or a slice of melon or small 
glass of fruit juice 
 One apple medium 116cals 
 Grapes 1/2cup 55cals 
 Banana 105cals 
 Pineapple 1 cup 113cals 
 Fruit salad (pineapple, banana, oranges, kiwi, melon, grapes) 1cup 125cals  
 Oranges 62cals 
 One Kiwi 46cals 
 Blueberries ¼ cup 21cals  
(D) Menu for diner: choose one option from group D 
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 1cup of Lentils soups  +2 sliced brown toast +  80 g green salad 310cals 
 6 ozSalmon grilled with lemon and olive oil  + 2 slice of wholegrain bread 
437cals 
 1 cup of vegetable soups + 2 slice of wholegrain  bread 332cals 
  2 cup of broccoli soup with low fat cream  With + 2-3 crisp breads 330cals 
 Tuna sandwich with salad + 1cup of vegetables soup + 10 g lemon 440cals 
 2cup of celery soup + 2-3 crisp breads + 1cup of corn 338cals 
 chicken sandwich with salad + 1 cup vegetables soup + 10g  lemon juice 
347cals  
(E) Menu for snack: choose one option from group E  
1. 4 Ginger biscuits + 1 glass of low fat milk 348cals 
2. 4 Oat biscuits + 1 glass of low fat milk 360 cals  
3. 4 Oat crackers + 1 glass of low fat milk 340 cals 
4. 3 wheat biscuits + 1 glass of low fat milk 295 cals 
5. 28 g of unsalted mix of nuts (almond, cashews, pecans, walnuts and peanuts) 
+ 1 glass of low fat milk  268 cals 
6. Slice one Apple + 1 tablespoon 16g of natural peanut butter 304 cals 
7. 25 unsalted pistachios+ 1 glass of low fat milk 263 cals 
Free food list (you can eat I whenever you like) 
 Sugar-free Gelatin 
 Coffee without sugar 
 Tea without sugar  
  Arabic coffee  
 Water  
 Lemon juice  
 Herbs, fresh or dried  
 Garlic  
 Vinegar  
 
Additional 600 Calorie for male only  
 
 Celery 60 gram with 1 tablespoon peanut butter  
 Sweet potato baked 2 small portion  
 1 slice of brown bread + 2 tablespoon hummus  
 1 slice of brown bread + 2 tablespoon baked beans with tomato sauce  
 1 bowl Red kidney beans with lemon and sweet corn salad  
 1 bowl rice noodles cooked with vegetables stir fry  
 1 bowl mix salad with potato +  1 tablespoon dressing low fat  
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Appendix 5 
 
Nutrition information: 
 This diet is rich in fiber, vitamins, minerals and low fat  
 You should eat a healthy diet high in fibre, fruit and vegetables and low 
in fat , salt and sugar. 
 It is very important to exercise regularly because physical activity 
decreases your blood glucose level. 
 Eating regular meals and including starchy carbohydrate at each meal  
 You should not skipping meals because that can help regulate your 
blood sugar levels  
 Starchy foods (Bread, chapatti, rice, pasta, breakfast cereals, potatoes, 
sweet potatoes and yam) at each meal will help stabilise blood sugar 
control  
 Limiting how much sugar and sugary foods are eaten  
 Reducing fat in the diet, especially saturated fats, due to increased risk 
of heart disease  
 Avoiding adding salt when cooking or at the table 
 Never drink on an empty stomach. You should always have something 
to eat before drinking  
 Do not count the carbohydrate in alcoholic drinks  
 Always have something starchy to eat whilst drinking alcohol or shortly 
afterwards e.g. crisps / sandwich. Occasionally, if you have drank over 
the recommended amounts a late night meal on the way home may be 
useful i.e. burger, chips, curry and rice.  
 Always have a starchy snack before going to bed even if your blood 
sugars appear normal  
 The Glycaemic Index (GI) is a scale that relates to the speed at which 
carbohydrate foods are absorbed. Low GI foods are absorbed into the blood 
stream slowly and high GI foods are absorbed quickly. Being aware of healthy 
low GI foods can help improve diabetes control. Choosing lower GI foods 
means your blood sugar levels will raise more slowly, avoiding high blood 
sugar readings. 
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Starchy foods (carbohydrates) 
Bread and chapatti, other cereals, (such as rice, pasta and breakfast cereals) 
and  
Potatoes 
• Try to use granary bread, basmati rice, pasta and high fibre breakfast 
cereals 
• Have foods from this group at each meal  
• Eat regular meals based on similar amounts of starchy foods each day  
• This will help to control your blood glucose level 
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Appendix 6 
List Below Any Changes For the participants: 
Week Changes in diet  Changes in 
weight  
Changes in 
blood 
pressure  
Change in  
Appetite 
1  
 
   
2     
3     
4     
5  
 
   
6  
 
   
7  
 
   
8  
 
   
9  
 
   
10  
 
   
11  
 
 
   
12  
 
   
Have you finished your meal? Yes or No   
Have you skipped any meals? Yes or No 
Appendix 7 
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Recording the Blood glucose level 
Week Dates  Blood glucose 
level (fasting) 
Blood glucose 
level after 2 hours 
of eating 
breakfast  
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
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Appendix 8 
Instruction for the participants 
Group 1(Modified diet) 
 You should choose one meal from each menu  
 You should avoid eat any sweets or soft drink 
 You can drink green tea or black tea without sugar or you can use 
alternative sugar. 
 You should avoid eat Ajwa dates  
Group 2(Ajwa dates+ Modified diet) 
 You should choose one meal from each menu  
 You should avoid eat any sweets or soft drink 
 You can drink green tea or black tea without sugar or you can use 
alternative sugar. 
 Avoid eat Nigella. 
 You should eat 1 Ajwa date between 7:00am and 12:00pm and you 
should eat it as a snack not with meal. 
Group 3(Nigella Sativa+ Modified diet  ) 
 You should choose one meal from each menu  
 You should not eat any sweets or soft drink 
 You can drink green tea or black tea without sugar or you can use 
alternative sugar. 
 You should avoid eat Ajwa dates. 
 You should eat 2g of Nigella with cup of milk low fat between 7:00am 
and 12:00pm and you should eat it as a snack not with meals. 
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Appendix 9  
Help a sister out by eating 
Nigella Seeds 
I am a PhD student at Manchester 
Metropolitan University and I am doing 
research on the effect of nigella seeds and 
measuring the Blood Glucose level by self-
monitoring weekly during three months. 
 The researcher will provide 2g Nigella 
seeds for each volunteer along 12 weeks. 
 Eating 2 g, Nigella seeds daily during 
three months. 
 Provide a modified diet (easy to follow) 
 Regular observation from the researcher 
 The researcher will provide self-monitoring 
for measuring blood glucose 
 Need 30 volunteers. 
If you need more information  
Contact me please 
Reham Algheshairy 
Mobile and what’s app number: 07453306855 
 REHAM.M.ALGHESHAIRY@stu.mmu.ac.uk  
 
Appendix 10 
 
 
210 
 
Help a sister out by eating 
Ajwa dates 
I am a PhD student at Manchester 
Metropolitan University and I am doing 
research on the effect of Ajwa dates and 
measuring the Blood Glucose level by self-
monitoring weekly during three months. 
 The researcher will provide Ajwa dates 
box from Al-Madina Al-Monawara for 
each volunteers. 
 Eating 1 Ajwa date daily during 12 weeks. 
 Provide a modified diet (easy to follow) 
 Regular observation from the researcher 
 The researcher will provide self-monitoring 
for measuring blood glucose 
 Need 30 volunteers. 
If you need more information  
Contact me please 
Reham Algheshairy 
Mobile and what’s app number : 07453306855 
 REHAM.M.ALGHESHAIRY@stu.mmu.ac.uk  
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Appendix 11 
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  .............................. الوزن الحالي : .....................الاسم: ............................. تاريخ الميلاد : 
 الطول : ........................... العنوان : .............................. رقم الهاتف او جوال : ...........................
 القسم الأول : معلومات شخصية
  : / هل انت1
  أنثى ○ ذكر             ○  
  / العمر : 2
  05فوق ال○  05-14○    04-13○   03-81○ 
  / المستوى التعليمي :3
  أخرى○ دراسات عليا ○ بكالوريوس ○ الثانوية ○ المتوسطة ○ 
 4/ الحالة الاجتماعية :
  أخرى ○ أرمله ○ مطلقه ○ متزوج ولديه أولاد ○ متزوج ○ أعزب ○ 
                                        
 القسم الثاني نمط الحياة:
  / هل انت مدخن :1
  لا ○ نعم              ○ 
  / هل تمارس الرياضة : 2
  لا      ○ نعم              ○ 
  / كم مرة تمارس الرياضة : 3
  إطلاقا لا امارس الرياضة○ 
  فقط في العطلات ○ 
  مرتين إلى ثلاث مرات في الشهر ○ 
  مرة في الاسبوع ○ 
  مرتين إلى ثلاث مرات في الاسبوع ○ 
  يوميا  ○ 
 
 
 القسم الثالث : لمرضى السكري
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  / هل لديك جهاز لقياس السكر في المنزل :1
  لا ○ نعم        ○ 
  / كم مرة تقوم بقياس مستوى السكر في الدم : 2
  يوميا ○ 
  مرة في الاسبوع ○ 
  مرتين الى ثلاث مرات في الاسبوع○ 
  كل شهر ○ 
  / هل تاخذ حبوب للعلاج من مرض السكري :3
  أحيانا ○ لا         ○ نعم        ○ 
  / هل تأخذ حقن الانسولين للعلاج من مرض السكري : 4
  أحيانا ○ لا        ○ نعم          ○ 
  / هل تعاني من ارتفاع او هبوط في ضغط الدم : 5
  لا    ○ نعم          ○ 
  / هل تأخذ حبوب للعلاج من ضغط الدم :  6
  أحيانا ○ لا          ○ نعم          ○ 
  / هل تأخذ حبوب للكوليسترول : 7
  أحيانا ○ لا           ○ نعم         ○ 
  / متى أصبت بداء السكري ؟ في عمر ........................... 8
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 31  xidneppA
 
 استمارة موافقة للإشتراك في البحث العلمي 
 
 
  عنوان البحث:
الحبة السودا وتمرة العجوة علي مرض السكر من النوع التحكم في مستوي الجلوكوز في الدم عن طريق تأثير
 الثاني 
     
 مكان إجراء البحث:
 مستشفي النور بمكه المكرمه
  
  ريهام محمد صالح الغشيري   اسم الباحث :
 
لقد قرأت استمارة القبول هذه وفهمت مضمونها. تمت الأجابة على أسئلتي جميعها. وبناء عليه فأنني، حرا 
 مختارا، أجيز إجراء هذا البحث و أوافق على الإشراك فيه، 
 وإني أعلم إن الباحث  وزملاءه ومعاونيه أو مساعديه سيكونون مستعدين للإجابة على أسئلتي، 
  صال بهم على الهاتف ___________ . وأنه باستطاعتي الات
كما أعرف تمام المعرفة بأنني حر في الانسحاب من هذا البحث متى شئت حتى بعد التوقيع على الموافقة دون 
 ان يؤثر ذلك على العناية الطبية المقدمة لي. أعلم أني سوف أحصل على نسخة طبق الأصل عن هذه الموافقة.
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  حرارية سعرة0081- _0061 ذات حمية
 
 
 
 التالية: الوجبات من واحدة وجبة إختيار يمكنك
  ) مساء ً 21 الى صباًحا 7 ( الإفطار وجبة (أ) 
 
  الدسم قليل حليب كوب + الدسم قليلة جبنة صغيرة ملعقة 1 + أسمر توست شريحتين •
  الدسم قليل جبنة شريحة + الطازج البرتقال عصير من كوب 1+ الأسمر الخبز أو التوست من شريحة 2•
 الحليب من كوب 1+ فول أو الحمص من كبيرة ملعقة  2 + أسمر رغيف ربع أو أسمر توست شريحة 2 •
  الدسم قليل
  الدسم قليل الحليب من كوب 1 + أسمر توست شريحة 1+ طازجة طماطم + مسلوقة بيضة 1 •
  تفاحة 1 + فليكس كورن أو نالشوفا حبوب من كوب ¾ + الدسم خالي حليب كوب 1 •
 من شريحة  + المدخن التركي من شريحتين  + ) خس - طماطم خيار ( اختيارك من السلطة من كوب 1 •
  الدسم خالي حليب كوب 1+ الأسمر التوست
  الدسم خالي حليب من كوب + تفاحة 1 + الدسم قليل الكريمي الجبن من +ملعقة فطيرة 1 •
 
 
 
  ) فقط واحدة وجبة اختيار يمكنك ( الغداء وجبة (ب)
 
  مشوي دجاج صدر من شريحة + الأسمر الرز من كوب 1 + الخضراء السلطة من كوب 1 •
 ( الباستا من كوب + زيتون وزيت بلسمك خل صوص ) طماطم + خس + جرجير ( السلطة من كوب 1•
  ) والصلصة المفروم اللحم مع معكرونة
  أبيض رز أو صيادية رز كوب 1+ مشوي سمك مجرا 07 + اختيارك من سلطة كوب •
 + خس + خيار ( اختيارك من الخضراء السلطة من كوب1+ اللحم مع الفاصوليا مرقة أو ايدام من كوب  1 •
  أحمر رغيف ربع + ) طماطم + جزر
 أو الأسمر التوست من شريحة 2 + اختيارك من سلطة من كوب 1 + مشوي لحم ستيك شريحة جرام07 •
  الأسمر فالرغي
 اللحم مع بامية ايدام أو مرقة من كوب 1 + ) فتوش أو خضراء سلطة أو تبولة ( اختيارك من سلطة كوب1 •
  الأسمر الخبز من رغيف ربع + الدجاج أو
  رز كوب 1 + الدجاج مع الملوخية من كوب 1 + اختيارك سلطة كوب 1 •
 
 
 
 ) العشاء و الغداء بين ( : السناك وجبة (ج)
  ) الفواكه من واحدة حصه يعادل ما واحد اختيار كنكيم ( 
 تفاح 1 •
  العنب من كوب  ½ •
  موز 1 •
  برتقاله 1 •
  الأناناس من كوب •
  ) كوب ١ ( سكر بدون مشكلة فواكه سلطة •
  كيوي •
  كوب) ٤/١( البري التوت •
 
 
  ) يومًيا فقط واحدة وجبة اختيار يمكنك ( العشاء وجبة (د)
  جرجير + أسمر رغيف ربع + العدس شوربة من كوب 1 •
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  نخاله رغيف ربع + الخضار شوربة كوب 1 •
  الدسم قليلة سايلة جبنة ملعقتين + نخالة شابورة 2 •
 الدسم قليلة الكريمة مع البروكلي شوربة من كوب 1 •
  اختيارك من خضروات مع تونه سلطه كوب 1 •
  الصاج على دجاج شاورما •
 نخاله رغيف ربع + الخضار شوربه •
 
 ) يومًيا فقط واحدة وجبة اختيار يمكنك ( العشاء بعد خفيفه وجبه (ز)
  الدسم قليل حليب كوب + الزنجبيل بسكوت من حبات 4 •
 الدسم قليل حليب كوب + النخالة بسكوت من حبات 4 •
 فستق) ، كاجو (لوز، مملحة الغير المكسرات من جرام 82 •
  القمح بسكوت من حبات 4 •
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 الغذائية الحمية تعليمات
 الملح: تناول من لحدا
الإكثار من تناول الملح يسبب احتباس الماء في الجسم، مما يؤدي إلى ارتفاع ضغط الدم الذي يعد من أهم 
مسببات مرض السكر. لذلك يجب مراعات كمية الملح المضاف أثناء الطهي بالإضافة الى تجنب إضافة الملح 
  لطعام السريع. المائدة. يتوجب أيضا الابتعاد عن تناول الأطعمة المحفوظة والمعلبة وا
 الصحية: بالألياف الغنية الأطعمة تناول على الحرص
 هناكو الإمساك. تمنع أنها الى بالإضافة الدم. في والدهون (السكر) الجلوكوز نسبة معادلة على الألياف تساعد
 مثل: بالألياف الغنية الأطعمة من العديد
 الكاملة، الحبوب من المصنوع والخبز مقشور الغير البني الأرز والشعير الكامل والقمح النخالة -1
 والعدس. والبازيلاء المجففة الفاصوليا مثل البقوليات الى بالإضافة
 عصرها عن والابتعاد مبالغة بغير المطبوخة أو مطبوخة الغير النية خاصته والفواكه الخضار -2
 وتقشيرها.
 الدهون: في العالية الأطعمة من الاقلال
 مرض عن تنتج التي الأمراض أكثر من وهي والشرايين القلب أمراض إلى يؤدي الدهون تناول من الاكثار إن
 يجب: لذا خطيره، تعتبر التي السكر
  الطيور.و الاسماك بلحوم وأستبدلها الدهون مستوى في العالية خاصة الحمراء اللحوم تناول من التخفيف •
 أو السمن مثل الطهي عند الدهون إضافة وتجنب الطهي قبل الطيور وجلد اللحم من الدهون بإزالة قم •
 /مارجرين. والصناعي الطبيعي والزبد الزيت
 من دلاً ب البخار أو الفرن في الخبز أو الشواء مثل الدهون إضافة الى تحتاج لا التي الطبخ طرق أستخدم •
 القلي.
 صلصة/"سوس". أو الزيت مثل الدهون بإضافة تقوم لا الطعام تقديم عند •
 والسجق. والنقانق الباردة واللحوم المقالي مثل بالدهون الغنية لأطعمةا تناول تجنب •
 الدسم لخاليا أو القليل الحليب تناول كذلك الدسم المنزوع أو القليل والجبن كريم الآيس من القليل تناول •
 الدسم. الكامل الحليب من بدلاً 
 الرياضية: ممارسة
 سمالج لصحة مفيدة انها كما بالدم. السكر معادلة انخفاض/ الى تؤدي يومي أو مستمر بشكل الرياضة ممارسة
  الجسم. في الزائدة الدهون من والتخلص والقلب
 وا الخبر مثل الرياضية التمارين قبل الكربوهيدرات تناول على الحرص يجب السكر مرضى من كنت إذا
  اللبن. أو ةالطازج الفاكهة او البسكوت
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 عامة ونصائح تعليمات
 ثلاث الأقل، على اليوم في وجبات 5 استهلاك مراعات السكر مرضى على يجب بالدم، السكر مستوى لتنظيم •
  خفيفة. وجبة واثنان رئيسية منها
 طعامك. قائمة في صنف أي استبدال حال في المرفقة البدائل بقائمة الاستعانة يجب •
 يوميا.ً منتظمة أوقات في وجباتهم يتناولون أن عليهم يتوجب الأنسولين يتناولون الذين المرضى •
 بحميتك ريض مما تليها التي الوجبة في أكبر بكميات تعويضها إلى يؤدي اليومية وجباتك لإحدى تناولك عدم •
 بالدم. السكر مستوى انتظام عدم إلى ويؤدى
 الوجبات. بين بوفرة الماء تناول على الحرص يجب •
 
 الغذائية: بالحمية الالتزام تستطيع كيل نصائح
 وتحضيرها. للوجبات المسبق التخطيط •
 صغيرة. لقيمات وتناول وببطء جيداً  بشكل الطعام مضغ •
 المستهلك. الطعام كمية تقليل على يساعدك اكي صغيراً  طبقاً  استخدام •
 الطعام. من بيرهك كميات تناول الى يؤدي ذلك لان غيره أو التلفاز مشاهدة مع الطعام تناول عدم •
 مرضى بيناس "للحمية" عليه كتب منتج كل فليس شرائها قبل السوبرماركت في المعلبة الأغذية مكونات أقرأ •
 رالسك من خال أنه يعني لا ولكن السكر أو الدهون أو الملح مستوى في منخفض يكون ان الممكن من السكر،
  الحرارية. السعرات أو
 حراري سعر 02 من أقل على منها الواحدة الحصة تحتوي والتي بالحمية الخاصة الأغذية تناول يمكنك •
 يوميا. حصص ثلاث بحدود
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Appendix 16 
Table 3.1: Time schedule for Diabetic participants (Intervention groups) 
 Minutes  
Induction and general question 3-4  
Sign the Consent form and 
Applying questionnaire  
2-3 
Anthropometric measurements 
(weight and height) 
5-8  
Reviewing the blood profile and 
measurements for BP, FBG, 2hPP 
andHbA1c 
2-4  
Total  20 -25  
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Appendix 17  
Table 3.3: Time schedule for healthy groups 
 Minutes  
Induction and general question 3-4  
Sign the Consent form and 
Applying questionnaire  
2-3 
Anthropometric measurements 
(weight and height) 
5-7  
Measuring blood glucose level by 
monitoring  
3-4   
Total  15 -20 
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Appendix 18  
Recording for replacing the tubes for Nigella sativa  
Week Dates  Replace the 
Nigella sativa 
tubes. 
Blood glucose 
level after 2 hours 
of eating 
breakfast  
Week 0 to week 1    
Week 1 to week 4    
Week 5 to week 8     
Week 9 to week 
12 
   
  
 
 
 
 
 
